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In C. elegans, the combined actions of trans-splicing, 3’ end formation and inhibition of 
transcription termination by RNA polymerase II (Pol II) are necessary to generate monocistronic 
transcripts from primary polycistronic transcripts. However, how these processes are regulated to 
create functional monocistronic units out of polycistronic transcripts is poorly understood.  
From a global perspective, certain transcripts are trans-spliced to either SL1, SL2 or both. 
The genes encoding SL1 trans-spliced transcripts have longer distances between the trans-splice 
site and the nearest upstream gene, and also have evidence of promoters adjacent to the trans-
splice sites. The converse is true for genes encoding SL2 trans-spliced transcripts. These 
properties demonstrate that the genes of SL2 trans-spliced transcripts are located within operons. 
The transcripts that are trans-spliced to a mixture of SL1/SL2, share features of both the SL1 and 
SL2 groups. These transcripts can be produced from two promoters: an operon promoter and an 
adjacent promoter. 
Using a unique mutation within a C. elegans operon that alters transcription termination, 
I demonstrate that, cids-1 and cids-2, proteins that bind to Pol II and, SRp20, known as an 
alternative splicing factor have effects on operon transcription.  In this context, Both CIDS-1 and 
CIDS-2 are able to enhance 3’ end formation. In the same context, SRp20 enhances either 
transcription termination and/or RNA degradation downstream of the 3’ cleavage site. These 
proteins may have similar roles in 3’ end formation and transcription termination in other genes 
and organisms as they are conserved across species.  
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CHAPTER 1 
Introduction 
 
 
 
C. elegans 
 C. elegans, a nematode, is a 
popular research model organism for 
several reasons. First, the life cycle of 
C elegans is short. At the typical 20⁰ 
C growing temperature, it takes only 
three days for a fertilized egg to 
become a 1 mm adult capable of 
producing progeny (Figure 1). 
Second, the worms are able to produce 
~300 progeny in a three day span. 
Additionally, C. elegans is a primarily 
hermaphroditic organism, though C. elegans hermaphrodites are unable to mate with other 
hermaphrodites. The hermaphroditic nature of C. elegans results in large genetically similar 
populations that can reproduce quickly, which is of great benefit to the researcher. 
Males are present in the C. elegans population, but at a very low level (0.2%). In general, 
males are caused by the loss of one X chromosome (Zarkower 2006). Hermaphrodites have two 
X chromosomes, while males are XO animals. When XO males mate with a hermaphrodite, ½ of 
the resultant progeny is male (Ward and Carrel 1979).  The presence of males in C. elegans is 
Figure 1: C. elegans is a small useful organism.  
Left, two larva, one at L4 is nearly as large as an adult. 
The other is much younger. Right, a embryo next to an 
adult head. 
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important for creating double mutants and for back crossing mutations to remove other nearby 
lesions  
Another reason C. elegans is a useful organism is because it is very amenable to RNAi 
screens (Andrew G. Fraser et al. 2000; Ravi S. Kamath et al. 2003). In most RNAi susceptible 
model organisms, RNAi is performed with siRNAs, or other time consuming or costly 
experiments. In C. elegans, the worms will ingest bacteria producing a double-stranded RNA. 
Within the worm, the double-stranded RNA is propagated, amplified, and used for RNAi, 
thereby reducing the expression levels of the gene that was targeted by RNAi (Sijen et al. 2001). 
A feeding library containing ~90% of C. elegans genes has been created for use in RNAi screens 
(Kamath et al. 2003). RNAi screens of the majority of the genome, such as the one described in 
Chapter 4, are relatively simple and commonly used (S. S Lee et al. 2002; Hamilton et al. 2005). 
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C. elegans mRNAs 
 
Figure 2: C. elegans Operon Transcription and Processing.  
Many steps are involved in the creation of monocistronic mRNAs functional for translation. 
Figures similar to this are used throughout the introduction. At the top of the figure the blue line 
shows a two gene operon encoded in the DNA with a single operon promoter indicated by the 
blue arrow. The first (5’) gene’s exons are represented by three pink boxes and the second gene 
two yellow boxes. Pol II (the blue circle with a blue tail) transcribes the entire operon into single 
polycistronic pre-mRNA indicated by the black line and colored exon boxes. Numbered black 
arrows below the pre-mRNA indicate the site and type of processing event used to create the 
monocistronic mRNAs from the polycistronic pre-mRNA. To create monocistronic units the 
polycistronic pre-mRNA must be processed by 1) trans-splicing 2) cis-splicing and 3) 3’ end 
formation.  
 
The diagram above depicts processes that create a functional mRNA in C. elegans. Many 
molecular events must be coordinated to create a functional mRNA including: transcription 
initiation, elongation, splicing, and 3’ end formation and transcription termination. In C. elegans, 
RNA processing is even more complex because not all transcripts are stand-alone monocistronic 
units. The processing reactions used to create monocistronic units are the main focus of this 
thesis.  
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Figure 3: Diagram of the process of transcription of an operon.  
Pol II initiates at the promoter at the 5’ end of the operon and transcribes the entire operon, 
creating a polycistronic pre-mRNA.  
 
Transcription  
Creation of a functional mRNA begins with transcription. RNA Polymerase II (Pol II), a 
multi-subunit complex, transcribes pre-mRNAs in three steps: initiation, elongation and 
termination. In initiation, Pol II binds the promoter, which is located upstream of the gene, and 
begins transcription of a pre-mRNA. In elongation, Pol II moves along the DNA while adding 
nucleotides to the 3’ end of the growing RNA chain. Finally, in termination, Pol II is either 
released or removed from the DNA and is free to begin the process of transcription again.  
The three steps of transcription are accompanied by several co-transcriptional RNA 
processing events including capping, splicing, and 3’ end formation. Capping, the addition of a 
guanosine triphosphate to the 5’ end of the RNA, occurs during the initiation phase of 
transcription. Splicing, the removal of introns from the pre-mRNA, generally occurs during the 
elongation phase of transcription. Finally, 3’ end formation, the cleavage of the pre-mRNA at the 
3’ end of the transcript followed by the addition of a polyA tail, occurs just before, and is linked 
to, the termination of Pol II. 
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 The largest subunit of Pol II (RPB1) has a C-terminal Domain (CTD) that acts as a 
―landing pad‖ for many of the co-transcriptional processing factors (Phatnani and Greenleaf 
2006).  The CTD is conserved across eukaryotes and is comprised of 26-52 heptad repeats (42 in 
C. elegans) of the YSPTSPS amino acid motif (Stiller and Hall 2002). Which proteins bind the 
CTD is influenced by modifications of the CTD itself. For example, the heptad repeats undergo 
changes in phosphorylation of the serines (A. Meinhart 2005). The serine in position 5 (Ser-5) is 
highly phosphorylated when Pol II is near the 5’ end of the gene being transcribed, while the 
serine in position 2 (Ser-2) is highly phosphorylated when Pol II is near the 3’ end of the gene 
(Phatnani and Greenleaf 2006). Although some co-transcriptional processing factors stay bound 
to the CTD throughout transcription, many proteins bind only when needed because they are 
sensitive to changes in the phosphorylation pattern of the repeats (Glover-Cutter et al. 2007; 
Hyunmin Kim et al. 2010).  For illustration some capping factors may bind to Pol II only as it is 
transcribing the 5’ end of the mRNA and some 3’ end formation factors may bind to Pol II only 
as Pol II transcribes the 3’ end of the mRNA. Therefore, the CTD ties the 3 steps of transcription 
to the processing of the RNA. 
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Figure 4: Diagram of splicing. Bottom half depicts a polycistronic pre-mRNA with a 
spliceosome binding over the introns.  
The spliceosome consists of balls representing proteins (blue) and RNAs (red). The boxes in 
upper contain representations two steps within splicing: on the left A complex and on the right B 
complex. The 5’ end of the downstream exon and the 3’ end of the upstream exon are brought 
together by the RNAs and proteins of the spliceosome.   
 
Splicing 
As Pol II travels down the length of a gene it transcribes the pre-mRNA including 
introns, non-coding sequences which must be removed before translation. The spliceosome, a 
large macromolecular complex, binds to the pre-mRNA and removes the intron, splicing the two 
exons on either side of the intron together. Meanwhile the intron becomes a lariat that is 
efficiently degraded. In higher organisms, most genes contain at least one intron, and many 
contain several. Therefore, on many genes the process of splicing is often completed multiple 
times per pre-mRNA. Splicing is required for nuclear export, stability and translation of the 
mRNA. 
Introns are defined by three sequence-specific regions necessary for splicing: the 5’ splice 
site, located at the 5’ exon-intron boundary; the branch point, located just upstream of the 3’ end 
of the intron; and the 3’ splice site, located at the 3’ intron-exon boundary. During splicing, the 
pre-mRNA splice sites and branch point are bound by components of the spliceosome that 
function in a highly stereotyped manner to remove introns.  
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The pre-mRNA 5’ and 3’ splice site consensuses sequences in C. elegans are very similar 
to vertebrate splice sites (reviewed in Blumenthal and Steward 1997a).Virtually all introns begin 
with a GU and end in an AG. The C. elegans exon-intron junction at the 5’ splice site has a 
consensus of AG|GURAGUUU, identical to the multiple-organism consensus (Blumenthal and 
Steward 1997a). The C. elegans intron-exon junction of the 3’ splice site has an extended 
consensus of UUUUCAG|R in comparison with the multiple-organism consensus YAG|G 
(Blumenthal and Steward 1997a). However, the C. elegans splice consensus is still similar and 
should be functional in other organisms. The 5’ and 3’ consensuses sequences are well conserved 
but they are not obligatory, since variants at both splice sites occur and are spliced (Farrer et al. 
2002; Aroian et al. 1993). 
The pre-mRNA branch point is an important site for lariat formation when splicing an 
intron. In humans and yeast, the branch point is a single adenosine located upstream of the 3’ 
splice site (Padgett et al. 1984; R Reed and Maniatis 1985; Fouser and Friesen 1986; Jacquier 
and Rosbash 1986). The branch point is found in the context of a branch-point consensus 
sequence and just 5’ of a polypyrimidine tract. In C. elegans, the branch point is also likely an 
adenosine since alignments of introns show a peak of adenosines between -16 and -18 from the 
3’ splice site. However, the branch point has no consensus sequence. The 4 U’s within the 
extended 3’ splice site are the only recognizable polypyrimidine tract, and these U’s are bound in 
C. elegans by the protein that binds the vertebrate polypyrimidine tract, U2AF65 (Hollins et al. 
2005).  
There are two other interesting intronic features in C. elegans that are of relevance to 
splicing. First, C. elegans introns tend to be shorter than yeast or vertebrate introns. The median 
intron length is 57bp (Choi and Newman 2006). Second, like plants and unlike humans, C. 
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elegans has introns that are very AU rich (~70%) in comparison with their nearby exons (~54%). 
The AU rich nature affects splice site selection in both plants and worms (McCullough and 
Schuler 1993; R Conrad et al. 1993b).  
During splicing, the spliceosome machinery must recognize and bind to the 5’ and 3’ 
splice site sequences and the branch point.  The spliceosome is one of the most complex and 
active macromolecules of the cell, containing 5 RNAs and over 150 proteins that collaborate in 
the removal of introns. The 5 RNAs (U1, U2, U4, U5, and U6) of the spliceosome have stem 
loop structures and sequences for binding to the pre-mRNA and to each other through base 
pairing. The RNAs exist in small nuclear ribonucleoproteins particles (snRNPs), where they are 
associated with proteins that facilitate the reactions and protect the RNAs (Bringmann et al. 
1983; Séraphin 1995). 
Several intermediate complexes (E, A, B, C) are detected during the splicing reaction. 
They are defined by their RNA and protein components and the order in which they appear 
implies an order of reaction (Wahl et al. 2009).  In E complex (early/commitment), U1 is base 
paired to the 5’ splice site, likely as the RNA exits Pol II just after being transcribed. Soon after, 
Branch Point-Binding Protein (BBP, homolog SF1) interacts with the branch point, U2AF65 (U2 
auxiliary factor 65) binds to the polypyrimidine tract associated with the branch point, and 
U2AF35 (U2 auxiliary factor 35) binds to the AG sequence of the 3’ splice site. During this step, 
U2AF35 and U2AF65 are tightly coupled. Next, in the A complex, U2 snRNP is bound to the 
branch point sequence in a step that requires ATP. The interaction is stabilized by SF3a, SF3b, 
and U2AF65. Consequently, U2 snRNP binding is accompanied by the displacement of 
SF1/BBP. Then, in the B complex, the U4/U6.U5 tri-snRNP is recruited (contains U4/U6 and U5 
snRNPs). For the first time all the splicing snRNPs (U1, U2, U4, U5, and U6) are present but the 
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complex is catalytically inactive because it requires rearrangement. The complex rearranges, 
releasing U1 and U4, and creating the configuration needed for the C complex. The C complex 
catalyzes two transesterification reactions. In the first, the 2’ OH of the branch point adenosine 
performs a nucleolytic attack on the phosphodiester bond of the 5’ splice site. The 5’ exon is 
released and the lariat forms. Again the complexes rearrange and in the second transesterification 
the 3’ OH of the free 5’ exon attacks the 3’ splice site. The lariat is released with U2/U5/U6 
remaining bound to it while the exon-exon junction is ligated. 
Many different proteins play key roles in splicing. Some act in the process of splicing 
while others facilitate correct splice site choice, especially in situations where alternative splice 
sites are available. Alternative splicing is the variable inclusion or exclusion of some exons from 
an mRNA and can possibly change the function of the produced protein. There are many 
varieties of alternative splicing such as: mutually exclusive exons, alternative 5’ splice site 
choice, alternative 3’ splice site choice, intron retention, and exon skipping.  
How is alternative splicing accomplished? First, the speed of polymerase is a factor in 
alternative splicing because at the time of splicing only splice sites that have been transcribed are 
available to splice (de la Mata et al. 2003). For instance, if a transcript has two possible 3’ splice 
sites that might pair with a single 5’ splice site, a slow polymerase might only transcribe the first 
3’ splice site, forcing one pattern of splicing, whereas a fast polymerase might transcribe both 3’ 
splice sites allowing another pattern of splicing. Second, alternative splicing can be affected by 
RNA binding proteins binding to the pre-mRNA, either blocking or enhancing splicing of a 
particular splice site. SR proteins are one class of these RNA binding proteins.  
SR proteins are needed for viability and are involved in splicing, both constitutive and 
alternative. Additionally, SR proteins have many other functions including enhancing nuclear 
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export and translation. SR proteins are named for their most important structural feature- RS 
domains, which are comprised of many serines and arginines. At least one role of RS domains 
seems to be to promote interactions between two proteins, both of which contain RS domains 
(Amrein 1994). For example, SRp20 and Cleavage Factor 1 (CF1m) interact through their RS 
domains (Dettwiler 2004).  Interestingly, SRp20 was discovered in our screen that uncovered 
genes involved in 3’ end formation (Chapter 4). It is possible that, similar to another SR protein 
(SRm160) (McCracken et al. 2002), SRp20 may sometimes be a link between splicing and 3’ 
end formation (Chapter 4).  
Aside from its involvement in splicing--a function common across organisms— SRp20 
plays roles in a number of other cellular processes. In particular, SRp20 has been implicated in 
polyadenylation in the Rous Sarcoma Virus (Maciolek and McNally 2007), IRES function in 
picorna viruses (Bedard et al. 2007),, and export of an intronless mRNA from the nucleus in 
mouse (Huang and Steitz 2001). 
 
Figure 5: C. elegans contains three potential isoforms of rsp-6, which encodes SRp20.  
The three isoforms are created by alternative splicing. In the above diagram the boxes represent 
exons and the pointed lines introns. The 3’ end of Isoform C is not known and is therefore 
depicted as an arrow.  
   
Because Srp20 is an important splicing factor, its regulation is likely to be critical. In 
human cell lines SRp20 is known to self-regulate through alternative splicing (Jumaa and 
Nielsen 1997). However, in other organisms it is unknown if SRp20 regulates its own levels. In 
C. elegans self-regulation through alternative splicing is likely. There are three possible isoforms 
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of SRp20 in C. elegans (A, B, C). Isoform A is highly expressed, B is highly transcribed but 
immediately degraded by Nonsense Mediated Decay (NMD) (Morrison et al. 1997), and C is not 
expressed at detectable levels. If high levels of SRp20 of Isoform A were to enhance expression 
of Isoform B, NMD would cause the overall level of SRp20 to decrease, creating a self-
regulating gene. Interestingly, the main difference between the isoforms is that Isoform A, the 
major isoform, contains an RS domain while the other two isoforms do not. The lack of an RS 
domain on these two isoforms likely means the functions of their encoded proteins, if any, would 
differ from isoform A. One of the SRp20 deletions I have studied, rsp-6(tm367), alters the 
expressed isoforms and therefore may prevent or alter certain functions of the gene.  
 
 
Figure 6: Depiction of the process of 3’ end formation. 
The DNA is a blue line, the exons are peach boxes, and the pre-mRNA 5’ and 3’ UTRs are a 
black line.  On the left, Pol II has just reached the 3’ end of the gene. The CstF (orange) and 
CPSF (maroon) complexes have bound to Pol II and the pre-mRNA. On the right, both cleavage 
and polyadenylation have occurred, and Pol II continues to transcribe the region downstream of 
the cleavage site.  
 
3’ end formation  
When Pol II reaches the 3’ end of the gene, the pre-mRNA is cleaved and polyadenylated 
through the process of 3’ end formation. Although 3’ end formation has not been studied in 
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depth in C. elegans, the genome contains close homologs to the mammalian canonical 3’ end 
formation factors. Therefore, I will describe what is known about 3’ end formation in mammals, 
emphasizing some differences between the C. elegans and mammalian factors.    
Pre-mRNAs contain at least two sequences required for 3’ end formation: a 
polyadenylation signal and a downstream element termed either the U-rich or GU-rich region. 
The two sequences are the main determinants for the position of cleavage. In vertebrates, the 
polyadenylation signal, with the consensus of AAUAAA, is located 10-30 nts upstream of the 
cleavage site, while the U-rich or GU-rich region is located 15-25 nts downstream of the 
cleavage site (Salisbury et al. 2006). A multi-species comparison suggested that the GU-rich and 
U-rich elements may be distinct but overlapping elements (Salisbury et al. 2006).  
In C. elegans, both the polyadenylation signal and the U-rich element are present but 
slightly different than in mammals. However, the canonical polyadenylation signal is found in 
only 39% of 3’ UTRs. Forty eight percent of 3’ UTRs have single nt variants of the AAUAAA 
while 13% of 3’ UTRs have no recognizable polyadenylation signal, showing an exact match is 
not necessary for proper 3’ end formation (Mangone et al. 2010).  A somewhat U-rich element in 
C. elegans is positioned 5-20 nts downstream of the cleavage sites, slightly closer than other 
animals (Salisbury et al. 2006).  
Canonical 3’ end formation requires at least four multi-subunit complexes. Two well 
studied complexes are cleavage polyadenylation specificity factor (CPSF) and cleavage 
stimulation factor (CstF) (Whitelaw and N Proudfoot 1986; Logan et al. 1987; Connelly and J L 
Manley 1988; Birse et al. 1998; Dichtl et al. 2002). Additionally, the Cleavage Factor Im (CFIm) 
and IIm (CFIIm) complexes function with CstF and CPSF. CFIm binds early in 3’ end formation 
and facilitates binding of other co-factors (Rüegsegger et al. 1996). CPSF and CstF complexes 
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bind the polyA signal and the GU rich region of the pre-mRNA, respectively, to cleave the pre-
mRNA. CstF contains 3 subunits named by their molecular size; CstF-50, -64, and -77. The 
CPSF complex contains 5 subunits; CPSF-30, -73, -100, -160, and Fip1.  CFIIm consists of 
Pcf11 and Clp1 and interacts with Pol II CTD (de Vries et al. 2000). Pcf11 functions in 
dismantling the Pol II elongation complex (Zhang et al. 2005). Finally, the CTD of the largest 
subunit of Pol II, which is associated with several polyadenylation factors, is also required for 
efficient 3’ processing (Hirose and Manley 1998; McCracken et al. 1997; Barillà et al. 2001; 
Fong and Bentley 2001) 
How, specifically, is cleavage accomplished? Throughout transcription, CPSF binds to 
the Pol II complex (Glover-Cutter et al. 2007).  When Pol II reaches the 3’ end of the gene, CstF-
77 also binds to Pol II (Glover-Cutter et al. 2007). At this point CPSF maybe handed off to CstF 
since CPSF can bind to either Pol II or CstF, but not to both simultaneously (Nag et al. 2007). 
CstF-50 binds Pol II, and CstF-64 binds the GU rich sequence on the pre-mRNA downstream of 
the cleavage site. Meanwhile CstF-77 bridges the other two CstF subunits binding them to CPSF 
through the CPSF160 subunit. CPSF160 binds the polyA signal (AAUAAA) and allows the 
endonuclease CPSF-73 to cleave the pre-mRNA (Mandel et al. 2006; Murthy and Manley 1995). 
Once the pre-mRNA is cleaved it is polyadenylated. CPSF is still bound to the polyadenylation 
signal and it also binds to polyA polymerase, which adds a tail of adenosine residues 50-200 nts 
in length, controlled by nuclear poly(A)-binding protein 1 (PABPN1) (Kühn et al. 2009). If 
processed correctly, the mature RNA can be exported and used as a template for protein 
synthesis. 
In C. elegans, the 3’ end formation process is likely to proceed similarly, because all of 
the subunits of CstF and CPSF have clear homologs in C. elegans. Only one subunit, CstF-64, is 
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notably different from its mammalian homolog in that it is missing the ―MEARA repeat‖ 
domain, a domain with unknown purpose, which is, in any case, not essential for CstF-64 
function in mammals (Hockert et al. 2010).   
 
 
 
 
Figure 7: Depiction of two models of transcription termination.  
DNA is a blue line, and RNA is a black line. Exons are depicted as peach boxes. On the left, the 
allosteric model, in which something about the structure of Pol II changes and Pol II is released 
or removed from the DNA. On the right, the Torpedo model, in which XRN-2 degrades the 
uncapped RNA remaining after cleavage, and when it catches up with Pol II it ―torpedoes‖ it off 
of the DNA. 
 
Transcription Termination 
After 3’ end formation, what happens to the Pol II complex? Eventually Pol II will be 
released or removed from the DNA in a process known as transcription termination. Before 
termination Pol II continues to transcribe the region downstream of the cleavage site. Using Pol 
II Chromatin Immunoprecipitation (ChIP), it is estimated that Pol II travels 1-1.5kb downstream 
of the cleavage site before terminating, both in mammals and in C. elegans (Haenni et al. 2009; 
Glover-Cutter et al. 2007; Dye and N. J Proudfoot 1999). As Pol II continues to transcribe the 
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DNA it produces an uncapped RNA that is subject to degradation by the exonuclease xrn-2 (Rat-
1 in yeast) (West et al. 2004; Minkyu Kim et al. 2004).  
Transcription termination requires several of the same components that 3’ end formation 
requires, including the presence of both an intact 3’-processing signal and the 3’ end formation 
factors CPSF and CstF (Whitelaw and N Proudfoot 1986; Logan et al. 1987; Connelly and J L 
Manley 1988; Birse et al. 1998; Dichtl et al. 2002). In fact, the processes are so tightly linked 
that it is difficult to separate them. Three models have been proposed to explain the connection 
between 3’ end processing and transcription termination. The first, known as the ―allosteric‖ 
model, proposes that termination is triggered by a conformational change of the Pol II complex 
that occurs after Pol II passes the polyadenylation signal (Logan et al. 1987). The second model, 
known as the ―torpedo‖ model, proposes that termination is triggered subsequent to the cleavage 
event by the exonuclease xrn-2 (Osheim et al. 1999; M. Kim et al. 2004; West et al. 2004). After 
cleavage, the uncapped RNA being transcribed is degraded by 5’ to 3’ exonuclease xrn-2. The 
torpedo model proposes that termination occurs when xrn-2 collides with Pol II ―like a torpedo‖ 
after having degraded the nascent transcript.  The third model is a hybrid model that unites the 
two classic models relying on experimental evidence that supports both the models (Luo et al. 
2006). 
The processes of 3’ end formation and transcription termination are strongly linked but 
separable.  Separation was demonstrated through a deletion of one domain of RNA15, the 
Saccharomyces cerevisiae homolog of CstF-64. The C-terminus of RNA15/CstF-64 contains a 
highly conserved all helical structure. When it is deleted from RNA15, 3’ end formation is 
inhibited but termination appears normal (Qu et al. 2006). Interestingly, the link between the two 
processes may be due entirely to the protein factors that function in both. 
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Finally, in certain situations other pathways are used to form 3’ ends. For example, some  
3’ ends, such as those of the Pol II-transcribed snoRNAs and cryptic unstable transcripts (CUTs), 
are formed by the Nrd1/Nab3 complex (J. T Arigo et al. 2006; K. L. Carroll et al. 2007; 
Grzechnik and Kufel 2008; Eric J. Steinmetz et al. 2001; Thiebaut et al. 2006; L. Vasiljeva and 
S. Buratowski 2006). The Nrd1/Nab3 complex is also used in one of two fail-safe termination 
pathways that occur in yeast and used if canonical termination is non-functional (Rondón et al. 
2009). The other fail-safe pathway functions through Pcf11, which is a subunit of CFIIm a 
member of the canonical pathway (Rondón et al. 2009; de Vries et al. 2000).  In C. elegans, it is 
unclear if these fail-safe pathways are present. Moreover, the pathways may not function 
similarly, as a clear Nab3 homolog is not identifiable in C. elegans.  
 
CID domain and 3’ end formation/transcription termination factors 
 
Four C. elegans genes encode proteins with a C-terminal interaction domain (CID) which 
is known to interact with the Pol II CTD (Meinhart and Cramer 2004); pcf-11 (polyadenylation 
and cleavage factor subunit 11), nrd-1 (nuclear pre-mRNA downregulation 1), cids-1 (CTD 
interaction domain suppressor 1) and cids-2 (CTD interaction domain suppressor 2).  Three of 
these four genes were identified in a genetic screen that uncovered novel 3’ end formation and 
transcription termination factors (described in Chapter 4). The first two genes, pcf-11 and nrd-1, 
have been studied extensively in other organisms and are referred to in the transcription 
termination section. The third gene, cids-1, is less well studied. However, RTT103, the yeast 
homolog of cids-1 has also been implicated in 3’ end formation (Kim et al. 2004). By co- 
immunoprecipitation, it was demonstrated that RTT103 interacts with RAT-1 (xrn-2), the 
exonuclease that degrades the RNA 3’ to the cleavage of the pre-mRNA (Kim et al. 2004).  
17 
 
Furthermore, in the RTT103 deletion strain there is an increase in Pol II occupancy downstream 
of the cleavage site of several highly expressed genes. The increase in polymerase correlates 
with an increase in RNA levels downstream of the cleavage site.  The last of the four C. elegans 
CID-containing genes, cids-2, is a protein of unknown function but the there is a human 
homolog, RPRD2 which has not been studied.  
  
 
Figure 8: Depiction of two RNAs which have been trans-spliced.  
Top shows an unprocessed pre-mRNA. The pre-mRNA is a black line, while the colored boxes 
are exons. Bottom shows a processed mRNA. After the pre-mRNA has been trans-spliced, the 
mRNA’s 5’ end is an SL exon. The mechanism by which SL1 and SL2 are distinguished is a 
principle of study in this thesis.  
 
Trans-splicing 
C. elegans has a pre-mRNA processing step, spliced leader (SL) trans-splicing, not 
shared by other ―model‖ animals. In trans-splicing, two RNAs that are transcribed separately are 
joined by splicing. In SL trans-splicing, a 22 nt exon from an SL RNA is spliced to a pre-mRNA 
(reviewed in T. Blumenthal 2005). Before trans-splicing, the pre-mRNA is transcribed and may 
be 5’ capped as a standard transcript. The pre-mRNAs that are destined to be trans-spliced have 
outrons; intron-like AU-rich sequences upstream of unpaired 3’ splice sites (Conrad et al. 1991). 
Trans-splicing occurs when the unpaired 3’ splice site present on the pre-mRNA is spliced to the 
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unpaired 5’ splice site on the SL RNA (R Conrad et al. 1991, 1993a, 1995). Once trans-splicing 
occurs, the pre-mRNA’s 5’ end is replaced by the 5’ end of the SL RNA. It was estimated in 
1994 that 70% of C. elegans genes were SL trans-spliced (Zorio et al. 1994). 
The predominant SL RNA in C. elegans is SL1. The SL1 gene is transcribed by Pol II 
and is located in a region that contains 110 tandemly repeated 1 kb units containing both the 5S 
rRNA and the SL1 RNA (Ferguson and Rothman 1999; Krause and Hirsh 1987a). As donor in 
the trans-splicing reaction, the SL1 RNA has a 5’ splice site that is a reasonable match to the 
consensus 5’ splice site sequence. The splice site is located 22 nt from its 5’ end (Figure 9) 
(Blumenthal and Thomas 1988). The SL1 RNA is in many ways similar to the U RNAs of cis-
splicing.  Similarities include: a trimethylguanosine cap (TMG), a predicted secondary structure 
with 3 stem-loops, and a number of associated proteins including the same Sm proteins that bind 
the U1, U2, U4, and U5 RNAs (Thomas 1988; Van Doren and Hirsh 1988; Bruzik et al. 1988). 
 
Figure 9: Potential structures of SL1 and SL2.  
Red characters indicate the 22 nt 5’ exon, black characters are the rest of the SL RNAs. The top 
diagrams SL1 and the bottom SL2. The TMG cap is represented by the green circle. The maroon 
circle indicates the SM binding site. Both potential structures have three stem loops and base 
pairs in the stem loops are indicated by black lines or dots.  
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Because trans-splicing likely evolved from cis-splicing, the two processes are very 
similar (Hastings 2005; Nilsen 2001). The 5’ splice site consensus on the SL RNA is the same as 
the cis-splicing consensus and the unpaired 3’ splice site consensus on the pre-mRNA is the 
same as the cis-splicing consensus. The trans-splicing reaction uses most of the cis-splicing 
spliceosome, the only exception being that U1 snRNP is not used in trans-splicing (Hannon et al. 
1991). In cis-splicing U1 snRNP base pairs with the 5’ splice site to mark it (reviewed in David 
A Brow 2002). However, in trans-splicing the 5’ splice site is on the SL RNA (Blumenthal and 
Spieth 1996; Krause and Hirsh 1987b) and apparently the U1 function is fulfilled in some other 
way (Hannon et al. 1991).   
Even though the trans-splicing reaction is similar to the cis-splicing reaction, the products 
are slightly different. Two products are created by trans-splicing. First, the functional product is 
the SL exon spliced to the rest of the mRNA. All SL trans-spliced mRNAs have a TMG cap and 
a 22nt spliced leader exon at their 5’ end that they received from the SL snRNP (Liou and 
Blumenthal 1990). Second, the waste product is a Y-branched molecule that consists of both the 
exonless portion of the SL and the outron (Murphy 1986). Like the lariat created in cis-splicing, 
the Y-branched molecule is presumably degraded (Blumenthal and Spieth 1996). Because trans-
splicing is thought to be relatively efficient and because the Y-branched molecule is degraded, 
determining the location of the promoter via the 5’ end of the pre-mRNA is difficult. As a result, 
the promoter locations of most trans-spliced genes are not known (Blumenthal and Spieth 1996). 
 How does the splicing machinery tell a cis-splice site from a trans-splice site? At least 
two experiments helped elucidate the mechanism. Introns contain both a 5’ and a 3’ splice site 
while outrons contain only an unpaired 3’ splice site. In the first experiment, a 5’ splice site was 
inserted into an outron of a trans-spliced gene and the outron became an exon and intron, 
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indicating that the 3’ splice site must be unpaired for trans-splicing to occur (R Conrad et al. 
1993a). Second, when an intron-like sequence and an unpaired 3’ splice site was placed upstream 
of a gene that was not normally trans-spliced, the gene was then trans-spliced, indicating that an 
AU-rich sequence with an unpaired 3’ splice site is sufficient for trans-splicing (R Conrad et al. 
1991).  Therefore, it is likely that the signal for trans-splicing is not a specific binding motif, but 
the presence of an outron with no functional 5' splice site upstream of a 3’ splice site (R Conrad 
et al. 1995). 
 
Figure 10: Depiction of operon processing.  
Operons are multi-gene units encoded in the DNA. The top is a depiction DNA (blue line) 
encoding an operon with two genes. The first has three pink exons and the second two peach 
exons. By transcription a polycistronic pre-mRNA is created, as depicted by the black line. The 
pre-mRNA must be processed by trans-splicing, splicing, and 3’ end formation to created 
monocistronic units available for translation. The SL exons are depicted as purple and green 
boxes. 
 
Operons 
Although SL1 snRNP is the predominant spliced leader, C. elegans has a second SL 
RNA, SL2, which has a very specific function. SL2 is trans-spliced to genes located downstream 
in operons. C. elegans operons are collections of 2-8 genes with small distances between them 
that are transcribed together in a polycistronic transcript.  The discovery of operons in C. elegans 
was in fact a consequence of the discovery of SL2 (Spieth et al. 1993). 
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C. elegans operons are similar to bacterial operons in that they have a single promoter 
and are transcribed as a polycistronic transcript (Spieth et al. 1993) . However, the two types of 
operons are more different than they are similar. First, bacterial operons are translated from the 
polycistronic transcript (reviewed in Osbourn and Field 2009). In contrast, C. elegans operons 
are translated after separation of mRNAs into monocistronic units by the processes of 3’ end 
formation and SL2 trans-splicing (Spieth et al. 1993). Second, bacterial operons sometimes 
encode entire pathways. Although some C. elegans operons encode genes with related functions 
(Blumenthal and Gleason 2003), i.e. the lin-15B/lin-15A operon, the genes in C. elegans operons 
are not necessarily functionally related (Blumenthal 2005).  
The SL2 exon was first discovered on the 5’ end of gpd-3 mRNA (Huang and Hirsh 
1989). The SL2 exon had the same length as the SL1 exon but a different sequence (Huang and 
Hirsh 1989). Interestingly, gpd-3 was ~100 nt from the gene upstream of it. Several other genes 
were tested for trans-splicing to SL2 and in general the genes in close proximity to an upstream 
gene were shown to be trans-spliced to SL2 (Spieth et al. 1993). This breakthrough led to the 
discovery of C. elegans operons.  
The SL2 RNA is both similar and different from the SL1 RNA. SL1 and SL2 are alike 
because they are contained within a snRNP and they can form similar predicted secondary 
structures (Figure 9) (Evans and Blumenthal 2000). Additionally, the size, cap structure and 
presence of the 5’ splice site are the same (Huang and Hirsh 1989). However, SL2 has a different 
sequence from SL1 and there are several variants of SL2 (named SL3-SL12) that have slightly 
different sequences from SL2, but seem to trans-splice to the same transcripts as SL2 (Ross et al. 
1995). However, SL2 genes and variants are scattered throughout the genome, instead of in a 
single tandem repeat region. 
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SL2 can substitute for SL1 when necessary. The rrs-1 mutant is a deletion of the entire 
5S and SL1 tandom repeat region (Ferguson et al. 1996). As expected, the mutation is 
homozygous lethal. However, a transgenic over-expression of SL2 was able to partially rescue 
the deletion of SL1 (presumably 5S is contributed maternally). Therefore, though the SL RNAs 
have different sequences and are generally used in different contexts, SL2 is able to functionally 
substitute in the absence of SL1 RNA. 
The processing of C. elegans operons requires many steps.  Pol II initiates transcription 
from the promoter at the 5’ end of the operon and, if successful, travels the entire length of the 
operon. However, the polycistronic RNAs are difficult to detect because the transcript is co-
transcriptionally processed by 3’ end formation and trans-splicing. The two processes likely 
occur in concert, since either process alone would leave an unprotected RNA end. (3’ end 
formation would leave an uncapped downstream RNA and trans-splicing would leave a non-
polyadenylated 3’ end.) The region between the 3’ end and the trans-splice site is known as the 
intercistronic region (ICR) and is presumable degraded as a Y-branched structure following 
trans-splicing.  Interestingly, operons require that the two processes of 3’ end formation and 
transcription termination be uncoupled. If the processes were linked, downstream genes in 
operons would not be transcribed, since 3’ end formation of the upstream gene would cause 
transcription termination. This unique situation provides an opportunity to study the two 
processes separately. If transcription is terminated by the torpedo model, the cap provided to the 
downstream gene by trans-splicing may prevent the pre-mRNA degradation and transcription 
termination.   
How is SL2 specified? SL2 was first linked to operons because the genes that are trans-
spliced to SL2 are in the same orientation in tight clusters, meaning they had little space between 
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genes. Therefore, the 3’ end of the upstream gene is, in general, unusually close to the SL2 trans-
splice site. SL2 trans-splicing of the downstream gene has been experimentally linked to four 
components that lie adjacent to the downstream gene: the upstream gene, its polyA signal, the 3’ 
end formation factor CstF-64, and the motif within the ICR known as the Ur element. 
To determine if the upstream gene helped specify trans-splicing of SL2 to downstream 
genes in operons, the Blumenthal lab created transgenic operons, controlled by a heat shock 
promoter. Several constructs contained deletions that removed of portions the upstream gene (S 
Kuersten et al. 1997). The smallest deletion removed a portion of the upstream gene while the 
largest deletion removed the entire upstream gene, including its 3’ end formation signal. Each 
mutation in the upstream gene decreased the amount of SL2 trans-splicing to the downstream 
gene while increasing the SL1 trans-splicing. Presumably this is true because the upstream gene 
helps in specifying SL2 trans-splicing to the downstream gene. However, even with complete 
deletion of the upstream gene some SL2 trans-splicing was retained.  This may indicate that the 
C. elegans transgenic system does not perfectly recapitulate the situation with endogenous 
operons.  
When transgenes are injected into C. elegans they create large extra chromosomal arrays, 
and during their creation the DNA is able to randomly recombine. The correct recombination 
might put one gene downstream of another. Therefore, even in strains where the upstream gene 
was completely deleted, it is possible that polycistronic transcripts were sometimes present. The 
potential presence of some polycistronic transcripts prevents the determination of whether the 
upstream gene is necessary for all SL2 trans-splicing. The upstream gene may be necessary for 
SL2 trans-splicing or it may simply enhance SL2 trans-splicing.  
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One sequence that affects operon trans-splicing is the polyadenylation (polyA) signal of 
the upstream gene (S Kuersten et al. 1997). The consensus polyA signal, AAUAAA is found at 
only ~25% of 3’ ends within operons. The rest either contain an identifiable variant (~55%) or no 
recognizable polyA site (Mangone et al. 2010). The perfect AAUAAA is somewhat more 
prevalent in non-trans-spliced genes (~45 %) (Mangone et al. 2010). However, the genes within 
operons seem to form typical 3’ ends. When the polyA signal within an operon was mutated, the 
ratio of the trans-spliced downstream products changed: a higher percentage of transcripts were 
trans-spliced to SL1 and a higher proportion of unprocessed product was also seen (Kuersten et 
al. 1997). The change in the ratio may be caused by a loss of SL2 trans-splicing, which would 
indicate that the polyA signal is necessary for SL2 trans-splicing. On the other hand, the change 
in the ratio may be due to an increase in SL1 trans-splicing. SL1 may trans-splice more often 
because there is more stable substrate to target when 3’ end formation fails.      
The specificity of SL2 for transcripts downstream in operons may be linked to the 
association of SL2 with the 3’ end formation factor CstF-64 (Evans et al. 2001). Specifically, 
SL2 co-IPs with CstF-64 (Evans et al. 2001). This interaction requires the third stem loop of 
SL2, which is also required for correct SL2 RNA identity. A mutation in the third stem loop of 
SL2 that failed to Co-IP CstF64 also did not trans-splice to the SL2 target gene gpd-3, but the 
mutant snRNP was still functional since, similar to wild type, it was able to partially rescue rrs-1 
(the SL1 deletion).  This implies that the interaction with CstF may be a crucial element in SL2 
use at downstream positions in operons.  
Within the ICR of operons there is a U-rich (Ur) element involved in trans-splicing of the 
downstream gene (T Huang et al. 2001). The Ur element was found by scanning mutagenesis of 
the entire ICR (Huang et al. 2001). When the Ur element, a 20 nt region located 50-70nt 
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upstream of the trans-splice site, was replaced with unrelated sequence, much of expression of 
the downstream gene was lost (Huang et al. 2001).  Presumably, without the Ur element the 
downstream RNA is either not transcribed or degraded. Several lines of evidence indicate the UR 
may be an exonuclease block, which could stall degradation of the ICR until after trans-splicing  
and therefore prevent transcription termination as well (Huang et al. 2001). In addition, the UR 
element is sufficient, since a construct is able to trans-splice to SL2 when the entire ICR is 
replaced with a polylinker sequence containing the Ur element (Huang et al. 2001). Finally, 
replacing the Ur element and much of the ICR with MS2 loops and expressing MS2 coat binding 
protein, is sufficient to rescue some expression of the downstream gene. However, all 
downstream transcripts are trans-spliced to SL1 instead of SL2. Therefore, the Ur element is a 
region of the ICR that is necessary for both trans-splicing in general and for SL2 specificity 
(Huang et al. 2001). 
 
SL2 trans-spliced genes 
In 2002 a creative and elegant approach, using microarrays, uncovered many genes that 
trans-splice to SL2 (Thomas Blumenthal et al. 2002), and thereby the operons in which they 
reside. Total RNA was reverse transcribed with oligo(dT) primer creating cDNAs. Then, by 
using a primer containing the T7 promoter followed by the SL2 sequence, SL2 containing 
cRNAs were in vitro transcribed from cDNA. The cRNA was reverse transcribed and used on a 
microarray with fragments of nearly 18,000 genes.   Using this method, ~1200 genes were found 
to trans-splice to SL2 and from this the C. elegans genome was predicted to contain ~1000 
operons. This suggested that 15% of C. elegans genes could be within operons. In addition, for 
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the 285 operons for which 3’ end formation sites were known, the median distance between 
genes was shown to be less than 200 nt.    
Though elegant at the time, this method has several caveats. First, extremely long genes 
are unlikely to be detected in this assay because the reverse transcriptase would need to travel the 
entire length of the gene for the subsequent amplification to occur. Second, this method reveals 
nothing about the ratio of SL1 to SL2 at these positions. Several genes now annotated as 
downstream in operons get a mixture of SL1 and SL2 (Wormbase), and the microarray 
experiment would result in annotating them only as SL2 genes. Finally, there has been no global 
search for SL1 trans-spliced genes.  This method was only used to isolate SL2 trans-spliced 
genes. Currently, RNA-sequencing technologies allow an improved look at SL1 and SL2 trans-
splicing of C. elegans genes (Chapter 3).  
At least 65 operons contain two promoters and are therefore labeled ―hybrid operons‖ 
(Peiming Huang et al. 2007). This was discovered using GFP fusions to DNA upstream of genes. 
In the study, 66 out of 272 regions of DNA, selected from DNA that was contained completely 
within operons were able to induce expression of GFP, implying the presence of a promoter 
internal to those operons. Also consistent with the presence of internal promoters within some 
operons, the Lieb lab found HTZ peaks, which are marks of promoters, internal to as many as 
37% of operons (Whittle et al. 2008). (In the same study, strangely, only 23% of genes had an 
associated HTZ peak.) Unfortunately, the SL specificity of the genes in hybrid operons was 
difficult to accurately determine because the only sequence data available was expressed 
sequence tags (ESTs), of which most genes have only a limited number. 
The current method of operon annotation involves manual curation based on both SL2 
trans-splicing and a short distance between genes on the same strand. Several cases make the 
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annotation of operons difficult. First hybrid operons add a layer of complexity to the annotation 
of operons (Whittle et al. 2008). Second, several genes were found in the microarray data in 
which the upstream gene was farther than 1kb from the SL2 trans-spliced gene (Blumenthal et al. 
2002). Are these cases of long ICRs or an alternative method of specifying SL2?  Third, some 
genes are mostly SL1 trans-spliced but have a short distance to the next upstream gene. Fourth, a 
few genes receive a mixture of SL1 and SL2. Currently operon annotation is decided on a case 
by case basis and new rules need to be established. 
I can imagine at least three possibilities to explain why some genes trans-splice to a 
mixture of SL1 and SL2. First, the mixture of SL1 and SL2 could be caused by the presence of 
two promoters (Blumenthal and Steward 1997). One promoter at the 5’ end of the operon would 
create polycistronic transcripts that would be trans-spliced by SL2. The other promoter, adjacent 
to the gene, would create an outron containing pre-mRNA that would be trans-spliced by SL1. 
Second, all transcripts could arise from the operon promoter but the increased distance of the 3’ 
end from the trans-splice site or the failure to cleave quickly may have an effect on SL choice 
(Blumenthal and Steward 1997). The CstF-64 bound SL2 might be too far from the trans-splice 
site to trans-splice efficiently. Third, a motif within the ICR could specify SL2 (which might be a 
CstF binding site) and the quality of this motif for the specification of SL2 could vary in 
efficiency (Evans et al. 2001). Because a number of genes that receive mixtures of SL1 and SL2 
were discovered in my research, I address this question in Chapter 3 both with bioinformatics 
and molecular experiments. 
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The Evolution of Trans-splicing  
The operons and trans-splicing in C. elegans makes it an appealing model organism to 
study RNA processing. On the other hand, it is not by any means the only organism that trans-
splices. Numerous diverse organisms use SL trans-splicing in a variety of ways (reviewed in 
Erika Lasda and Tom Blumenthal, 2010, in press)). It is now clear that trans-splicing is thought 
to have evolved multiple times in different organisms (Derelle et al. 2010).   
What advantage does trans-splicing confer? First, the organism can use trans-splicing for 
operons and thereby reduce its genome size or gain whatever other selective advantage that 
operons may provide. Second, the SL and a trimethylguanosine cap may give a translation 
advantage to trans-spliced RNAs (Lall et al. 2004; Guofeng Cheng et al. 2007; Wallace et al. 
2010). Third, the trans-splicing event allows for erroneous start codons (AUG) to accumulate 
upstream of the correct start codon because the upstream AUGs are removed by trans-splicing 
(Lall et al. 2004; R E Davis 1996; Hastings 2005). In non-trans-spliced genes, AUGs between 
the promoter and the correct start codon would be expected to be deleterious. Regardless of the 
selective pressure that has created and maintained trans-splicing, the process and the presence of 
operons create many interesting questions, hopefully answerable through the study of C. elegans. 
. 
 
Summary 
In summary, C. elegans is an important organism for the study of RNA processing. I have 
studied C. elegans operons to analyze SL choice. In addition, I have studied novel 3’end 
formation and transcription termination factors in the operon context. This research has led to a 
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broader understanding of RNA processing in C. elegans, with implications for related processes 
in other organisms. 
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CHAPTER 2 
Materials and Methods 
 
Methods for Chapter 3 
C. elegans strains. 
 The following stages and strains of C. elegans were processed for RNA sequencing 
(RNA-seq) : embryonic him-8(e1489) (50% males), N2 early embryos, late embryos, lin-
35(n1745) L1, L1, L2, L3, dauer entry daf-2(e1370), dauer daf-2(e1370), dauer exit daf-
2(e1370), L4, L4 males, JK1107 L4 (no gonad) glp-1(q224),  young adults, aged adults (spe-
9(hc88 )), adults exposed to Harposporium spp (tentative assignment), and adults exposed to S. 
marcescens (Gerstein et al., 2010). All worms were N2 (wild type) grown on NMG plates and 
fed E. coli strain OP50, unless otherwise noted. 
 
RNA isolation and transcriptome sequencing.  
RNA was extracted, reverse transcribed, and the resulting DNA was subject to deep 
sequencing on the Solexa/Illumina platform as detailed in Hillier et al. 2009 and Gerstein et al., 
2010. Trans-splice site locations, number of reads, and depth of coverage per million reads 
(dcpm) for each gene were determined as described in the supplemental methods of Hillier et al. 
2009 and are outlined below.   
Briefly, a database was created of all SLs trans-spliced to each possible splice junction in 
the genome (as predicted or annotated by GENEFINDER (P. Green, unpubl. version 1.1), 
TWINSCAN (Korf et al. 2001) (version in ws170 WormBase), and WORMBASE (T. W. Harris 
2004) version ws170). Reads were then matched to the database using cross_match , retaining 
only the database matches (with score >=24, <=2 mismatches). At least one of the trans-spliced 
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reads at each trans-splice site had to have 9 bases matching the SL sequence to be considered. 
Number of reads refers to the number of sequencing reads matching the above criteria at a single 
site in the genome. 
  Fold coverage is an approximate measure of the number of sequences representing a 
specific position in the genome.  To calculate dcpm, one first calculates depth of coverage, which 
is the approximate number of reads at a single position within the gene, analogous to fold 
coverage. The number of reads across a gene is smoothed using overlapping windows. Both non-
unique and below-threshold reads are excluded from this calculation (For details of calculation 
see Supplemental Methods of Hillier et. al.). To make the depth of coverage (dc) comparable 
across data sets, the dc of the gene is divided by the number of millions of reads in the data set. 
One can recover the approximate fold-coverage of a gene, by multiplying the dcpm by the 
number of millions of reads in the data set (generally 14-20 million). 
  
Programs used 
The databases were built in MySQL Server version: 5.0.77 Source distribution. The 
calculations, manipulations and the retrieval of the data in chapter 3 were performed with Python 
2.6.4 and IPython 0.8.4 using the numpy(0.4.0rc1), cogent(0.4) and mysqldb(1.2.1) site 
packages. The graphs were drawn with either the python site-package matplotlib(0.99.1.1) or 
Microsoft Excel (12.0.6545.5000). 
 
SL1/SL2/SL2 variant ternary plot. 
For each trans-splice site the percentage of SL1, SL2, or SL2-variant reads at each 
position was calculated. The percentage was plotted on a ternary plot drawn with matplotlib. The 
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ternary plot was based on code by written by C. P. H. Lewis while at the University of 
California, Berkeley, 2008-2009. 
 
Ratio of SL1/SL2 (SL2+SL2 variant).  
The number of SL1 and SL2 reads for each site was totaled across stages to determine the 
total number of reads for a given site. For each trans-splice site the ratio of SL1/SL2 was 
calculated by counting the number of SL1 reads vs. the number of SL2 reads.  Sequences that 
corresponded with SL2 variants were included as SL2 reads in this calculation. The percent SL2, 
which refers to the number of SL2 reads divided by the number of total trans-spliced reads at a 
single position was also calculated.  
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Genomic units.  
 
Figure 11: Order of events used to create the three lists that contain the genomic units.  
All genomic information originated from the ws207 gff3 file indicated in dark blue. All the light 
blue boxes indicate intermediate steps in creating the three files used for mapping trans-splice 
sites indicated by green boxes. 
 
I used the WormBase ws207 gff3 file to create a list of genes, operons, and introns. 
Positions of the genomic units were mapped to WormBase ws170 coordinates using 
unmap_gff_between_releases, (downloaded from http://www.sanger.ac.uk), which facilitated the 
conversion of the whole gff file to ws170 coordinates.  I created a gene/transcript list by 
selecting all entries in the gff file in which the feature was protein_coding_primary_transcripts or 
pseudogene, and sub-selecting transcript name/gene name out of the line_group. I then created a 
list of all operons in the gff file by selecting all entries in which the feature was operon and sub-
selecting the operon name out of the line_group column. I created a list of genes in operons by 
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selecting all genes whose coordinates were completely within the coordinates of an operon and 
on the same strand as the operon. I determined a gene order (numbered by position in the operon) 
within each operon by ordering the genes in each operon by their 5’ end. If two genes had the 
same 5’ end I used the shorter of the two genes as the first gene, because often the longer gene 
was a mis-annotation of the gene structure. If a single gene had multiple 5’ ends I used the most 
5’ of the 5’ ends. Finally, I created a table, trans_gene_ops, that contained every transcript/gene 
in the gene/transcript list, the location of the 5’ and 3’ ends of the transcript, the operon the 
transcript was contained within (if applicable), and the position of the gene within the operon (if 
applicable). 
I also created a 3’ cis-splice site list by collecting all entries in the gff file where the 
feature was intron and the source was coding_transcript. I then collected all the 5’ end positions 
from the introns which are 1 nt 5’ to the splice site location. For introns on the positive strand, I 
added one nt and for those on the negative strand, I subtracted one nt. I then removed all cis-
splice sites that were also annotated as the 5’ end of a protein-coding primary transcript, or a 
pseudogene. I used the introns instead of the exons to find the 3’ splice sites, because if I had 
used exons I would have had to filter out all first exons in the exon data set.  
Finally, I created a file that contained the frame of the cis-splice site by selecting all of 
the exons from the gff file when the source was coding_transcript and the feature was exon and a 
frame was indicated. 
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Categorizing of the trans-splice sites. 
I categorized the trans-splice sites as either a ―gene trans-splice site,‖ a ―trans-spliced cis-
splice site‖ or ―other.‖  I assigned gene trans-splice sites if the site or the first AUG downstream 
of the site mapped within 50 (Table 1) or 500 (Table 2) nts of the 5’ end of a known gene. I 
categorized a trans-splicing cis-splice site when it mapped within 10 nt of a cis-splice site. All 
other sites were categorized as ―other‖ sites.  
 
Figure 12: Decision tree for annotation of trans-splice sites.  
 
Specifically, I first created a table (potential_cis) of trans-splice sites that had the 
potential to be categorized as trans-spliced cis-splice sites. If a trans-splice site was within 10 nt 
of a 3’ cis splice site, it was added to the potential trans-spliced cis-splice site list (potential_cis). 
Then, to determine in which of the three categories a site should be annotated, I determined the 
position of the first AUG after each trans-splice site (See p. 38, Length of 5’ UTRs). Using the 
trans_gene_ops for the location of all 5’ ends of genes, I then calculated 4 values: the distance 
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from the trans-splice site to the closest downstream 5’ end and upstream 5’ end and the distance 
from the first AUG to the closest downstream 5’ end and upstream 5’ end. Of the four distances 
calculated, whichever distance was smallest was considered to be the distance to the closest 
gene. If the distance to the closest gene was less than 10 nt from the trans-splice site, that site 
was automatically annotated as belonging to that gene (Figure 12). Therefore, if any isoform of 
a gene was trans-spliced, the gene was counted as a trans-spliced gene.  
Next, if the distance to the closest gene was less than 500 (or 50 in Table 1) the site was 
annotated as belonging to the closest gene, as long as there was not a cis splice site within 10 nt 
of the trans-splice site (as determined by the trans-splice sites in the potential_cis list). In that 
case it was annotated as a trans-spliced cis-splice site. I then attempted to annotate any trans-
splice site not previously annotated as a trans-spliced cis-splice site if it was present in the 
potential_cis list. All other sites were annotated as other. I have created a question tree to depict 
how the categorization of the trans-splice sites was determined (Figure 12). 
Frequency of Trans-splicing at Each Trans-splice Site.  
We first counted the number of non-trans-spliced reads for each trans-splice site at the 5’ 
end of a gene by determining the number of reads whose entire sequence mapped exactly to the 
genome and whose 5’ end was between -22 to -9 upstream of a trans-splice site and in the same 
orientation.  We used these positions to ensure that the non trans-spliced genomic reads would be 
in an equivalent position to the trans-spliced reads.  Since the length of a spliced leader is 22 nt 
and since we required at least a 9 nt overlap to assign a spliced leader, the positioning of the 
genomic reads allowed us to directly compare their abundance to that of the trans-spliced reads.  
Frequency of trans-splicing was calculated as the number of trans-spliced reads divided by the 
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sum of the trans-spliced reads and the non-trans-spliced reads. If a gene had multiple trans-splice 
sites, we kept only site with the higher trans-splicing frequency for the graph. 
Trans-splice sites within HTZ peaks.  
I used the HTZ peak data from Supplemental Table 3 of Whittle et al. (2008). The 
positions were converted to WormBase ws170 coordinates using remap_gff_between_releases  
which was downloaded from the Sanger Center website (downloaded 1/23/2010). I considered a 
trans-splice site as having an HTZ peak only if the peak overlapped the trans-splice site. I did not 
use nearby peaks because downstream genes in operons could be close to the peaks of the 
upstream gene especially if the peak is several kb long and the first gene is short. 
 Distance to the upstream gene.  
The 3’ ends of the genes were determined by the Bartel Lab (Jan et al. 2010) with 
poly(A)-position profiling by sequencing (3P-Seq). Briefly, biotinylated oligos were ligated on 
to the 3’ ends of RNAs. RNAs were then reverse transcribed with a primer to the ligated oligo 
and dTTP as the only nucleotide. RNase H was used to digest the reverse transcribed products, 
thereby releasing only the polyA- tailed mRNAs from the biotin. Those released mRNAs were 
used as substrate for RNA-seq.  Distance to the next upstream gene is the position of the most 
abundant polyadenylation site of the upstream gene to the position of the trans-splice site. In 
operons, this is also called the length of the ICR. 
 
 Intron length of genes around ICRs 
I calculated the intron length for the genes adjacent to each ICR. If either of the genes did 
not contain an intron I excluded it from the intron length analysis. Intron length, in this case, 
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refers to the sum of the average intron length of all the introns in the upstream gene and the 
average intron length of all the introns in the downstream gene.  
 
RT-PCR to determine SL use in mutants 
I received the tbb-1(gk207) and C23H3.4(ok1693) strains from the Japanese National 
Bioresource Project for the Experimental Animal Nematode. Strains were grown on NGM plates 
spread with OP50. I isolated mixed staged worms by washing populations off plates. I then 
immediately placed the worms into 4x volume of TRIzol and froze them at -80.  I thawed the 
pellets, vortexed them, and refroze them in liquid nitrogen 3 times. After thawing one last time, I 
isolated according to the TRIzol protocol. I treated the RNA with DNase, cleaned it by phenol-
chloroform extraction, and then reverse transcribed it with random primers, according to the 
SuperScript II protocol. I created a dilution series of the cDNA to confirm that PCR reactions 
were in the linear range. A PCR for the control gene rpl-26 was first performed at several cycle 
numbers to confirm that PCR was in the linear range. Primers used can be seen in Appendix C.  I 
adjusted the amount of cDNA used for PCR with SL1 and SL2 in the C23H3.4 gene PCRs 
according to the levels seen in the rpl-26 RT-PCR.  I did not normalize the tbb-1(gk207) PCRs to 
rpl-26, as the level of W09D10.1 was not changed significantly in the deletion strain. I 
performed at least 3 biological replicates for each strain.  
 
Length of 5’ UTRs 
I determined the position of the first AUG after each trans-splice site. First, I determined 
the position of each AUG in the ws170 genome by searching the fasta-formatted file for ATG 
and its reverse complement (CAT). Then I compared this list to the positions of the trans-splice 
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sites, and determine the position of the first AUG after (3’ to) the trans-splice site on the same 
strand. The sequence of the SL plus the sequence from the trans-splice site to the first AUG is 
considered the sequence of the 5’ UTR. I created a histogram showing the number of genes with 
various distances from the trans-splice site to the AUG.  
 
 
 
Methods for Chapter 4 
Cloning and sequencing the lin-15B(n765) mutation 
Preliminary analysis by Mingxue Cui of the lin-15B(n765) strain suggested that the 
mutation was within the third exon of lin-15B. I used primers on either side of exon 3 to RT-PCR 
the mutation in the mutant strain (Appendix C). I cloned the RT-PCR into a Topo vector and sent 
it for sequencing.  
 
Explanation of color codes. 
Color of highlight to indicate lin-15B 
Color of highlight to indicate sequence is neither lin-15B nor H18 
Color of highlight to indicate sequence of the BLAST-matched insert (928 bp) 
Color of font coded to show there are 20 nts of lin-15B after the insert, then some random 
sequence then ~the same lin-15B sequence. 
Color of font coded to show that the 5’ end of the insert is part of H18N23.2b 3’UTR. 
Underlines indicate positions of polyA signals. 
 
TCGTTCCGTCAACAGCTACAGCTTCTCAAATGTCAAGTTTACGAACATTGTGTGTTTATGAACCATCGA
CACACACTTCTCCACGTCCCCCTTCCCCTTCCTTCCCACTCCCCACCAACGTGCGGGCTTAATATGTTAC
AGTTACTGTAGAATGGTACCTTATCATGCCAAATAAAAATTCTAAATAGAATATTGTTTTTTTGTTTTAA
ATATTGATTTTTTCAAATTTTCAGTAAAGTTGTAGATCAGAAAATTTTCAAAAAAAATGGAAGAATGAT
ATAAACTTTTAGAACATAATTTACTGGTATTCGTCAGAGCTACAACGAGTTACAACCATTTCAAAGAA
CTGCCGTATTTTTTCGTACACATTCCGGCTTAAAATATCAACCCAAAAATGCATGTTGTATTTACCTTTC
AGTCGATTTACCATTTCAAATACAAATAATATATATATTATATATTTATTCAAACAAAAAAAGATAGC
ACATGACATAGAGGTAATCACCGGTGAGAAGGATTGAATAATAAAATGATCACATAAACCAGACATA
GTTAGGGTGATCAAGTTGGGGGAAGAAATAACTCAAGGGGAATAGAATTAAGACGTGTCGAAAACGC
TTGACGGCTGAGTGGTTTCAGTAGATGTTGAGCCAGTCGGTTCCAGAGTGGCAGGTTCATTAGTAGAAA
ACTATTGTTGATTGGTACACAGGCACGCATCATGTATGGACACCGTGGAGAGCGGGACTTCTTTAGTGC
TGAGACATCCGGAAAGTGGTATTCGCCAGATAAGATGTTGTGGTAGGTCTTTAATATTTGGAGAATTCG
CTGGTGTTGAACGGATTTTTGATTTGACTGAGCCAGTCGATCATCGTATGACGTGTATGAGACATTGCA
40 
 
TCGTTGATACACTTTTCTTGAATGGAATTTCAGCGGCATTTCAAGTAGTTTTATCATACGTTTGGAGCTA
GGGTTGTAGATTTCACATCCGGATATGTATAGCAAATTTAGCAAATTTTATTTTTTTTTTTTTCGGATAT
GTATAGCAAATTTAGAAGGTAAATTTAGCGTTTTTAACCTTTATATAAAACCCACAAATTTCAGAATGC
AA 
 
Figure 13: Sequence of lin-15B(n765) mutation. 
This mutation was identified in lin-15B(n765 explanation of the color codes.  
 
Strains 
We received the cids-1, cids-2, and rsp-6 mutant strains from the Japanese National 
Bioresource Project for the Experimental Animal Nematode, the C. elegans Gene Knockout 
Consortium and the Caenorhabditis Genetics Stock Center. I backcrossed the cids-1(tm2175) 
and the cids-2(tm2802) six times before analyzing the phenotypes of the deletions. The rsp-
6(ok798) and rsp-6(tm367) strains were backcrossed by my collaborator Mingxue Cui in the Han 
lab. Unless otherwise noted, strains were grown at 20⁰C on NGM plates and fed OP50 or NA-22. 
 
RNAi Screen. 
The RNAi screen was performed as reported in (M. Cui et al. 2006) except for the 
following changes. Many C. elegans homologs of CPSF and CstF subunits are essential for C. 
elegans development. RNAi of these genes produced severe embryonic lethality, which makes 
the investigation of postembryonic development (vulval development in our study) impossible. 
To overcome this problem, RNAi feeding cultures for genes that had lethal phenotypes were 
diluted with a second bacterial culture expressing dsRNA of the control GFP gene, thereby 
reducing the effectiveness of the RNAi. Multiple dilutions were created, and for the screen the 
dilution with greatest multivuvla (Muv) suppression was used in each Synthetic multivulva 
(SynMuv) count. 
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Total  RNA preparation  
Worms were grown for 4 to 5 days, washed with M9 buffer, and embryos or adults were 
harvested and broken by freezing and thawing in TRIzol reagent (Gibco BRL). Total RNA was 
prepared by TRIzol extraction.  
 
Tiling Array Data 
Total RNA was prepared from four C. elegans strains, lin-15B(n765), lin-15B(n765);rsp-
6(tm367), N2 and rsp-6(tm367). RNA was reverse-transcribed with random primers and then 
DNA Polymerase 1 was used to make double-stranded cDNA. The double stranded cDNA was 
digested with the endonuclease APE1 (Affymetrix) and fluorescently labeled. The cDNA then 
was hybridized to a GeneChip C. elegans Tiling 1.0R Array (Affymetrix) and scanned by a 
GeneChip Instrument System. The Affymetrix IGB program was used to visualize results.  
 
RT-PCR of C12D12.1, rsp-6, SL1 and SL2 to lin-15B 
First-strand cDNA was prepared by reverse transcription using Superscript II (SSII) 
(Invitrogen) and random primers. For each procedure the PCR primers are listed in Appendix C.  
Samples were electrophoresed on a 1% agarose gel. 
 
RT-PCR across 3’ ends (C16C10.8, R10E4.2, R05D11.5, rnp-7 and Y37E3.8) 
 First-strand cDNA was prepared by reverse transcription by using SSII (Invitrogen) and 
gene-specific primers downstream of the cleavage site of the gene. For each procedure the PCR 
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primers are listed in Appendix C.  Multiple PCR cycle numbers were attempted to assure PCRs 
were in the linear range. Samples were run on a 1% agarose gel. 
 
qRT-PCR Analysis. 
First-strand cDNA was prepared by reverse transcription by using SSII (Invitrogen) and 
random primers or a specific oligonucleotide primer (see Appendix C). The 20-μl reverse 
transcription reaction was diluted to 300 μl with water, and 3 μl of diluted reverse transcription 
reaction was used for each qRT reaction. Each 10-μl qRT-PCR mixture contained 0.25 μM of 
each primer (Table S3) and 5 μl of 1X SYBR Green Mix (Applied Biosystems). qRT-PCR was 
performed in triplicate on an ABI 7900HT Fast Real-Time PCR System (Applied Biosystems). 
Standard curves using 1 pg to 250 ng of cDNA pools were used. Relative fold changes were 
calculated by using the standard curve method for relative quantization, and numbers were 
corrected by removing outlier points that had a coefficient of variation greater than 17%. The 
rpl-26 gene was used as an internal control for data normalization.  
Phenotype analysis of cids-1 and cids-2 deletions 
 Worms [wild type (N2), cids-1(tm2175) and cids-2(tm2802)] were placed at 15 C, 20 C 
and 25 C as L4 (larval stage 4, P0). When their progeny had lived an entire generation at the 
temperature, 5 L4 hermaphrodites were picked to a new plate and allowed to lay eggs. The F2 
generation was counted for the percentage of males.  The percentages from three biological 
replicates were averaged. 
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Heat shock of cids-1 and cids-2 tagged strains 
 The CIDS-1 and CIDS-2 tagged transgenic strains were heat shocked for two hours 
before samples were isolated. The samples were subjected treated in a bead-beating for 10 
second each to break up the cells. The bead-beater prepared protein samples were stored at -80 C 
until used.  
 
Immunoprecipitation 
 One ul Anti-polyHis from Sigma was affixed to 200 ul of DYNAL® Magnetic Beads 
using the Dynal beads procedure.  Protein samples (100 ul) were mixed with the beads affixed 
with antibody, and washed at least 2 times according to protocol. Samples were then removed by 
soaking the beads in loading buffer with β-mercaptoethanol and high heat (95⁰).  
 
Western blot 
 Samples were run on an 8% acrylamide gel (Acrylamide/BIS ratio 37.5:1) and transferred 
to a PVDF membrane using a Mini Trans-Blot System from Biorad and following the suggested 
Biorad procedure. Membranes were then washed with 1X PBS and blocked in 5% dry milk in 
1X PBS for an hour. Membranes were again washed (3x) and soaked with primary antibody in 
5% dry milk and 1XPBS over night. (Anti-Serine 2 was used at a 1/100 dilution, anti- Serine 5 
was used at a 1/100 dilution. Both are rabbit polyclonal abs from Bethyl LabsMembranes.) The 
membranes were washed and soaked in secondary (Anti-light chain rabbit antibody, 1/1000 from 
Jackson). Membranes were washed in 1X PBS with Tween and the antibodies were detected 
with Thermo Scientific Pierce ECL Western Blotting Substrate.  
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Methods for Chapter 5 
Collection of sequences 
The data set examined consists of the 182 putative internal 3′ processing sites within 
operons and the 931 putative non-operon terminal 3′ processing sites described and used in a 
previous Blumenthal publication (Graber et al. 2007). Sequences were represented in the 
standard International Union of Biochemistry/International Union of Pure and Applied 
Chemistry nucleic acid codes.  
Computational searches for UAYYUU and UAYYU 
Sequences were aligned by the 3′ end processing site and divided into 10-nt blocks. 
Regular expressions were used to search for the words TAYYTT and TAYYT within the 
sequence (T was used instead of U because DNA sequences were searched). The word was 
counted as present in a 10-nt block of sequence if the 3′-most nucleotide of the word was within 
the block. The percentage of sequences with at least one word present was plotted for each 10-nt 
block relative to the 3′ cleavage site.  
Computational searches for UAYYUU and all 1-nt variants 
All 1-nt variants of the word TAYYTT were determined (for example, VAYYTT is a 1-
nt variant of TAYYTT). Each of the data sets was searched for the word and each of its variants. 
Locations were determined based on the 5′-most nucleotide of the word or variant. The number 
of copies of each word or variant located 40–60 nt downstream from the cleavage site was 
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determined for each sequence. The percentage of genes in each data set with x copies of the word 
or variant was calculated (x = 0–5). 
Probability of TAYYTT or a 1 nt variant 
 The nucleotide composition of the 100 nt after the cleavage site for all of the sequences 
from both data sets was calculated by counting all the nts in each of those sets and dividing by 
the total number of nucleotides in all sets. The probably of obtaining the word TAYYTT was 
calculated using the nucleotide composition. Each 1 nt variant was determined, (TAYYTV, 
TAYYVT, TAYRTT, TARYTT, TBYYTT, VAYYTT) and the probability of each was 
calculated. The probability of finding any of the words and a single position was the sum of the 
probabilities of each. Number of position the word could reside in (num_pos) is block length (20 
nt) minus word length (6) plus 1. Therefore num_pos = 15. I then used this equation to calculate 
the probability of x occurrences of the word ―((combin(num_pos, x)*((1-probabity of any of the 
words)^(num_pos-x)) *((probability of any of the words)^x)‖ in Microsoft Excel. To get the 
probability of greater than or equal to x occurrences I used 1-sum(probabilities of all values less 
than x). This equations assume that words can overlap arbitrarily.  
 
Methods for Appendix A 
Tiling array 
See above (p. 41 Tiling Array Data). 
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Creation of a program to compute expression of exons 
Data was normalized in the TAS (from Affymetirix, version 1.1.02) program by setting 
the median value of all probes to an arbitrary value of 500.  A program was then written in 
python and mySQL using mysqlDB as an interface.  
In brief the program was designed to:  
1) Calculate expression of each exon or each gene  
2) Find the difference between exons and genes on a wild-type vs. mutant array 
3) Calculate the significance of each difference by a t test 
4) Output a list of the expression differences for multi-exon genes, single exon genes, 
small multi-exon genes and exons of all genes 
The values for the average expression across triplicate samples were used for all analysis 
of gene differences. The program calculates total expression across each exon by adding the 
expression of all probes between the start and the stop of each exon. The difference between the 
two arrays, ―wild type‖ lin-15b(n765) and ―mutant‖ lin-15b(n765);rsp-6(tm367) was calculated 
on a per–exon and per-transcript basis. The differences were then divided by the number of 
probes in each exon or each transcript to normalize this number between large and small exons.   
After the program calculates differences, the gene lists were divided into multi-exon and 
single exon genes. Another list of the tRNA expression difference was calculated. Any exons 
without probes were removed from the analysis.  A list of the difference in expression was 
created for 1230 smallest multi exon genes and the 375 smallest multi-exon genes. Results were 
plotted by histogram in Excel. 
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RT-PCR for nspa-8 
Total RNA was prepared as above (p. 41, Total  RNA prep). First-strand cDNA was 
prepared by reverse transcription by using SSII (Invitrogen) and random primers. For each 
procedure the PCR primers are listed in Appendix C.  Samples were run on a 1% agarose gel. 
 
Northern blot 
 Total RNA was prepared as above (p. 41, Total  RNA prep). RNA was run on an 8% 
bis/acrylamide gel, and transferred to Hybond membrane using the protocol and Trans-Blot SD 
Semi-Dry Transfer Cell from Biorad. The membrane was probed with a radioactive probe, 
created by PCR with P32-dCTP.  The membrane was then washed at high stringency and was 
exposed for 1 day to a phosphor imager screen, which was then scanned.  
 
Ligation assay for polyA tail length 
 Total RNA was prepared as above (p. 41, Total  RNA prep). RNA was then treated with 
CIP to remove phosphates from non-capped RNAs. This must be done because during the 
ligation step RNA with a phosphate on the 5’ end will ligate in place of the adapter and then the 
adapter will not ligate where you need it. CIP was extracted from the treated RNA with a phenol 
chloroform solution. T4 RNA ligase and the RNA/DNA oligo, DMSO and PEG were added to 
the total RNA and the reaction was left overnight at 15C.⁰. Samples were again Phenol 
Chloroform extracted and then reverse transcribed with an oligo complementary to the ligated 
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oligo. PCRs were performed with gene-specific forward primers and a reverse oligo to the 
ligated 3’ end. 
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CHAPTER 3 
 
A global analysis of trans-splicing in C. elegans 
 
Portions taken from ―A global analysis of trans-splicing in C. elegans‖ Allen MA, Hillier LW, 
Waterston RH and Blumenthal T. 
  
 
 
Introduction 
C. elegans has two RNA processing features that distinguish it from many other model 
organisms. First, the transcripts of a majority of genes are trans-spliced to a spliced leader (SL). 
SL trans-splicing is a process in which an SL replaces the 5’ end of a transcript by spliceosomal 
splicing. The 22 nt SL exon is donated by a SL snRNP (small nuclear ribonucleoprotein) to a 
pre-mRNA with an unpaired 3’ splice site located near the 5’ end. The second distinguishing 
feature is that many genes are transcribed in polycistronic units, known as operons, where a 
single promoter serves several genes. Operons can be up to eight genes long and the 
polycistronic pre-mRNAs are separated into individual transcripts by 3’ end formation 
accompanied by SL trans-splicing.  
These two features have at least three important implications. First, deletions/insertions 
within an operon may not only affect the expression of the gene containing the mutation, but also 
the genes downstream of it in the operon (Mingxue Cui et al. 2008). Second, in a strain with 
enhanced sensitivity to RNAi, RNAi of an operon gene can also affect expression of the 
downstream genes in the operon (Guang et al. 2010). Third, the trans-splice site is the 5’ end of 
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the mRNA, but not the pre-mRNA. Thus the promoter is often not directly adjacent to the 5’ end 
of the transcript, but rather upstream of the outron or the entire operon (Blumenthal and Spieth 
1996). 
SL trans-splicing was first reported in trypanosomes and subsequently in C. elegans 
(Sutton and Boothroyd 1986; Krause and Hirsh 1987b). Since then, trans-splicing has been found 
in several other phyla, including some chordates (Vandenberghe et al. 2001).  In 1994, the 
Blumenthal lab estimated that 70% of C. elegans genes were trans-spliced, based on the limited 
genomic and cDNA sequence data available at that time (n=381) (D A Zorio et al. 1994). Two 
methods were used to make this estimate. First, 37 cosmids were analyzed for 3’ splice sites that 
might be able to act as trans-splice sites. Second, reported cDNAs from the literature were 
surveyed for trans-splicing. The percentages of genes trans-spliced determined by the two 
methods approximately agreed; therefore this early estimate has not been updated. However, the 
advent of new sequencing technologies allows us to more accurately estimate the percentage of 
genes trans-spliced from a much larger data set. 
 
Categorizing Genes by Trans-splicing 
C. elegans uses two types of SL snRNPs for trans-splicing: SL1 and SL2, the latter of 
which has several sequence variants, termed SL3-SL12 (M. MacMorris et al. 2007; Ross et al. 
1995; Blumenthal 2005). The SL RNAs are similar in several ways: ~100 nts long, predicted 
three stem loop structure, 22 nts exon, consensus 5’ splice site, and 5’ trimethylguanosine 
(TMG) cap.  
Using trans-splicing, the genes in C. elegans can be categorized into four groups: non-
trans-spliced genes, SL1 trans-spliced genes, SL2 trans-spliced genes and genes trans-spliced to 
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mixtures of SL1 and SL2.  Non-trans-spliced genes are transcribed from a promoter directly 
upstream of their 5’ UTRs, similar to genes in other organisms. SL1 trans-spliced genes are 
transcribed with an outron, an intron-like AU rich sequence at their 5’ ends (R Conrad et al. 
1991).  The 3’ end of the outron is an unpaired 3’ splice site. Trans-splicing to the 3’ splice site 
removes the outron, which is degraded. SL2 trans-spliced genes are transcribed in polycistronic 
units known as operons in which a single promoter is located at the 5’ end of the operon. All of 
the operon genes, except the 5’ most gene, are trans-spliced to SL2.  Finally, genes that trans-
splice to mixtures of SL1 and SL2 have not been well studied, but the known cases have been 
assigned to operons based on the presence of some SL2 trans-splicing. 
C. elegans operons were discovered as a result of SL2 trans-splicing to genes in the same 
orientation in tightly-packed clusters (J Spieth et al. 1993). When genes in tight clusters were 
investigated by RT-PCR, it was discovered that they were all trans-spliced to SL2 (Spieth et al. 
1993). Conversely, when genes that had been shown to be SL2 trans-spliced were investigated, 
they were subsequently found to be downstream in tightly linked gene clusters (Spieth et al. 
1993). Several of these genes belong to polycistronic transcripts as demonstrated by 
identification of polycistronic cDNAs that were presumably reverse transcribed from RNAs that 
had not yet been processed (D A Zorio et al. 1994). Later, microarray analysis demonstrated an 
overwhelming correlation between these gene clusters and SL2 trans-splicing to downstream 
genes (Blumenthal et al. 2002).  
How is SL2 specified at downstream genes? Four potential, but not necessarily 
independent, requirements have been proposed: 1) a motif between two genes in an operon, 2) 3’ 
end formation of the upstream gene, 3) 3’ end formation factors and 4) a small distance between 
the genes in the operon. There is a U rich (Ur) sequence element within the ICR, the region 
52 
 
between two operon genes that is required for trans-splicing. When the Ur is mutated, expression 
of the downstream gene is lost (Huang et al. 2001). Presumably 3’ end cleavage of the upstream 
gene leaves an uncapped and unprotected 5’ end on the pre-mRNA, and transcription is 
terminated or the downstream RNA is degraded before trans-splicing can protect the downstream 
gene. The exact function of the Ur is unknown, but it is likely to be a binding location for either a 
protein or an RNA (Liu et al. 2003; Lasda et al. 2010) A bound factor would block degradation 
of the transcript until trans-splicing had created a capped, SL2 trans-spliced transcript.   
Additionally, 3’ end formation of the upstream transcript may be necessary for SL2 trans-
splicing. Deletions removing the polyA signal show changes in the ratio of SL1 to SL2 at the 
downstream gene (Kuersten et al. 1997). Furthermore, the 3’ end formation factor CstF-64, has 
been shown to co- immunoprecipitate with SL2 (Evans et al. 2001). The association is dependent 
on the third stem loop of SL2. When the third stemloop was mutated in transgenics, the modified 
SL2 RNA was unable to target genes that would normally be trans-spliced to SL2 (Evans et al. 
2001). 
Operon Annotation 
The current method of operon annotation involves manual curation based on both 
detection of some SL2 trans-splicing and a short distance between genes on the same strand. 
However, some genes fall into categories that make it difficult to determine if they are within an 
operon: genes that are SL2 trans-spliced but have a long distance to the next upstream gene, 
genes that are predominantly SL1 trans-spliced but have a short distance to the next upstream 
gene, and genes that receive a mixture of SL1 and SL2. An additional complication for 
annotation is the category of  ―hybrid operons‖, in which there are internal promoters within an 
operon (Huang et al. 2007). Using GFP fusions to genomic regions within operons, the Jones lab 
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showed that 25% of the operons they studied contained internal promoter elements (Huang et al. 
2007).   Sixty seven of the genomic regions tested were able to drive expression of GFP. 
Furthermore, in a ChIP-chip of HTZ (an H2A isoform found at promoters), 37% of operons 
contained peaks within operons, possibly indicating internal promoters (Whittle et al. 2008). (An 
impressive percentage since, strangely, only 23% of all genes had an HTZ peak.)  Hybrid 
operons, therefore, add an additional layer of complexity to the annotation of operons (Whittle et 
al. 2008). 
The most accurate method for annotation of every operon would be the demonstration of 
a polycistronic transcript. However, due to efficient processing of polycistronic transcripts, this 
method is currently limited to just a few operons. Operons could be annotated globally, if SL2 
trans-splices only to downstream genes.  Additionally, determining the presence or absence of 
promoters at trans-spliced genes could solidify the theory that SL2 is trans-spliced to 
downstream genes in operons and SL1 is trans-spliced adjacent to promoters. Furthermore, if 
SL2 is specifically trans-spliced to genes downstream in operons and SL1 is specific for genes 
with adjacent promoters, genes that are in hybrid operons may receive a mixture of SL1 and SL2. 
Therefore, identifying genes with a mixture of SL1 and SL2 trans-splicing could assist in 
identifying hybrid operons.  
As part of the modENCODE project (Celniker et al. 2009), deep RNA-sequence data has 
been generated for 19 different C. elegans stages and conditions (Hillier et al., 2009; Gerstein et 
al., in preparation). High-throughput sequence reads in this project (>1 billion total) were 
mapped not only to the genome and candidate splice junctions, but also to candidate trans-splice 
acceptor sequences. The best matches for approximately 13 million of the sequencing reads were 
trans-splicing events, which mapped to 28,249 genomic positions.  Using these trans-splice sites, 
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I will answer several questions in this chapter about RNA processing in C. elegans. 1) Do all 
trans-splicing events occur at the 5’ ends of genes? If not, where else are they found? 2) Are the 
SL1 and SL2 trans-splicing events generally distinct and specific phenomena? 3) What 
percentage of the ~20,000 C. elegans genes are trans-spliced? 4) What percentage of genes are 
trans-spliced to SL1, SL2 or mixtures of SL1 and SL2?  5) Is there a relationship between 
SL1:SL2 ratios and intercistronic length? 6) Is there a relationship between SL1:SL2 ratios and 
promoters? 7) Why do some genes get mixtures of the two SLs? 
 
Results 
Categorizing trans-splicing events 
 By visual inspection of some of the 28,249 trans-splice sites, two major categories 
emerged: trans-splice sites that mapped to the 5’ ends of genes and trans-splice sites that mapped 
to cis-splice sites. Therefore, I first wished to determine how many sites fell into either category. 
Cis-splice sites were easy to categorize, because they are well annotated in the current 
WormBase (ws207). However, the 5’-most position of a gene is sometimes annotated by the 5’ 
end of a known transcript, but for other genes it is annotated at the position of the start codon. 
This complicates the process of categorizing trans-splicing events to the ―5’ ends of genes‖. 
Therefore, I tried several criteria to categorize the trans-splice sites (see Materials and Methods 
p. 35). First, I required that the trans-splice site or the first AUG downstream of the trans-splice 
site be less than 50 nts from an annotated 5’ end of a gene.  By this criterion, 42% of the trans-
splice sites in our data set could be categorized as gene trans-splice sites (Table 1). By the 
criteria in Table 1, 11,805 of the 28,249 trans-splice sites mapped to the 5’ ends of 10,128 
annotated genes. Then, I tried requiring that the trans-splice site be less than 500 nts from an 
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annotated 5’ end of a gene (Table 2). By this criterion, 48% of the trans-splice sites detected 
could be categorized as the 5’ end of a gene. Most of the trans-splice sites within 500 nts of an 
annotated 5’ end are likely the actual 5’ end of the transcript. Therefore, for the analysis I 
performed subsequently, I used these trans-splice sites unless otherwise noted. By the criteria in 
Table 2, 13,462 of the 28,249 trans-splice sites mapped to the 5’ ends of 11,165 annotated genes. 
Interestingly, 1,884 genes had more than one trans-splice site, and by visual inspection many of 
these sites are alternative first exons. 
Table 1: Most trans-splice sites 
map to either the 5’ end of a gene 
or a cis-splice site. 
I divided the 28,249 trans-splice 
sites detected into three categories: 
gene trans-splice sites, trans-
spliced cis-splice sites and other. 
The other category contains the 
trans-splice sites that were not 
included in either of the other two 
categories. This category might 
include unannotated genes, genes 
with alternative/unmapped 5’ ends, and sites within genes that do not map near a cis-splice site 
or within 50 nts from the 5’ end of a gene. The middle column lists the number of trans-splice 
sites that fit each of the criteria. Finally, the right-most column contains the percentage of the 
sites I detected that are in the indicated category.   
 
Category Number  Percent of detected 
trans-splice sites  
Gene trans-splice 
sites(within 500nt) 13462 48%  
Trans-spliced cis-
splice sites 11827 42%  
Other  2960 10%  
Total 28249  
Table 2: Increasing the permissible distance from the trans-splice site to annotated 5’ end 
of a gene increases the number of trans-splice sites categorized as the 5’ ends of genes.  
Category Number  Percent of detected 
trans-splice sites  
Gene trans-splice sites 
(within 50 nt) 11805 42% 
Trans-spliced cis-
splice sites 11827 42% 
Other  4617 16% 
Total 28249  
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I again divided the trans-splice sites detected into three categories: gene trans-splice sites, trans-
spliced cis-splice sites and other. See Table 1 for a description of the columns. In this instance, I 
increased the permissible distance for a site to be mapped to the 5’ end of a gene to 500 nts. The 
larger distance, as expected, increased the number of trans-splice sites mapping to the 5’ end of a 
gene. 
 
Because the positions of 3’ splice sites for the majority of exons is very well defined, a 
trans-splicing event had to be with 10 nts of an annotated cis-splice site to be categorized as a 
trans-spliced cis-splice site (Table 1; Table 2). By this criterion, 42% of the trans-splice 
positions detected were categorized as trans-splicing to 3’ cis-splice sites. The trans-spliced cis-
splice sites are explored more in-depth later in this chapter. I categorized sites as "Other" if they 
were not categorized as either a gene trans-splice site or a trans-spliced cis-splice site.  
  
Frequency of Trans-splicing 
 I used the gene trans-splice sites to determine if the sites were trans-spliced all of the 
time. I calculated the frequency of trans-splicing at each position and I determined that almost all 
C. elegans sites at the 5’ ends of genes are trans-spliced more than 90% of the time (Figure 14). 
Figure 14 shows that for the most part, if a gene trans-splice site is transcribed, it is trans-spliced 
efficiently. The sites with low frequencies of trans-splicing might be due to either genes for 
which pre-mRNA is a high proportion of the transcript population or trans-splicing events that 
are inefficient.  
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Figure 14: Most trans-splice sites are trans-spliced nearly 100% of the time.  
I first determined the ―Frequency of Trans-splicing‖ at each trans-splice site at the 5’ end of a 
gene. The total reads at each position of a trans-splicing event were calculated. The total reads 
included both trans-spliced reads and non-trans-spliced reads that map to the trans-spliced 
position (See Materials and Methods p. 36). Frequency of trans-splicing at each trans-splice site 
was then determined by dividing the number of trans-spliced reads by the number of total reads 
at each trans-splice site. If a gene had multiple trans-splice sites (n=1884 genes), I only included 
the site with the highest frequency. Genes were binned by frequency of trans-splicing. For each 
5% frequency bin, the number of genes within that range of frequencies is plotted on the Y axis. 
 
Trans-splice sites with lower frequency of trans-splicing have poorer consensus matches 
A few trans-splice sites have a low frequency of trans-splicing. One reason for 
inefficiency could be trans-splice sites with worse matches to the splice-site consensus. Less 
perfect trans-splice sites would not be expected to trans-splice as efficiently due to less efficient 
U2AF binding. Therefore I binned the sites based on their frequency of trans-splicing and for 
each bin I plotted the proportion of the trans-splice sites with a match to each nt of the 3’ splice 
site consensus (UUUUCAG|R). The bin of the trans-splice sites that had the highest frequency 
had the best match to the 3’ consensus (Figure 15). Those that were trans-spliced less frequently 
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have overall worse matches to the consensus. It is not known if the same effect occurs with the 
trans-spliced cis-splice sites.   
 
 
Figure 15: Less frequently spliced trans-splice sites are less likely to match the 3’ 
consensus.  
All trans-splice sites were binned in bins of 25% frequency of trans-splicing (See Figure 14 for 
calculation). For example the left side of the graph shows trans-splice sites with frequency 
between 0-25%. The last bin contains all the sites that have a frequency of exactly 100%. Within 
each bin, I have plotted the percentage of trans-splice sites with a match to each nucleotide of the 
3’ consensus. For example, position -4 from the splice site, which is a U in the consensus, is only 
in 48% of the splice sites in the bin with a frequency of trans-splicing between 0%-25%.  As the 
frequency of trans-splicing increases so does then number of sites with matches to the consensus.  
 
 
~60% of all C. elegans genes are trans-spliced 
Our results show that the mRNAs from at least 50% of C. elegans genes are trans-spliced 
(Table 3). Many years ago it was estimated that 70% of genes are trans-spliced, a somewhat 
higher percentage than my current results (D A Zorio et al. 1994). However, it is possible that I 
have not detected all of the trans-splicing events because some genes may not have been 
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expressed highly enough to allow detection. To determine how many expressed genes are trans-
spliced, I removed all genes from the analysis whose expression was below certain thresholds 
that might have led to a failure to detect SL events. I used depth of coverage per base per million 
reads (dcpm) as a read-out of expression level for each gene (Hillier et al. 2009). When I 
required a low dcpm of 0.05 (~1x average coverage of every nt in most samples), 58% of genes 
can be documented as trans-spliced and this figure increases further to 67% and 69% when I 
increased the required coverage level (Table 3). Two possible interpretations can explain this 
result: highly expressed genes may have a greater propensity to be trans-spliced or, alternatively, 
all genes have an equal chance of being trans-spliced but trans-splicing of low-expressed genes 
even at this threshold level is sometimes below detection levels. 
 
Table 3: More than 50% of C. elegans genes are trans-spliced.   
Trans-splice sites were mapped to the 5’ ends of protein coding genes. To guarantee trans-
splicing could have been detected if present, gene expression cutoffs were used. Genes with 
expression levels lower than the minimal expression level cutoff were removed from analysis. 
(Trans-splice sites with a frequency of trans-splicing less than 50% were also removed. Also, 
only sites whose expression levels had been calculated were included (i.e. many pseudogenes 
were removed).  The middle column lists the number of genes above the cutoff and the last 
column is the percentage of included genes that are trans-spliced.   
To evaluate which interpretation is more likely, I binned the trans-spliced genes based on 
their expression level. This analysis shows that, the greater the expression of the gene, the more 
likely it is to be trans-spliced (Figure 16).  Therefore the highest cutoff levels in Table 3 cannot 
be used to estimate the number of genes that are subject to trans-splicing. Because a gene with a 
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dcpm of 0.05 would likely show any trans-splicing event that occurs, I suggest that ~60% of all 
genes are trans-spliced, but that ~70% of genes expressed at a high level are trans-spliced. 
 
Figure 16: Higher expressed genes are more likely to be trans-spliced.  
Genes were divided into bins based on expression level. Percentage of genes in each group that 
are trans-spliced is shown on the Y-axis. The number above each bar indicates the number of 
genes in the bin. 
 
 
Positions that trans-splice to SL2 also trans-splice to SL2 variants  
 The SL3-SL12 genes have been termed SL2 variants due to their sequence similarities 
with SL2.  It is assumed that they trans-splice to the same sites as SL2. Indeed, many genes have 
multiple ESTs (expressed sequence tags) that are trans-spliced to either SL2 or an SL2 variant.  
To determine if SL2 and SL2 variants are really used indistinguishably at the same genes I 
plotted SL1, SL2, and SL2 variant usage for every trans-spliced site on a ternary plot. All the 
variants were combined into one category because it is difficult to tell them apart in sequencing 
reads that sometimes cover only the 3’ end of the SL. In Figure 17, each point represents a 
single gene positioned according to the fraction of reads of SL1, SL2, and SL2 variant. I show 
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that positions that receive SL2 also receive its variants  but positions that receive SL1 get only 
SL1. Few sites get 100% SL2 or 100% SL2 variant. Therefore, for the rest of the chapter, unless 
otherwise noted, I have combined all of the SL2 and SL2 variant reads into a single collection 
called ―SL2‖. Interestingly, the sites that receive SL2 typically get ~30% SL2 and ~60% SL2 
variant. We are unsure why the sites receive more variant than SL2 but this may be due to the 
expression levels of SL2 and variant RNAs, which are unknown. 
 
Figure 17: SL2 and SL2 variants are trans-spliced to the same sites.  
For each trans-splice site, the percentage of the trans-spliced reads at that position that is SL1, 
SL2 or SL2 variant was plotted as a spot on the graph. The transparency of the spot indicates the 
number of trans-spliced reads at that site. The binomial exact test was performed (on the 
SL1:(SL2+SL2 variant ratio)) to remove samples lacking an appropriate read number to 
accurately calculate SL proportions. The axes of the ternary plot are read by following the slant 
of the numbers on the axes. The large number of spots in the lower left corner is nearly 100% 
SL1 and less than 10% SL2 and SL2 variant. In contrast neither of the other two corners has 
much signal, demonstrating that few genes are 100% SL2 or 100% SL2 variant. Instead there is a 
large population of sites that are ~25% SL2, ~65% SL2 variant and ~10% SL1.   This 
demonstrates that SL2 and SL2 variants tend to trans-splice to the same sites.  
 
SL1 and SL2 trans-splicing are separate phenomena 
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Previous results had indicated that SL1 is spliced primarily to outron splice sites which 
should be near promoters, whereas SL2 was primarily spliced to trans-splice sites of downstream 
operon genes (Blumenthal et al. 2002; D A Zorio et al. 1994). However, several genes that 
received mixtures of SL1/SL2 had been noted in the literature (Fouser and Friesen 1986; Padgett 
et al. 1984; R Reed and Maniatis 1985). In order to examine the question of whether most sites 
received only SL1, only SL2, or a mixture of the two, I calculated the ratio of SL1 to SL2 trans-
spliced at each of the 28,249 positions, and divided all of the sites into 100 bins from 0% to 
100% SL2 (Figure 18). I used the binomial exact test on each of the SL1/SL2 ratios and 
removed all sites that had p-values above 0.05. The data clearly show a peak of greater than 
12,000 trans-splice sites with 100% SL1, and a second peak of trans-splice sites with mostly SL2 
reads. These data strongly support the previous observation that SL1 and SL2 are 
mechanistically separate and distinct phenomena, since the majority of trans-splice sites are 
trans-spliced either to high levels of SL1 or SL2 and far fewer trans-splice sites receive a mixture 
of the two SLs.  Additionally, the analysis reveals something novel about SL2 trans-splicing 
positions. While the trans-splice sites that receive a majority of SL1 receive 99-100% SL1, the 
trans-splice sites that receive a majority of SL2 receive only 80-95% SL2. This could indicate 
that SL1 is the default spliced leader, whereas SL2 trans-splicing requires additional 
specification. Alternatively, it could simply be a consequence of the 10 fold higher level of SL1 
RNA in the cell, making it able to out-compete SL2 by mass action (Kuersten, R. Conrad, and T. 
Blumenthal, unpublished data).   
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Figure 18: SL1 and SL2 trans-splicing are separable phenomena.  
Histogram showing the number of gene trans-splice sites with indicated SL1:SL2 proportion on 
the Y-axis. The X-axis shows the proportion SL1/SL2 by the opposing triangles and ranges from 
100% SL1 to 100% SL2. All trans-splice sites are shown. The majority of trans-splice sites have 
either high SL1 (>90% SL1) or high SL2 (>80% SL2). Few trans-splice sites have a mixture of 
SL1 and SL2. 
 
SL1 use is common, and SL2 is reserved for genes downstream in operons 
Figure 18 included all categories of trans-splice sites:  gene trans-splice sites, trans-
spliced cis-splice sites and other. To determine if the pattern seen was similar if only gene trans-
splice sites are included, I performed the analysis with only sites at the 5’ ends of genes (Figure 
19A). If a gene had multiple trans-splice sites all sites were included. Similar to the analysis of 
all sites, the majority of the trans-spliced genes are trans-spliced to SL1 predominantly, while a 
smaller population of genes are trans-spliced to mostly SL2. The annotation of operons was 
based completely on genes with a small distance to the upstream gene and some SL2 as 
determined by ESTs, TEC-REDs (Trans-Spliced Exon Coupled RNA End 
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Determination)(Hwang et al. 2004), and microarrays (Hwang et al. 2004; Blumenthal et al. 
2002). Would similar results be obtained by an entirely novel technique, deep sequencing? I 
subdivided the trans-spliced genes into three sub-groups; non-operon genes Figure 19B, first 
genes in operons  Figure 19C, and downstream genes in operons Figure 19D. Trans-spliced 
genes located outside of operons are trans-spliced, in general, to SL1 (Figure 19B). Similar to 
non-operon genes first genes in operons are trans-spliced to SL1, rather than SL2 (Figure 19C). 
In sharp contrast, genes annotated as downstream in operons are trans-spliced to high levels of 
SL2 or sometimes a mixture of SL1 and SL2 (Figure 19D). Overall, 81% of trans-splice genes 
have high levels of SL1 (>90% SL1), 14% have high levels of SL2 (>70% SL2) and only 5% 
have a mixture of the two SLs (>=10% SL2 and <=70% SL2). 
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Figure 19: SL1/SL2 trans-splicing ratios at each trans-spliced gene.  
Histograms showing the number of trans-splice sites with indicated SL1:SL2 proportion on the 
Y-axis. The X-axis shows the proportion SL1/SL2 by the opposing triangles and ranges from 
100% SL1 to 100% SL2. The binomial exact test was run on each SL1:SL2 ratio and samples 
with a p-value more than 0.05 were removed. A) All trans-splice sites that map to the 5’ ends of 
genes. B) All trans-splice sites at the 5’ end of genes not in operons. C) All trans-splice sites at 
the 5’ ends of genes that are the most 5’ in operons. D) All trans-splice sites at the 5’ ends of 
genes downstream in operons. 
 
Notably, there are ~150 genes annotated as downstream in operons whose mRNAs are 
trans-spliced almost entirely to SL1. These genes are likely of two types. The first type 
encompasses genes in SL1-type operons, where the trans-splice site occurs on the same 
nucleotide as the polyadenylation site of the upstream gene (Williams et al. 1999). It is unknown 
why the genes downstream in SL1-type operons are trans-spliced only to SL1. The second type 
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includes genes that have likely been mis-annotated as being within operons. We are examining 
these genes individually to correct the annotation. 
 
 
Percentage of gene sub-group that is trans-spliced 
 No cut-off 
Low  
(dcpm 0.05) 
Medium 
(dcpm 0.5) 
High  
(dcpm 5) 
Genes not 
in operons 47% (16660) 56% (13442) 65% (9316) 66% (2221) 
First genes 
in operons 88% (1253) 88% (1241) 90% (1177) 95% (343) 
Second 
genes in 
operons 95% (1236) 96% (1209) 97% (1132) 97% (188) 
 
Table 4: First genes in operons are more likely to be trans-spliced than non-operon genes.  
Three sub-groups were created; genes not in operons, first genes in operons, second genes in 
operons. The first column lists the gene sub-group. In the second column the percentage of the 
genes that trans-splice is shown. In the columns 3-5 an expression cut-off was used, to select for 
genes expressed at a high enough level to see the trans-splicing event. The number in parentheses 
indicates the total number of samples. 
 
First genes in operons are trans-spliced more frequently than non-operon genes 
 A common misconception about operons is that the first gene in an operon is always 
trans-spliced. This is clearly not true, as the first gene in one of the most studied operons, the 
mai-1, gpd-2, gpd-3 operon, is not trans-spliced. However I wondered if the first genes in 
operons were more likely to be trans-spliced than non-operon genes.  I used several cutoffs of 
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expression to determine what percentage of genes with certain expression levels was trans-
spliced. Of genes located at the 5’ ends of operons, ~88% are trans-spliced (Table 4). This is far 
higher than the percentage seen in non-operon genes. This result may be due to or be a cause of 
the earlier result that high expressed genes are more likely to be trans-spliced than are low 
expressed genes. Also, we note that a small percentage (5%) of genes annotated as second genes 
in operons were not detected in our data (Table 4, second genes in operons category (95% 
detected)). They may be expressed at too low a level to be detected or more likely they may have 
been mis-annotated as downstream in operons. 
 
 
The percent of SL2 varies as a function of the distance to the upstream gene  
It is well established that genes that receive SL2 are most often located within tight 
clusters of genes. We wondered if the genes that receive SL1/SL2 mixtures were also closely 
spaced. Therefore, I plotted the distance to the upstream gene vs. the percent SL2 (Figure 20).  
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Figure 20: SL2 trans-splicing as a function of distance between genes.  
The distance between the polyadenylation site of the upstream gene and the trans-splice site of 
the downstream gene (Y-axis) is plotted vs. the SL2 percent of the downstream gene (X-axis). 
The binomial exact test was run on each SL1:SL2 ratio and samples with a p-value of more than 
0.05 were removed.  Box and whiskers plot in which the top of the box equals the 1
st
 quartile and 
the bottom is the 3
rd
 quartile. The median value is denoted by a line within the box. The whiskers 
are 1.5x the inner quartile range. Outliers are represented by x. All three panels show the same 
data with progressive magnifications of the lower ranges. The top panel shows all values. The 
numbers above the top panel are the number of genes in each category. The dotted line in the top 
panel denotes the maximum value of the middle panel, in which only values below 10,000 are 
plotted. Similarly, the bottom shows only values below 1,000. On the right, the data for all 
currently annotated downstream operon genes is shown. 
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The box on the left shows that genes trans-spliced mostly to SL1 are in general quite far 
from the next gene upstream. However, the rest of the boxes clearly illustrate that with any 
amount of trans-splicing to SL2, the distribution of the distance to the next gene upstream is 
dramatically changed. This implies that even the genes with only 10% SL2 are likely in operons. 
The graph also demonstrates that, in general, the higher the percentage of SL2 trans-splicing the 
smaller the distance between genes.  Finally, the single bar to the right of the vertical line shows 
that when all of the genes annotated as downstream in operons are considered, the genes are, in 
general, quite close together. 
 
Elongated ICRs associate with elongated genes 
When I measured the lengths of all ICRs within annotated operons (Figure 20; Figure 
21), I found that most ICRs are 50-200 nts long (median = 129). However, the grey x symbols 
(Figure 20) represent outliers and there are notable exceptions that have very long ICRs, even 
greater than 2000 nts (Figure 20). By visual inspection of the data, I noticed the long ICRs 
tended to be associated with expanded genes, such as those genes in regions of the genome 
closer to the ends of the chromosomes (Prachumwat et al. 2004). It is unknown whether the ends 
of chromosomes contain elongated genes, but it may be due to insertions of repetitive DNA. 
Therefore, I asked whether long ICRs and long genes are associated. Because introns are also a 
non-coding transcribed region similar to ICRs, I used intron length as a proxy for gene length. 
The ICRs were divided into bins based on their lengths and the number of ICRs in each bin is 
listed above the bar. I removed from the data set any ICR adjacent to a gene with no introns.  In 
Figure 21B, the boxes show that as the ICR length increases, so does the intron length of the 
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adjacent genes. This suggests that expanded ICRs are sometimes associated with expanded genes 
and therefore are likely to be a consequence of the same phenomenon. 
 
Figure 21: ICR length vs. gene length. 
A) Histogram of all ICRs shows that most ICRs are less than 200 nt long. ICR length is in bins 
of 50nts. Number of ICRs with the indicated length is shown on the Y-axis. B) Box and whiskers 
plot of average intron length of the genes upstream and downstream of the ICR vs. the ICR 
length. Intron length was calculated as the sum of the average intron length upstream and the 
average intron lengths downstream of the ICR. The number of genes in each category is 
indicated by numbers above the graph. ICR lengths are in bins of 200nt. 
 
SL percentage and internal operon promoters 
SL1 trans-splicing should occur at the 3’ ends of outrons, and the promoter of SL1 genes 
should be adjacent to the trans-splice site and upstream of the outron. In contrast, SL2 trans-
splicing should occur at downstream genes in operons, more than a gene’s length from the 
promoter. The association between promoters and SL choice has not been studied globally. 
Additionally, some genes receive a mixture of SL1 and SL2. We speculated that pre-mRNAs 
from genes that receive a mixture of SL1 and SL2 would represent what has been termed ―hybrid 
operons‖. Hybrid operons contain two promoters; the operon promoter and the gene promoter. 
Perhaps precursors receive SL2 when transcribed from promoters at the 5’ ends of operons, 
whereas precursors receive SL1 when transcribed from a proximal promoter between the operon 
genes. This idea predicts a correlation between the presence of a proximal promoter and an 
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SL1/SL2 mixture at a given trans-splice site. As a mark of promoters, I used HTZ ChIP data 
(Whittle et al. 2008). HTZ is a histone H2A isoform that is present at promoter regions. In the 
ChIP-chip experiments to localize HTZ peaks throughout the genome, only 23% of annotated 
genes had an HTZ peak. Therefore some promoters may not have been detected. In addition, 
37% of operons contained internal peaks, possibly indicating internal promoters (Whittle et al. 
2008). HTZ peaks were used as a marker for promoters because they were the only mark 
available at the time of the analysis. 
Using HTZ as a marker for promoters, I noted which trans-splice sites were contained 
within HTZ peaks and which were not. I then divided the trans-splice sites into bins based on the 
ratio of SL1/SL2. Figure 22 shows that trans-splice sites with high SL1 are more likely to have 
HTZ than those with high SL2 [bins p-value by hypergeometric cumulative probability 
numbered from left to right: bin1=6E-08, bin9=7E-10, bin10=3E-26]. Trans-splice sites with a 
mixture of SL’s are the most likely to have an HTZ peak [bin2 =1E-08, bin3= 1E-02, bin3= 2E-
05, bin4=7E-05, bin5=1E-02, bin6=7E-01, bin8=5E-01]. I hypothesized that genes that receive a 
significant percentage of SL1 are transcribed from a proximal promoter. This would explain why 
trans-splice sites with high SL1 were more likely to be within an HTZ peak than trans-splice 
sites with high SL2. However, this does not explain why genes that receive a mixture of 
SL1/SL2 are more likely to be within an HTZ peak than isolated genes that get high SL1. I 
wondered if this result was due to our method of analysis: I required that the trans-splice site be 
within an HTZ peak. This requirement is necessary because if I allowed the peak to be upstream 
of the gene I might accidently detect a promoter adjacent to the upstream gene (especially within 
operons where genes are close together). However, the method is not perfect because in reality 
the HTZ peak for a gene can be anywhere upstream of the trans-splice site. For genes that 
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receive a mixture of SL1/SL2, which we annotated as in operons, the intergenic distances tend to 
be short (Figure 21), thereby limiting the space for an adjacent promoter to be near the trans-
splice site of the gene. Genes that receive primarily SL1, however, have a much longer distance 
between genes, and the promoter may therefore be farther from the trans-splice site.  
 
Figure 22: Relationship between trans-splicing specificity and proximal promoters.  
Below: Histogram of the total number of genes with indicated SL1/SL2 proportion. Above: the 
percent of those genes associated with a peak of the minor histone HTZ, which marks promoters 
(Whittle et al. 2008). A) Genes with high percent SL1 (low SL2) are more likely to be in an HTZ 
peak than genes with high SL2. Trans-splice sites with mixed SL are the category most likely to 
be in an HTZ peak. B) When genes with <500 bp intercistronic distance are analyzed, those 
trans-splice site with high SL1 or mixtures of SL1 and SL2 are even more likely to be in an HTZ 
peak. Dotted line indicates the percent of all genes with an HTZ peak (Whittle et. al. 2009). 
 
To determine if the distance between genes was affecting our ability to detect promoters, 
I limited the data set to genes that had less than 500 nts distance between them. Figure 22B 
shows that the percentage of genes with promoters detected goes up significantly when the 
distance between genes was limited.  The percentage of genes with high SL1 in HTZ peaks is 
nearly double the reported percentage of genes with HTZ peaks (Whittle et al. 2008), while the 
genes with mixed SL1/SL2 are still the most likely to be in an HTZ peak, and thus to have an 
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internal promoter. Finally, the percent of SL2 genes that have an HTZ peak does not increase 
substantially. 
 Interestingly, some genes with high SL2 have HTZ peaks over the trans-splice site. 
However, the HTZ peaks associated with these genes tend to be much longer than the peaks for 
the genes that get high SL1 (Figure 23). Longer peaks may be large enough to be associated 
with promoters of other genes. In any case, these data make it clear that higher levels of SL1 
trans-splicing are associated with the presence of proximal promoters. 
 
Figure 23: SL2 trans-splice sites in HTZ peaks tend to be within longer peaks.  
The percentage of peaks with each length was calculated for each of three categories; 1) all 
peaks, 2) all peaks that contain trans-splice sites, and 3) all peaks that contain trans-splice sites 
predominately trans-spliced to SL2. The ―all peaks‖ category contains all the peaks in the Leib 
lab data set and shows a distribution of peak sizes. The majority of peaks that contain trans-
splice sites are between 1000-2000 nts long. In contrast the peaks that contain SL2 trans-splice 
sites are in general greater than 3000 nts long, which implies that the peaks may be associated 
with promoters of upstream genes.   
 
0% 50% 100%
Peaks containing high SL2 
(>70%) trans-splice sites 
n=184
Peaks containing trans-splice 
sites n=2727
All peaks n=5159
Percentage of peaks with indicated length
Most SL2 sites are within long HTZ peaks
0-100
100-1000
1000-2000
2000-3000
>3000
74 
 
 
Figure 24: SL2 trans-spliced sites within HTZ peaks tend to be within long peaks.  
Diagram of one example of a trans-splice site that is trans-spliced to 97% SL2 and yet is located 
within an HTZ peak. Genes on the reverse strand are in cyan and forward strand are in pink. 
Gray regions are UTRs. The green box represents an operon. The red line points to the sight 
receiving 97% SL2 and the blue box above represents the HTZ peak, which is over 5000 nt long 
and encompasses several genes. 
 
Deletions of promoters in hybrid operons changes the SL1/SL2 ratio 
I reasoned that genes with mixtures of SL1/SL2 were likely to have two promoters:  the 
internal promoter, which creates the majority of transcripts trans-spliced to SL1 and the promoter 
at the 5’ end of the operon, which creates the transcripts trans-spliced to SL2. The high 
frequency at which the genes with SL1/SL2 mixtures had adjacent promoters, by the HTZ 
criterion, was consistent with this hypothesis. To further test this idea I searched the available C. 
elegans mutations for deletions upstream of genes with SL1/SL2 mixtures that would delete 
either the promoter at the 5’ end of the operon or the proposed internal promoter. I tested two 
candidate mutations: C23H3.4(ok1693) and tbb-1(gk207) (Figure 25).  
The deletion C23H3.4(ok1693) is within an operon and is 40 nts upstream of the trans-
splice site for the gene C23H3.4, which receives 71% SL1/29% SL2 (673 reads). Because of the 
mixture of SL1/SL2 and the presence of an HTZ peak, I predicted that C23H3.4 had an internal 
promoter. In C23H3.4(ok1693) over 2/3 (963 bp) of the ICR (1547 bp) upstream of C23H3.4 is 
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deleted, so I predicted that the hypothetical promoter might be removed (Figure 25A). I used 
RT-PCR to determine the level of C23H3.4 RNA relative to a control gene (rpl-26) and 
discovered that the level of C23H3.4 RNA had dropped ~4 fold in C23H3.4 (ok1693), 
supporting the idea that one of its two promoters had been deleted. I examined the ratio of SL1 
vs. SL2 using RT-PCR after normalizing loading to the transcript level of C23H3.4. As predicted 
by our hypothesis, deletion of part of an ICR containing the predicted internal promoter causes a 
dramatic shift in the SL1/SL2 ratio (Figure 25A). The percentage of SL1 trans-spliced product is 
much lower in the mutant strain whereas the percentage of SL2 trans-spliced product is higher. 
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Figure 25: Effect of promoter deletions on the SL1/SL2 ratio.  
Diagrams at the bottom of each panel are to scale. Pointed blue rectangles indicate genes, hollow 
pointed green rectangles indicate operons, and hollow red boxes indicate deletions. Black arrows 
indicate predicted locations of promoters and the triangle indicates the trans-splice site analyzed 
by RT-PCR. A) RT-PCR in wild type (WT) and C23H3.4(ok1693) (Δ). Left shows that in 
comparison to the loading control the level of C23H3.4 has dropped in the deletion strain. To 
make visualization of SL1/SL2 ratio easier, in the gels on the right the SL1 and SL2 PCRs have 
been normalized based on the transcript level of C23H3.4. In wild type, SL1 is present at higher 
levels than SL2. In the deletion strain the pattern has changed, SL2 is greater than SL1. B) RT-
PCR in wild type (WT) and tbb-1(gk207) (Δ). Left shows RT-PCR of mature mRNAs. The two 
upstream genes in the operon have lost expression demonstrating that the promoter has been 
deleted. In contrast, W09D10.1 has not lost much expression.  Right shows RT-PCR of 
W09D10.1 trans-spliced to SL1 and SL2, and the ratio has again changed: SL2 trans-splicing has 
been lost.  
 
Would a deletion of the promoter at the 5’ end of an operon lower the level of SL2 trans-
spliced product of a downstream gene that receives a mixture of SL1/SL2? I tested the mutation 
tbb-1(gk207) which deletes the majority of the region upstream of the operon CEOP3700.  This 
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deletion also removes the trans-splice site of the first gene. The third gene in the operon, 
W09D10.1, has two trans-splice sites 6 nts apart, which both receive mixtures of SL1/SL2. 
Based on RNA sequencing data, W09D10.1 cumulatively receives 44% SL1/56% SL2 (381 
reads). I performed RT-PCR to show that the mutation eliminates expression of both the first and 
second genes in the operon (Figure 25B), indicating that the operon promoter has indeed been 
deleted. However, the third gene, which I predicted to have an internal promoter because of HTZ 
and the mixture of SL1/SL2, does not lose expression. Consistent with our expectation, by 
removing the promoter at the 5’ end of the operon, the level of the SL2 trans-spliced product is 
dramatically reduced, whereas the level of SL1 trans-spliced product remains unchanged. These 
data are consistent with the idea that transcripts of downstream operon genes emanating from the 
promoter at the 5’ end of the gene cluster are primarily SL2 trans-spliced, whereas transcripts 
coming from a proximal-internal promoter are essentially outron-containing transcripts and are 
therefore SL1 trans-spliced.  
 
Most annotated operons can be computationally predicted 
Prior to this work operon annotations were completely hand curated by Tom Blumenthal 
based on both a short distance to the upstream gene and presence of some SL2 (gathered from 
ESTs, TEC-REDs, and microarrays). To determine if the annotated operons, in general, matched 
what was seen in our data set, I computationally predicted a complete set of operons based solely 
on trans-splicing data. Distance to the upstream gene was not used as a criterion in my analyses, 
since recent results suggest operon genes are sometimes far apart (Jason Morton et. al. 2010, 
submitted).  
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To create a computationally predicted list of operons, I analyzed each gene. If a gene was 
trans-spliced to >=10% SL2, I predicted it was in an operon with its upstream gene. If multiple 
genes in a row were trans-spliced to SL2, they were all included in the operon. The first gene of 
the computationally predicted operons had to be either not be recognized as trans-spliced or 
trans-spliced to greater than 90% SL1. When my computationally predicted operons were 
compared to the currently annotated operons 70% of the operons matched completely (meaning 
they contained all of the same genes). Another ~20% were partial matches, meaning that at least 
two of the genes in an annotated operon were together in a computationally predicted operon. 
Therefore ~90% of the annotated operons can be predicted solely on the basis of SL2 trans-
splicing. The genes that are in the annotated list and not in the predicted list or genes that are in 
the predicted list and not in the annotated list are discussed in the discussion.  
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Figure 26: The majority of annotated operons are computationally predicted based solely 
on SL2 trans-splicing.  
Computationally predicted operons were predicted solely on the basis of genes that receive SL2. 
Genes that receive >10% SL2 were considered downstream in an operon and the operon 
extended 5’ until a gene was found that did not have >10% SL2. Left shows Venn diagram of the 
exact overlap (n=912) of the annotated (n=1267) and predicted (n=1423) operons. Depicted in 
the diagram below the Venn diagram is the definition of exactly-matching operons. The blue 
outline is an operon around three genes represented by colored arrowhead rectangles. If an 
operon has three genes in the annotated operon list, the operon must contain exactly the same 
three genes in the predicted operon list to be called an exactly-matching operon. On the right, a 
second Venn diagram shows the percentage of all operons that have exactly matching or partially 
matching operons. A partial match is when an operon in one operon list has at least two of the 
same genes as an operon in the other list. Depiction of an example of a partial match is 
diagramed above the Venn diagram. The top operon contains three genes (the red, green and 
orange genes). The bottom operon has two genes in common with the top operon and is therefore 
a partial match (the green and orange genes).   
 
Rare trans-splicing to cis-splice sites 
Thus far I have focused on the trans-splice sites that map to the 5’ ends of genes. 
However, I noted that higher numbers of sequencing runs were associated with higher levels of 
rare trans-splice sites that map to sites other than the 5’ end of any gene. The number of these 
sites was higher as the number of sites found at new 5’ ends of genes became saturated. I noticed 
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that many of the less abundant and newly recognized trans-splicing events mapped to annotated 
cis-splice sites (Table 1; Table 2). In Table 5, I show the number of gene trans-splice sites and 
the number of trans-spliced cis-splice sites recognized if I require more than one read to include 
a site. Interestingly, many trans-spliced cis-splice sites have only one read. It has been 
recognized previously, both in vitro and in vivo, that trans-splicing sometimes occurs at cis-
splice sites (Erika L. Lasda et al. 2010; Choi and Newman 2006). In fact, because the 3’ splice 
sites used in cis-splicing and trans-splicing have the same consensus sequence (Bektesh and 
Hirsh 1988; J Thomas 1988), it is somewhat surprising that trans-splicing at cis-splice sites is not 
even more prevalent. I determined that the average distance to the first AUG for the trans-spliced 
genes is smaller than the average distance to the first AUG after the trans-spliced cis-splice sites. 
Additionally, one third of the first AUGs after the trans-spliced cis-splice sites are in the same 
frame as the cis-spliced version. This is not more than expected by chance, and implies that 
trans-splicing to cis-splice sites is not a general mechanism for creating large numbers of 
alterative isoforms. 
Minimum 
Number of 
Reads 
Trans-splice sites at the 
5’ end of genes  
Trans-splice sites  
at cis-splice sites  
1 13462(100%)  
 
11827(100%) 
2 12721(94%) 6895(58%) 
5 11606(86%) 3462(29%) 
10 10676(79%) 2128(18%) 
50 8317(62%) 695(6%) 
 
Table 5: Rare trans-splicing at cis-splice sites.    
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I calculated the number of gene trans-splice sites or trans-spliced cis-spliced sites that have 
greater reads than the minimum number of reads in the left hand column. As the minimum 
number of reads increases, the number of sites detected decreases.   Requiring at least 2 trans-
spliced reads at each site drops the number of cis-splice sites detected from 11,827 to 6895. This 
indicates the trans-splicing events are rare. 
 
Trans-splicing to Cis-splice Sites Occurs at the 3’ Splice Site of Long Introns 
I found that in total 11,827 trans-splicing events map to cis-splice sites (11% of all known 
cis-splice sites; Table 2). These rare trans-splicing events tended to occur in long introns, as 
previously reported by Choi and Newman (2006). I analyzed all introns, grouping them into bins 
based on their length. As seen in the bottom of Figure 27  the majority of C. elegans introns are 
very small (<200 nt). In fact, 47% of introns are between 41 and 60 bp (Choi and Newman 
2006). However, as the upper graph shows, very few of the small introns are ever trans-spliced. 
Furthermore, the larger an intron is, the greater the likelihood of a trans-splicing event. Of the 
~3000 introns with lengths greater than 1800 nts, 50% are trans-spliced at least one time in our 
data set.  
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Figure 27: Rare trans-splicing at intron 3’ splice sites vs. intron length.  
Introns were divided into bins of 200 nts according to their length.  Right: all trans-spliced cis-
splice sites. Left: all trans-spliced cis-splice sites with two reads or more. The bottom graphs 
show the number of introns in the genome with the indicated length. The top graphs shows the 
percent of the introns in each bin that have an associated trans-splicing event.  
 
Trans-splicing to Cis-splice Sites is mostly SL1 
Finally, I wondered if the trans-splicing events occurring at cis-splice sites were mostly 
SL1, or were some of the cis-splice sites trans-spliced to SL2. We found almost all sites are 
highly or fully SL1trans-spliced (Figure 28). This may be because SL1 is the default SL or it 
may be because SL1 RNA is at 10 fold higher levels than SL2 (S. Kuersten, R. Conrad, and T. 
Blumenthal, unpublished data). There are a few sites (<100) that receive some SL2. Visual 
inspection reveals that these sites are generally either 5’ ends that have not been currently 
annotated, or alternative operons (Morton et. al. 2010).    
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Figure 28: Trans-spliced cis-splice sites generally splice to SL1. 
For explanation of figure axes see Figure 18. Trans-spliced cis-splice sites are shown. The 
binomial exact test was used to remove any sites whose SL1/SL2 ratio had a p-value of more 
than 0.05. The majority of trans-spliced cis-splice sites have high SL1 (>90% SL1). Fewer than 
100 sites have greater than 10% SL2.  
 
 
Trans-spliced genes have very short 5’ UTRs 
 By selecting only the trans-splice sites that mapped to the 5’ end of a gene, I was able to 
define the 5’ UTRs for ~10,000 genes. I determined the distance from each gene trans-splice site 
to the first start codon (AUG) downstream. The length of each UTR is the distance to the first 
AUG plus the length of the SL exon (22nt).  I showed that the majority of trans-splice sites are 
very close to the first AUG downstream (Figure 29). Most were less than 100 nts and almost 
1000 trans-splice sites were directly adjacent to the AUG. A similar pattern was seen in 1997 
(Thomas Blumenthal and Steward 1997b) with 83 genes, so I compared the previous results with 
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the results I obtained (Figure 30). I found many more long UTRs than was originally found, 
likely due to the low number of genes used in the original data.   
 
Figure 29: Trans-splice sites are close to the first AUG downstream.  
I calculated the distance from each trans-splice site at the 5’ end of a gene to the first start codon 
downstream and created a histogram of distances. A) Distances were binned in 1 nt bins from 0 
to 99 and the last bin contains all distances greater than or equal to 100 nts. B) Distances were 
binned in 100 nt bins and the last bin contains all distances greater than 400 nts. 
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Figure 30: Comparison of the 1997 and current measures of the percentage of trans-spliced 
genes with the indicated distances from the trans-splice site to the AUG. 
Trans-splice sites were binned with respect to the distance from the trans-splice site to the first 
AUG (1997 values from (Blumenthal and Steward 1997b). Percentage of the trans-splice sites in 
that category is on the Y axis. The current estimates have many longer UTRs than in seen in the 
smaller dataset from 1997. For genes with multiple trans-splice sites, all trans-splice sites were 
included. 
 
 
SL2 trans-spliced genes are slightly more likely to have a start codon directly adjacent to 
the trans-splice site 
When I performed a similar analysis on trans-splice sites with a majority of SL1 (>90%) 
or a majority of SL2 (>70%) I saw a small difference between the populations. I binned the 
UTRs in 1 nt bins. For 6% of SL1 trans-spliced genes, the AUG begins on the first nt after the 
trans-splice site (binomial exact p-value 1.02421E-06). In contrast, 14% of SL2 genes have an 
AUG immediately adjacent to the splice site (binomial exact p-value 2.05371E-14)(Figure 31). 
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Figure 31:  Fourteen percent of SL2 genes have a trans-splice site directly adjacent to the 
first AUG downstream. 
Percentage of genes in two categories are shown: SL1 genes that get greater than 90% SL1 and 
SL2 genes that get greater than 70% SL2. X axis shows distance from trans-splice site to the first 
AUG downstream. The Y axis shows the percentage of sites in each category. In the left most 
bin the trans-splice site is directly adjacent to a start codon. The left most bin shows the largest 
difference between the populations. 
 
Discussion 
Analysis of the large collection of modEncode RNA sequences has solidified past 
observations about trans-splicing while enhancing our understanding of the relationship between 
trans-splicing and other features of the genome including the distance between genes, the 
presence of promoters, and the annotation of operons. I have studied trans-splicing in C. elegans 
at a global level and shown that SL1 and SL2 trans-splicing are distinct phenomena and that the 
percent of genes whose transcripts are subject to trans-splicing (trans-spliced genes) may be 
somewhat lower than previous estimates.  
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Finding trans-splice sites using RNA-seq and categorizing trans-splicing events  
RNA-sequencing unveiled ~28,000 positions in the genome that are trans-spliced.  I used 
annotated 5’ ends of genes and annotated cis-splice sites to discover which trans-splicing events 
were at the 5’ ends of genes or at cis-splice sites. I used multiple criteria in an attempt to discover 
all trans-spliced genes. I first used the criterion that a trans-spliced position had to be within 50 
nts of an annotated 5’ end to be categorized as a gene trans-splice site. This criterion may have 
been too narrow. Annotations of C. elegans 5’ ends are inconsistent and so the criterion was 
adjusted. When I widened the criterion I discovered that nearly half of the trans-spliced positions 
(13,462) map within 500 nts of a 5’ end. The average gene length in C. elegans is 2.5kb. 
Therefore I did not increase the allowable distance above 500 nts (Katju and Lynch 2003).  Forty 
percent of the trans-spliced positions are within 10 nt of a cis-splice site (11827).   The other 
10% do not map to either of these categories but may belong to genes that are unannotated, genes 
with alternative/unmapped 5’ ends, and genes with internal trans-splice sites that do not map 
near a cis-splice site or within 500 nts from the 5’ end of a gene.  
 
 
Frequency of Trans-splicing 
Almost all trans-splice sites that map to the 5’ ends of genes are trans-spliced nearly all of 
the time (Figure 14). This suggests that trans-splicing is in general very efficient. However, 
there were some trans-splice sites that showed a lower frequency. Sites with a low frequency of 
trans-splicing could occur in at least three situations: a trans-splice site of a gene for which a 
large proportion of the transcripts are pre-mRNAs, a trans-splice site located in an unfavorable 
region (i.e. GC rich sequence or other), or a trans-splice site with a poor match to the 3’ spice site 
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consensus sequence. I have shown that at least some of the sites with a low frequency of trans-
splicing have poor matches to the consensus (Figure 15).  
 
What percentage of C. elegans genes are trans-spliced?  
In 1994, it was estimated that 70% of C. elegans genes were trans-spliced (Zorio et al. 
1994). That estimate is similar to the genome-wide estimate presented here: ~60% of genes are 
trans-spliced. However, there are two potential issues with this estimate. First, detection of trans-
splicing is dependent on sufficient expression. My data clearly show a trend that using higher 
expression cutoffs reveals a higher percentage of genes trans-spliced. This trend could be due to 
higher levels of trans-splicing in highly expressed genes, or alternatively, failure to detect trans-
splicing of genes expressed at low levels. The former is most likely true because when genes 
were binned by expression level, the higher the expression the more likely the gene was to be 
trans-spliced even at very high expression levels where detection of trans-spliced genes should 
be saturated. Second, the lack of proper 5’ end annotations may affect my estimate. This should 
not be a large problem, because I allowed the trans-splice site or the first AUG after the trans-
splice site to map within 500 nt of any annotated 5’ end. I suggest few annotated trans-spliced 
genes should have annotated 5’ ends more than 500nt away from both the trans-splice site and 
the first AUG, because most mis-annotated 5’ ends are annotated as the position of the start 
codon of the gene and most 5’ UTRs are <500 nts.  
In 1994, it was also estimated that 55% of C. elegans genes are trans-spliced to SL1, 
while 15% are trans-spliced to SL2.  My data are more detailed, since they also include a third 
category, genes trans-spliced to a mixture of SL1 and SL2, as defined by genes that get >10% 
but <70% SL2.  With this new category, I estimate that 40 % of C. elegans genes are not trans-
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spliced, 82% are trans-spliced to SL1, 13% are trans-spliced to SL2, and 4% are trans-spliced to 
a mixture of the two spliced leaders. 
 
SL2 and SL2 variants 
 There is a population of trans-splice sites that receive 100% SL1. There is also a 
population of trans-splice sites that receive ~10% SL1, ~65% SL2 variant, and ~25% SL2; few 
genes receive 100% SL2 variant or 100% SL2. This demonstrates that genes trans-spliced to SL2 
are also trans-spliced to SL2 variants. Visual inspection of the ESTs of genes that are trans-
spliced to SL2 seems to show more trans-splicing to SL2 than to SL2 variants. Conversely, in 
our sequencing reactions in general, genes trans-spliced to SL2 have somewhat more SL2 variant 
than SL2. The reason for this observation is unknown, but it could be a consequence of 
molecular technique or of computational processing. Given that the SL2 and SL2 variant reads 
are trans-spliced to the same sites, I combined the SL2 and SL2 reads into one category called 
"SL2" for subsequent analyses. 
 
 
SL1 and SL2 trans-splicing are distinct phenomena.  
My data indicates that for the majority of trans-splice sites either SL1 or SL2 dominates; 
a mixture is uncommon. Furthermore, SL1 is used far more commonly than SL2. At least two 
theories could explain how SL1 and SL2 are specified. First, both types of trans-splice sites may 
have surrounding sequences that signal SL1 or SL2 specificity. Consistent with this idea, an Ou 
element has been identified upstream of SL1 genes (Graber et al. 2007). However, the Ou 
element and the Ur element of SL2 genes share many features and they may function in 
enhancing trans-splicing rather than in SL choice. A second idea is that SL2 may be specified, 
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while SL1 is used as the default SL. If SL1 is the default SL there are at least three reasons why 
SL2 genes may receive a low level of SL1: 1) SL2 may be imperfectly specified, 2) the speed of 
SL2 trans-splicing may be limited and sometimes SL1 may outcompete SL2, and 3) the SL2 
RNA is at ~10-fold lower levels then the SL1 RNA (S. Kuersten, R. Conrad, and T. Blumenthal, 
unpublished data).  Finally, one other rationale for suggesting SL1 is the default SL is that cis-
splice sites, which are trans-spliced infrequently, tend to be trans-spliced to SL1, rather than SL2, 
although this could again be a consequence of the 10-fold higher level of SL1 RNA (Figure 28). 
 
SL2 trans-splicing and the annotation of operons.  
The most definitive way to demonstrate the existence of an operon would be to identify a 
polycistronic RNA. However, because of processing of the pre-mRNA, both by 3’ end formation 
and trans-splicing between the genes, detecting polycistronic RNAs has proved possible only 
occasionally, so an alternative method must be used. So far, operons have been manually curated 
using the dual criteria of trans-splicing to SL2 and short intercistronic distance. This thesis 
demonstrates that annotation based on these criteria is generally quite accurate.  
Interestingly, visual inspection of the computationally predicted operons that are not in 
the list of annotated operons (Figure 26), showed a specific reason they might have been 
excluded from the annotated list. These computationally predicted operons often involve genes 
with great distances between them. Hand annotation required both SL2 trans-splicing and a short 
distance to the upstream gene, so many of the novel predicted operons would have been 
disqualified because of the distance between the genes. These computationally predicted operons 
with large ICR lengths may be real operons, since Jason Morton in the Blumenthal Lab has 
demonstrated at least two operons have more than 2 kb between genes (Morton et. al. 2010, 
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submitted). Alternatively, within these operons there may be closer unannotated genes that could 
serve as the real first genes of the operons. 
 Operons not discovered by the computational predictions but that are within the 
annotated list have at least five possible causes: 1) genes whose trans-splice sites were too far 
from the annotated 5’ end and were therefore not categorized as trans-spliced, 2) genes that are 
expressed at such a low level their trans-splice site was not found in the data set , 3) SL1 genes 
that are so highly expressed that even a 1% proportion of SL2 was enough to be picked up by the 
past methods of SL2 gene recognition (microarray or TEC-red), 4) genes mis-annotated as SL2 
trans-spliced by microarray or TEC-Red and 5) SL1-type operons. These annotated operons will 
need to be examined to determine if they are really operons. 
 
SL trans-splicing and distance to upstream genes 
I have shown, at the whole genome level, a very strong relationship between high levels 
of trans-splicing to SL2 and presence of another gene nearby in the same 5’ to 3’ orientation. 
Furthermore, I demonstrate a strong relationship between the SL2 percent and the distance to the 
nearest upstream gene. What is responsible for this relationship?  I hypothesize that it is related 
to the mechanism of SL2 trans-splicing.  Indeed, it constitutes an important hint as to what that 
mechanism might be. Close apposition of the 3' end formation machinery and the trans-splicing 
machinery seems to favor SL2 trans-splicing. This suggests that the 3' end formation machinery 
acting just upstream of the SL2-accepting trans-splice site is at least partly responsible for the 
choice of SL2.  This is supported by the previously demonstrated association between the 3' end 
formation factor and the SL2 snRNP, an association that is dependent on the exact sequence of 
the loop at the top of the third stem (D Evans et al. 2001). 
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Genes that receive mixtures of SL1 and SL2 are close together, though not as close as 
genes that receive high levels of SL2. In contrast, SL1-trans-spliced genes very rarely have 
closely spaced upstream genes in the same orientation. For this reason, I feel confident that most 
operons can be identified using SL2 trans-splicing.  However, there are a few examples in the 
genome where high levels of SL2 trans-splicing occur without a gene just upstream. These could 
be due to some operons having long spacing between genes. Long ICRs are in some cases the 
product of an expanded genic region (Figure 21). In these cases the forces that either cause or 
allow introns to be long, also seem to cause or allow ICRs to be long. Alternatively, these rare 
cases of high levels of SL2 trans-splicing to genes without a gene just upstream could be due to 
failure to properly annotate the upstream gene or even the presence of a gene that has not been 
annotated at all. 
  
SL2 percent and HTZ peaks. 
 SL1 trans-spliced genes should be adjacent to a promoter and SL2 trans-spliced genes 
should arise from the promoter adjacent to an upstream gene. When we compared the percentage 
of high-SL1 trans-splice sites within an HTZ peak to high-SL2 trans-splice sites within an HTZ 
peak, we expected that SL1 trans-splice sites would reside within peaks, while SL2 trans-splice 
sites would not be associated with peaks. 
Thirty percent of SL1-gene trans-splice sites (>90%SL1) are within an HTZ peak (which 
is higher than the % of total genes with a peak). Since SL1 genes generally have larger distances 
between genes, there is a large region in which a promoter can reside. By requiring the peak to 
contain the trans-splice site, I found only promoters directly adjacent to the trans-splice site. 
Therefore, I limited distance between the genes in an attempt to select for genes which were 
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closer to their promoters. The percent of SL1 gene trans-splice sites within HTZ peaks rose to 
40%. Conversely, only ~10% of genes which receive high SL2 have trans-spice sites within an 
HTZ peak. This number did not increase when the distance between genes was limited. 
Additionally, I have shown that many of the SL2 sites are within extremely long peaks which 
have the capacity to encompass more than one gene.  This result demonstrates that SL1 trans-
splice sites are far more likely to be within HTZ peaks than SL2 trans-splice sites. SL1 trans-
splicing may be a direct effect of promoter proximity and sequence motifs near promoters or 
may be an indirect effect based on SL1 being the default SL. 
 Trans-splice sites with a mixture of SL1/SL2 have not been subject to global analysis 
previously. I showed that these sites are the mostly likely to be within HTZ peaks. When I 
required a smaller distance between genes for the analysis, this increased the percentage of trans-
splice sites within a peak, demonstrating that the limited distance between genes may limit the 
location of the promoter.  The fact that these sites are the most likely to be within a peak suggests 
that some or all of the sites are adjacent to a promoter 
  
Deletions near genes trans-spliced to a mixture of SL1 and SL2.  
The presence of high levels of SL1 is linked with the presence of a proximal promoter, 
whereas the presence of high levels of SL2 is linked with the lack of a proximal promoter. Thus, 
SL2 trans-splicing is reserved for genes that are downstream in operons. Interestingly, however, 
there are a few genes that receive a mixture of SL1 and SL2, and I suggest that these genes are 
properly annotated as operons. Our results suggest that these genes are members of hybrid 
operons. Genes with as low as 10% SL2 have a restricted distance to the upstream gene (Figure 
21). This implies that these genes are required to be close together and are therefore in operons. 
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Also, genes that receive both SL1 and SL2 often have HTZ peaks associated with their trans-
splice sites, indicating that there is a promoter between the genes.  
The genes in these operons can most likely be transcribed from two different promoters. I 
hypothesized that when a gene within a hybrid operon is transcribed from the promoter upstream 
of the operon, a polycistronic mRNA is created, and SL2 is trans-spliced. When the same gene is 
transcribed from the promoter located adjacent to it, the pre-mRNA has an outron and SL1 is 
trans-spliced. If the two promoters were used to similar extents, this would create the observed 
mixture of spliced leaders. This hypothesis is consistent with the results seen in the two deletion 
strains analyzed.  
In the CEOP2004 operon, the gene C23H3.4 is trans-spliced to a mixture of SL1/SL2, 
and so could have two promoters. When the region directly upstream of this gene was deleted in 
C23H3.4(ok1693), the total level of the transcript decreased, consistent with it having an 
adjacent promoter. The ratio of SL1/SL2 also changed: the SL1 proportion decreased while the 
SL2 proportion increased. This is likely due to the deletion of an internal promoter. Of course the 
deletion has also moved the genes in the operon closer together, which might also result in 
increased SL2.  
In the CEOP3700 operon, the gene W09D10.1 is trans-spliced to a mixture of SL1/SL2. 
In the mutation tbb-1(gk207) the promoter at the 5’ end of the operon has been deleted, which 
results in the complete loss of expression of the first two genes. However, W09D10.1 is still 
expressed, a clear indication that it is not transcribed solely from the promoter at the 5’ end of 
the operon. The overall expression of this gene is not decreased, which may mean that the 
internal promoter is more active in the mutant, or there is some other form of expression level 
regulation. Even though the level of the W09D10.1 mRNA did not change, the SL1/SL2 ratio 
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did. Consistent with our hypothesis, the percent of transcripts trans-spliced to SL2 decreased 
dramatically, as would be expected if SL2 trans-spliced products are transcribed from the 
promoter at the 5’ end of the operon. Interestingly, even with this promoter deleted, there is still 
a small amount of SL2 trans-spliced mRNA, which could come from the adjacent promoter or 
from residual transcription upstream.  
 
Trans-spliced genes have very small 5’ UTRs. 
 The majority of trans-spliced 5’ UTRs are very short (over ½ are under 35 nts) (Figure 
29). This may be an advantage for trans-spliced genes. First, the ribosome is able to spend less 
time scanning for the start codon when the 5’ UTR is short. Second, accumulating AUGs 
upstream of a trans-splice site would not be deleterious. In contrast, for genes without a trans-
splice site accumulating an AUG anywhere between the promoter and the real start codon could 
have deleterious effects.   
 In addition, I have shown that trans-splice sites directly adjacent to start codons are more 
prevalent in the SL2 population than the SL1 population (Figure 31). I suspect this is due to the 
3’ ends of the 22nt SL1 and SL2 exons: the last 3 nts of the SL1 exon are GAG whereas the last 
three nts of the SL1 exon and its variants are AAG. It has been shown that the majority of 
translation start sites in C. elegans have information content 5’ to the AUG and have a consensus 
of AAAAUG as do yeast and ciliates (Blumenthal and Steward 1997b). In yeast, this consensus 
was shown to be important for translation efficiency and the -3 position was shown to have the 
most impact on translation (Pittman and Dever 2010). Therefore, when the AUG is directly 
adjacent to the SL2 trans-splice site, the -3 position from the AUG is an A (AAG|AUG), 
predicted to enhance translation. When the AUG is directly adjacent to the SL1 trans-splice site, 
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the -3 position from the AUG is a G (GAG|AUG), which should not enhance translation. I 
suggest this dissimilarity in the -3 position may account for the differences in the percent of 
genes containing an AUG directly adjacent to the trans-splice site.  
 
Low-level trans-splicing at cis-splice sites. 
Cis-splice sites are trans-spliced very rarely, but more often when the intron is large. 
These sites are in general trans-spliced to SL1 rather than SL2. At least two theories explain 
trans-splicing to cis-splice sites. First, this trans-splicing could be due to weak promoters within 
the introns that cause a very low level of transcription (Choi and Newman 2006). Second, the 
long introns may be sometimes interpreted as outrons by the splicing machinery since any AU-
rich sequence can act as an outron at the 5’ end of an mRNA (R Conrad et al. 1995) and an 
outron can be converted to cis-splicing by inserting a 5’ splice site within it (R Conrad et al. 
1991) It is clear that cis- and trans- splice sites are interchangeable given the appropriate pre-
mRNA context.  
I hypothesize that long introns are more easily mistaken for outrons because of the 
increased physical distance between the 5’ and 3’ splice sites. If these trans-splicing events 
represent inaccuracies, as seems probable, this may explain why C. elegans introns are typically 
quite short (Blumenthal and Steward 1997b). To prevent inappropriate trans-splicing that would 
destroy transcripts, introns in C. elegans may have shortened over evolutionary time. Mistaken 
trans-splicing could also be a regulatory mechanism for genes with large introns. Trans-splicing 
to a cis-splice site could be used to inactivate transcripts depending on circumstances. In 
addition, there are several cases reported in the literature of trans-splicing to a cis-splice site that 
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creates an alternative isoform which is functional when translated (Yin et al. 2010; Choi and 
Newman 2006).  
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CHAPTER 4 
 
CIDS-1, CIDS-2 and SRp20’s Context Specific Enhancement of 3’ End Formation and 
Transcription Termination 
 
Portions taken from ―Genes involved in pre-mRNA 3'-end formation and transcription 
termination revealed by a lin-15 operon Muv suppressor screen.‖ 
 
Cui M*, Allen* MA, Larsen A, Macmorris M, Han M, Blumenthal T. 
*Authors contributed equally to this work. 
 
 
Introduction 
C. elegans operons provide a useful framework for unraveling the processes of 3’ end 
formation and transcription termination.  Operons employ co-transcriptional 3’ end formation to 
separate individual cistrons from the polycistronic RNA. In typical systems, 3’ end formation 
and transcription termination (release of Pol II from the DNA) are inextricably linked.  In sharp 
contrast, for C. elegans operons the two processes must be separate; otherwise, Pol II would 
terminate before transcribing the downstream genes. This makes C. elegans an optimal organism 
for studying 3’ end formation and transcription termination factors. We discovered potential 
novel 3’ end formation and transcription termination factors while looking for suppressors in a 
C. elegans strain with a unique deletion/insertion within an operon. 
The C. elegans lin-15 operon used in our screen contains two genes, lin-15B and lin-15A, 
which are both involved in vulval development (Clark et al. 1994; LS Huang et al. 1994). lin-
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15B and lin-15A belong to the class B and class A synthetic Multivulva (SynMuv) genes, 
respectively. The SynMuv phenotype, multiple vulva (Muv), requires loss of function of one A-
class and one B-class gene (reviewed in (Fay and Yochem 2007). Uniquely, the lin-15 operon 
contains one member of each class transcribed from a single promoter upstream of the first gene, 
lin-15B. Nevertheless, a single mutation, lin-15B(n765), was able to reduce or eliminate 
expression of both genes.  
In order to search for the potential targets or regulators of the SynMuv genes, a genome-
wide RNAi screen was carried out on the lin-15B(n765) mutant strain (Cui, E. Bridget Kim, and 
Min Han 2006). Fourteen suppressors were allele specific, and interestingly, the allele-specific 
group contained genes that encode subunits of the known 3’ end formation factors CstF and 
CPSF.   I demonstrate here that the lin-15B(n765) mutation is a deletion/insertion that inserts the 
3′-end formation region from another gene into lin-15B. The mutation results in a premature 3′-
end formation signal in lin-15B and therefore interferes with complete transcription of the 
operon, such that lin-15A expression is reduced. Many genes in the allele-specific class are 
known 3′-end formation factors. Thus the remainder of this class of suppressors is of special 
interest, because they could play previously unknown roles in 3′-end formation or transcription 
termination. In this chapter, I report analysis of four of the less-characterized suppressors, three 
containing CIDs and one SR protein. 
 
Results 
The lin-15B(n765) mutation is a unique insertion  
Although lin-15B(n765) was preliminarily characterized as a 200 bp deletion (Clark et al. 
1994), I cloned and sequenced the lin-15B(n765) mutation and identified it as deletion/insertion 
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(Method Section p. 39). I found that a 171-bp DNA fragment was deleted from the third exon of 
the lin-15B gene and a 928-bp DNA fragment was inserted in the same location (Figure 32). The 
928bp insertion contains the 3’ end cleavage and polyadenylation signal of the unrelated 
H18N23.2b gene (See Materials an Methods for sequence p. 39). Furthermore, the insert creates 
a stop codon and a polyadenylation site in the third exon of lin-15B.  
 
Figure 32: The lin-15B(n765) inserted 3’ end is cleaved/polyadenylated and thus reduces 
cleavage/polyadenylation of the real lin-15B 3’ end.   
Wild-type (N2) and lin-15B(n765) total RNAs were isolated and reverse transcribed with an 
anchored oligo(dT) primer.  To amplify the inserted 3’ ends, the two primers in blue were used 
sequentially with oligo(dT) (Gel A). The lin-15B(n765) strain shows a new polyadenylated 3’ 
end, exactly where the inserted sequence indicates 3’ end formation should occur. To amplify the 
actual lin-15B 3’ end, the two primers in red were used in sequential inner and outer PCRs with 
oligo(dT) as the reverse oligo. Gel B demonstrates the use of the real lin-15B 3’ end has 
decreased in the lin-15B(n765) mutant. 
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I used RT-PCR to determine if the inserted 3’ end is cleaved and polyadenylated and if 
use of the 3’ end of lin-15B has decreased (Figure 32). The top of the figure depicts lin-15B. 
First, using an anchored oligo(dT), I reverse transcribed total RNA from mixed stage wild-type 
(N2) and lin-15B(n765) worms. To detect if the inserted 3’ end was being cleaved and 
polyadenylated, I did nested PCR. In gel A, no band is present in the wild-type lane because 
there is no insert. In the lin-15B(n765) lane, the band of about ~250 indicates that the lin-
15B(n765) inserted 3’ end is cleaved and polyadenylated, creating a short lin-15B transcript. The 
shortened transcript likely encodes a truncated protein without its predicted DNA binding 
domains.  
Because the inserted 3’ end is being cleaved and polyadenylated, we predicted use of the 
lin-15B 3’ end would decrease. To test this idea, I amplified the 3’ end of lin-15B by nested 
PCR. Gel B shows a product in both lanes corresponding to use of the lin-15B 3’ end (Figure 
32). The wild-type lane (left) clearly shows more product than the lin-15B(n765) lane (right), 
indicating that the 3’ end of lin-15B is used less in the lin-15B(n765) strain. This is likely due to 
a lack of RNA polymerase reaching that 3’ end. Finally, the rest of the lin-15B operon has been 
sequenced, and no other mutations were found. Therefore, the single DNA lesion contained 
completely in the lin-15B gene causes the SynMuv phenotype of the strain. 
 
lin-15B(n765) causes a drastic reduction of the lin-15A mRNA level  
Since a SynMuv phenotype requires inhibition of both a class A and a class B SynMuv 
gene, the lack of full length lin-15B transcript created by the lin-15B(n765) mutation would not 
be predicted to be sufficient to cause the SynMuv phenotype. The deletion/insertion in lin-15B 
must also affect another gene, specifically a SynMuv A gene. Since lin-15A is located just 
downstream of lin-15B and within the same operon, lin-15A was a likely candidate. In wild-type 
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worms, the 3’ end formation signal of lin-15B is only ~100-bp upstream from the 5’ end of the 
lin-15A gene. It is thought that the small distance between genes in operons is necessary for them 
to function properly (Blumenthal et al. 2002) but the new 3’-end formation signal inserted in lin-
15B(n765) is over 4-kb upstream from the trans-splice site of lin-15A. Consequently, we 
hypothesized that this mutation would result in the operon no longer being transcribed as an 
operon. In this case, Pol II transcription might terminate after the inserted 3’ end, before it 
reached the downstream gene. In this case, the transcript level of the downstream gene, lin-15A, 
which is normally trans-spliced, may be at a very low level. After cleavage at the insert, the 
transcript downstream of the cleavage site and upstream of lin-15A might be unstable because it 
would not receive a cap by trans-splicing. 
Using real-time RT-PCR, I demonstrate that in the lin-15B(n765) strain the level of RNA 
downstream of the insert within the operon is decreased (Figure 33). Figure 33A shows qRT-
PCR of an amplicon upstream of the inserted 3’ end, which has increased 4-6 fold in the lin-
15B(n765) strain. This may be due to autogenous regulation by the SynMuv pathway, which 
could result in transcriptional upregulation of the lin-15B and lin-15A transcripts. In stark 
contrast, the level of lin-15B transcript downstream of the inserted 3’ end has dropped 
dramatically (Figure 33B). The level of lin-15A has also dropped dramatically (Figure 32). 
Interestingly, the level of lin-15A mRNA does not drop as much as the level of lin-15B 
downstream of the insert. This is presumably because, after trans-splicing, lin-15A should have a 
cap and is therefore stable but the product downstream of the cleavage is likely uncapped and 
therefore unstable. However, because the level of lin-15A has dropped so dramatically, I was 
unable to determine if the remaining lin-15A is trans-spliced (Figure 51).  
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To obtain a picture of transcript levels across the entire operon, I measured RNA levels 
using C. elegans whole genome tiling arrays. The GeneChip® C. elegans Tiling 1.0R Array 
from Affymetrix has over 3.2 million probes tiled across the genome. The probes are 25-mers 
with small or no gaps between. Briefly, I reverse transcribed total RNA into cDNA and used the 
single stranded cDNA to create double stranded cDNA. I cut, labeled, and hybridized the cDNA 
to the array. The bottom panel of Figure 33 represents the level of RNA at the lin-15B and lin-
15A locus. Similar to the qRT-PCR results at the 5’ end of the operon, the signal in lin-
15B(n765) is somewhat higher than the wild-type signal. However, after the third exon of lin-
15B (the location of the insert) the signal in lin-15B(n765) drops dramatically and continues 
below the wild-type level for the rest of the operon. This demonstrates that the level of RNA 
downstream of the new cleavage site is reduced. By Pol II ChIP, Alfonso Garrido-Lecca in the 
Blumenthal lab demonstrated that the level of Pol II is reduced after the third exon in lin-
15B(n765), indicating the reduction in the RNA level is at least partially a result of transcription 
termination.  
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Figure 33: Level of transcript downstream of the insert is reduced in lin-15B(n765).  
Top panel shows a diagram of lin-15B and lin-15A above three graphs of qRT-PCR results 
aligned with the position in the operon. In the diagram, blue represents lin-15B and maroon 
represents lin-15A. The insert/deletion with the polyA site is indicated by the green and red 
boxes above the third exon of lin-15B. Each of the three graphs displays three biological 
replicates. The black diamonds represent wild-type signal and the red boxes represent lin-
15B(n765) signal. The graph A demonstrates an increase in the level of the RNA upstream of the 
insert. The graph B indicates a dramatic decrease in the level of lin-15B RNA downstream of the 
insert. The graph C indicates a dramatic decrease in the level of lin-15A RNA. The bottom panel 
shows the hybridization signal across lin-15B and lin-15A on a tiling array on a log 10 scale. The 
genes are diagramed at the bottom and the black line above the diagram is wild-type signal while 
the red line is lin-15B(n765). Similar to the qRT-PCR results, the tiling array shows an increase 
in signal at the 5’ end of the gene and a dramatic reduction in signal downstream of the insert. 
The changes are similar in both types of experiments, though they look slightly different because 
the tiling array is on a log 10 scale. 
 
Thus, the lin-15B(n765) mutation is unique since it alters transcription termination within 
an operon resulting reduced mRNA levels of the second gene. In combination, the two effects, 
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the shortened lin-15B transcript and the reduction in the lin-15A level, should be sufficient to 
cause the SynMuv phenotype of the lin-15B(n765) strain.  
 
. 
 
Knockdown of CstF and CPSF causes allele-specific suppression of lin-15B(n765)  
In a genome-wide RNAi screen, Mingxue Cui identified fourteen genes that suppress the 
SynMuv phenotype of lin-15B(n765) and not the SynMuv phenotype of three other SynMuv 
mutant combinations tested: 1) lin-15B(n309) [another mutation of the lin-15 operon, which may 
delete part or the entire operon since 15kb has been lost] 2) lin-8(n111); lin-15B(n765) [the same 
deletion used in the RNAi screen combined with a SynMuv class A mutation] and 3) lin-
8(n111); lin-15B(n744) [combination of two mutations one within lin-15B and one in a SynMuv 
class A gene]. The allele-specific group included genes that encode the subunits of CstF and 
CPSF which are involved in transcription termination and pre-mRNA 3’ end formation (Figure 
34) (Mingxue Cui et al. 2006). Note that the levels of suppression are quite variable depending 
on the gene knocked down by RNAi. This could be due to differences in the functions of these 
proteins or it could be due to differences in the RNAi effectiveness. In any case, RNAi of all of 
these genes reproducibly suppressed the Muv phenotype of lin-15B(n765) but failed to suppress 
the Muv phenotype of other alleles.  
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Figure 34: The SynMuv phenotype of lin-15B(n765) is suppressed by feeding-RNAi of the 
14 allele-specific suppressors.   
lin-15B(n765) worms were fed with bacteria expressing dsRNA of either the GFP gene as 
control or each of the genes indicated. Several of the genes are known 3’ end formation factors 
[cpsf-1 encodes CPSF160, cpsf-2 encodes CPSF100, cpsf-4 encodes CPSF30, cpf-1 encodes 
CstF-50, and cpf-2 encodes CstF-64]. (RNAi completed by Mingxue Cui.) 
 
Knockdown of CstF and CPSF causes allele-specific suppression through blocking cleavage 
thereby increasing expression of lin-15A  
We hypothesized that RNAi of CstF and CPSF subunits rescued the lin-15B(n765) 
phenotype because the insert contains a new 3’ end. If 3’ end formation is partially inhibited, as 
it would be when CstF and CPSF levels are reduced, the inserted 3’ end would be bypassed, 
perhaps resulting in inhibition of termination. When 3’ end formation/transcription termination is 
bypassed there is more transcription of the downstream lin-15A gene, and the SynMuv 
phenotype is thereby rescued. To test this idea, I performed qRT-PCR with three amplicons, 
measuring effects of suppressor-gene mutations on the expression of the operon (Figure 35). For 
RT-PCR A (yellow box) the primer used for reverse transcription (green arrowhead) was located 
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downstream of the cleavage site within the transposed sequence, whereas the PCR was done with 
primers near the 5′ end of lin-15B (Figure 35). Therefore, RT-PCR A reveals changes in 3′ 
cleavage, because only uncleaved RNA can be a template.  An increase in the product would 
indicate a decrease in cleavage. RT-PCR B (light blue box) reveals the level of lin-15B RNA 
downstream of the transposed cleavage site. This PCR product could increase when 3′-end 
cleavage is reduced or when transcription termination is inhibited and/or RNA degradation  is 
reduced. RT-PCR C measures levels of lin-15A mRNA, which should increase if any step of 3′-
end formation or transcription termination is abrogated.  
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Figure 35: The level of lin-15B and lin-15A transcript increases when the level of CstF-50, 
CstF-64 or CPSF-160 is reduced.  
The diagram at the top of each panel depicts the lin-15B gene as a maroon rectangle, the lin-15A 
gene as a purple rectangle and the lin-15B(n765) insert as a yellow rectangle. Below the gene 
diagram, the colored boxes represent qRT-PCR amplicons and the green arrowheads represent 
gene-specific reverse transcription oligos.  Below each amplicon is a graph corresponding to the 
qRT-PCR results. The RT-PCR A and B used gene specific primers while RT-PCR C was 
random primed. All experiments were conducted on lin-15B(n765) worms. The grey circles 
represent the control sample: lin-15B(n765) worms subjected to RNAi to an empty vector. The 
scale of the graphs is arbitrary and in each graph one of the grey circles was set to 10. Samples 
greater than the top value in the graph are listed above the graph with their associated values. 
Each lane within each graph represents a biological replicate. The colored squares symbolize the 
lin-15B(n765) strain treated with RNAi of a 3’end formation factor. Panel 1) CstF-50 Panel 2) 
CstF-64 Panel 3) CPSF-160. 
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 In Figure 35, the top of each panel has a diagram of lin-15B and lin-15A. Below each 
diagram there are three graphs representing qRT-PCR of the three RT-PCR products, which will 
be used repeatedly throughout this chapter.  I used multiple control reactions, RNAi of lin-
15B(n765) worms with non-C. elegans sequence (empty vector), and each control reaction is 
represented by a grey circle. In panel 1, the colored boxes are the level of the above amplicon 
after RNAi of CstF-50. In the RT-PCR A graph, the level of the product dependent on cleavage 
has increased, indicating that there is less cleavage when the level of CstF-50 is reduced. I also 
show the level of RNA downstream of the cleavage site has increased (RT-PCR B). Similarly, 
RT-PCR C shows that the level of lin-15A transcript has increased. Panel 1 has no biological 
replicate, but Panels 2 and 3 both have two biological replicates. CstF-64 and CPSF-160 show 
similar results to CstF-50. The levels of all three products increase when lin-15B(n765) was 
treated with RNAi to CstF-64 and CPSF-160.  Furthermore, Mingxue Cui showed that lin-15A 
expression is necessary to rescue the phenotype. Taken together, these results show that CstF and 
CPSF RNAi rescue the phenotype of SynMuv because 3’ end formation/transcription 
termination is abrogated, and therefore lin-15A expression is increased. 
 
Greater lin-15A levels do not necessarily indicate greater Muv suppression.   
 Since the lin-15A level is increased by RNAi of CstF and CPSF subunits, and since lin-
15A is necessary for rescue of the SynMuv phenotype, I examined whether the increase in the 
level of lin-15A correlated with the level of SynMuv rescue (Figure 36). To answer this question 
I fed the worms a dilution series of CstF-64 RNAi-feeding bacteria. I used several dilutions (1/2, 
1/10, 1/100) which would presumably change the level of CstF-64 expression and thereby 
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change the level of 3’ end formation/transcription termination.  By diluting the CstF-64 feeding 
bacteria with empty-vector RNAi feeding bacteria, I was able to alter the expression level of lin-
15A and the level of SynMuv. The top panel (Figure 36) shows the MUV suppression of the 
CstF-64 RNAi treated samples. The bottom graph (Figure 36) indicates the level of lin-15A 
detected by RT-PCR. The control sample (undiluted empty vector) level of lin-15A was set to 1. 
All the empty vector RNAi samples have similar levels of lin-15A. The samples on the right 
show that the undiluted CstF-64 RNAi had the highest level of lin-15A, an increase of >4 fold. 
The worms that ingested less CstF-64 RNAi bacteria, showed less lin-15A induction.  
Interestingly, the 1/10 dilution of CstF-64 feeding vector, showed the greatest Muv 
suppression, though it did not have the highest lin-15A level. This experiment indicates that the 
level of lin-15A does not directly correlate with the amount of suppression. One possible cause is 
reduction of 3’ end formation in lin-15A. This assay will detect both pre-mRNA and mRNA. If 
the lin-15A 3’ end was not properly formed, the level of the transcript might increase without 
producing more functional protein. I attempted to test the level of 3’ end formation of lin-15A 
but was unable to attain sufficient quantities of RNA, since lin-15A has low expression and the 
uncleaved 3’ end of lin-15A is difficult to detect. A western of lin-15A would also have been 
useful, but unfortunately an antibody was not available at the time of this experiment. In 
summary, for the rescue to occur, 3’ end formation must fail at least occasionally at the inserted 
end and yet still function at least partially at the 3’ end of lin-15A.  
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Figure 36: Greater lin-15A levels do not necessarily indicate greater Muv suppression.   
Top panel shows the Muv suppression for each of the dilutions. Worms fed 1/10 CstF-64 RNAi 
feeding bacteria showed the greatest Muv suppression. Bottom panel shows the level of lin-15A. 
As a control, lin-15B(n765) was fed RNAi feeding bacteria with empty vector and the undiluted 
empty vector lin-15A level set to 1. Samples were diluted with empty vector. (1/100 empty 
vector sample was lost.) Each of the empty vector fed sets had approximately the same level of 
lin-15A as shown by the bottom graph. Worms fed undiluted CstF-64 feeding bacteria had the 
greatest increase in lin-15A levels. Worms fed successive dilutions of the CstF-64 bacteria had 
lower increases in their lin-15A levels.  
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Examination Four of the Allele Specific Suppressors 
We hypothesized that the other allele-specific genes may function in a similar fashion to 
CstF and CPSF. The SynMuv phenotype could be suppressed by any of the following 
mechanisms: reducing the levels of 3’ end formation at the inserted 3’ end formation site, 
reducing transcription termination caused by the inserted site, reducing degradation of the RNA 
downstream of the new cleavage site, or  increasing the level of trans-splicing to the lin-15A 
mRNA. We wished to discover if the allele specific suppressors had unknown functions in 3’ end 
formation and/or transcription termination. 
 I focused on four of the allele-specific rescuing genes (rsp-6, cids-1, cids-2, and nrd-1). 
One gene, rsp-6, encodes SRp20, an SR protein that affects alternative splicing and other pre-
mRNA processing events (Bjork et al. 2009). Three genes (cids-1, cids-2, and nrd-1) encode 
proteins containing a CID (C-terminal interaction domain). The presence of a CID indicates that 
the three proteins are likely to interact with Pol II, and CIDs are found in other proteins that are 
predicted to regulate pre-mRNA (Steinmetz et al. 2001; Meinhart 2005). The yeast homolog of 
CIDS-1, RTT103, has been shown to interact with CTD phosphorylated at serine 2 and may 
influence RNA degradation downstream of cleavage in yeast (M. Kim et al. 2004). The second 
CID protein I studied, cids-2, is a protein of unknown function with a CID most clearly related to 
cids-1. The third CID protein I studied, nrd-1, is required for CUT and snoRNA 3'-end 
processing that interacts with serine 5 phosphorylated CTD in yeast (Grzechnik and Kufel 2008; 
Lidia Vasiljeva and Stephen Buratowski 2006b; Lidia Vasiljeva et al. 2008). Of the four 
candidate genes, only the cids-1 homolog has been shown to function in pre-mRNA transcription 
termination; therefore I wished to test the function of each of these genes.  
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We requested deletion mutants for the candidate genes through the Japanese National 
Bioresource Project for the Experimental Animal Nematode and the Oklahoma C. elegans 
Knockout lab of the International C. elegans Gene Knockout Consortium. We received four 
deletions that were within three of the suppressor genes. I used these deletions to study the 
functions of the encoded proteins. 
 
Genetic Deletions Recapitulate RNAi Results 
To first validate the observed Muv suppression by RNAi of candidate genes, we used the 
available deletions of the candidate genes. All four deletion alleles were able to replicate the 
RNAi results: rsp-6(tm367), rsp-6(ok798), cids-1(tm2715), and cids-2(tm2802) (Figure 37-
MingXue Cui). Consistent with the rsp-6 RNAi results, both rsp-6(tm367) and rsp-6(ok798) 
strongly suppressed the Muv phenotype of lin-15B(n765), from 100% Muv down to below 10% 
Muv (Figure 37-Mingxue Cui). Both the cids-1(tm2715) and cids-2(tm2802) alleles significantly 
suppressed the Muv phenotype of lin-15B(n765), consistent with their being strong loss-of-
function alleles. Analysis of the deletions of these candidate genes allowed us to conclude that 
the suppression of the Muv phenotype is not due to off-target effects of RNAi. Additionally, by 
comparing the deletion results with RNAi results we can infer that the deletions are loss of 
functions, at least in this assay. 
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Figure 37: Suppression of the Muv phenotype of lin-15B(n765) by deletion strains 
compared with RNAi-treated worms.  
Percentage of Muv worms was determined for each deletion strain and compared with the 
relative Muv suppression of RNAi of the same gene. Control is RNAi of GFP (completed by 
Mingxue Cui). 
 
 
Deletions of candidate genes cause increase in lin-15A mRNA level 
We hypothesized that knockdown of the suppressor genes rescued the phenotype because 
of decreased transcription termination or a related process. If the hypothesis were true, rescue of 
the SynMuv phenotype would be the result of an increase in the levels of lin-15A mRNA, as did 
RNAi of CstF-50, CstF-64 and CPSF-160. Using quantitative RT-PCR (qRT-PCR), I examined 
the overall level of lin-15A mRNA in lin-15B(n765) animals combined with deletions or RNAi 
for each of the four candidate genes.  
I show in Figure 38 that RNAi of genes known to be involved in pre-mRNA 3’ end 
formation and transcription termination caused significant increase in the overall lin-15A 
transcript level. Similar to the known 3’ end formation factors, deletion or RNAi of the candidate 
genes also increases the level of lin-15A transcript (Figure 38). Each of the four candidate genes 
I focused on shows a reproducible increase in the level of lin-15A. However, some deletions 
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show a more significant increase than others. Mingxue Cui further demonstrated that the 
restoration of lin-15A activity is the key reason for the suppression of the Muv phenotype of lin-
15B(n765) (Cui et al. 2008). Thus, both candidate genes and 3’ end formation/transcription 
termination genes increase the lin-15A transcript, offering support for our hypothesis; the 
candidate genes rescue because either pre-mRNA 3’ end formation or transcription termination 
has been disrupted.  
 
Figure 38: When levels of allele specific Muv suppressers are reduced or eliminated, lin-
15A levels are increased in the lin-15B(n765) background.  
In the diagram above, the maroon rectangle represents lin-15B and the purple rectangle 
represents lin-15A. The line between the genes represents the ICR, while the yellow rectangle 
represents the insert and the red box below lin-15A shows the qRT-PCR amplicon. Total RNA 
was random-prime reverse transcribed. Then qRT-PCR was used to amplify the amplicon. For 
each experiment, levels were determined for non-suppressed lin-15AB(n765) worms (circles) 
and for RNAi-treated or deletion strains (squares). The scale of the graph is arbitrary, and based 
on the median control value set to 10 (grey circles). For SRp20, the three experiments controlled 
by white circles were independently set to 10. For results outside the range plotted, the squares 
are shown above the graph, and the levels are given with their standard deviations. 
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cids-1 and cids-2: deletion phenotypes and protein interactions 
The cids-1 deletion, cids-1(tm2715), is a 543-bp deletion that extends from exon 2 to 
exon 5 (Figure 39). This deletion results in a frameshift and an early stop codon that is expected 
to trigger NMD. The cids-1(tm2715) allele is therefore expected to be a null allele. The cids-2 
deletion, cids-2(tm2802), is a 389-bp deletion that extends from exon 3 to 6 (Figure 39). It is 
expected to produce a shorter in-frame transcript encoding a truncated protein that deletes 79 
internal amino acids. However, the majority of the CID is removed, so it presumably would be 
unable to interact with Pol II if it were produced.   
After backcrossing the cids-1(tm2175) and cids-2(tm2802) strains six times I created the 
double mutation cids-1(tm2715);cids-2(tm2802). I examined the three strains for several 
phenotypes including lethality, sexual alterations and variations in rate of development. I also 
tested the strains at several growing temperatures (15⁰, 20⁰[typical growing temperature], 25⁰). 
The cids-1(tm2715), cids-2(tm2802) and the cids-1(tm2715);cids-2(tm2802)  deletion strains are 
very healthy. At typical growing temperatures I detected no phenotype. Since the mutations in 
CPSF and CstF are unviable, this result indicates that neither CIDS-1 nor CIDS-2 is likely to 
perform required roles in 3’ end formation.  
However, at 25⁰, 4% of the offspring of all three of the strains were male. This is 20 
times the fraction of males the wild-type strain produced. Before creation of the double mutant, I 
examined the mail tail morphology of cids-1(tm2715) and cids-2(tm2802) in an attempt to assess 
the cause of the phenotype. The males from both deletion strains showed normal male 
morphology (Figure 40). Therefore, I attempted to mate the cids-1(tm2715) and cids-2(tm2802)  
males. As judged by the presence of male progeny, the cids-1(tm2715) males do mate.  However, 
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in the case of cids-2(tm2802), I attempted to mate more than 20 males in three separate attempts 
and failed to recover outcross progeny. Hence, the cids-2(tm2802) males may be abnormal or 
sterile.  
  
 
Figure 39: Strains used to study the function of CIDS-1 and CIDS-2. 
Top panel shows diagrams of cids-1 and cids-2 in blue. Below each gene is a red bar indicating 
the extent of the deletion within the gene. Bottom panel is a depiction of the transgenic construct 
used to make transgenic strains capable of expressing tagged versions of cids-1 and cids-2. In 
each construct, a heat-shock promoter is followed by the gene of interest which is in frame with a 
Protein A/His tag.  
 
 
Figure 40: Male genitalia seen in males of cids-1 and cids-2 deletions.  
The tails of the males from cids-1(tm2715) and cids-2(tm2802) have a typical fan and the correct 
number and spacing of rays. In both strains, tails contain spicules (not seen from this angle). In 
the cids-1(tm2715) strain mating males produced male progeny. No male progeny were detected 
when cids-2(tm2802) strain males were mated.    
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Serine 5 and Serine 2 phosphorylated Pol II CTD co-immunoprecipitate with CIDS-1  
To determine if the CID domain of cids-1 was functional, I used a transgenic C. elegans 
strain created before I joined the lab (created by Peg MacMorris, Diego Zorio, and Tassa Saldi). 
Two similar strains that expressed tagged versions of both CIDS-1 and CIDS-2 were created. 
The two strains are integrations of the constructs depicted in Figure 39, which are controlled by 
a heat shock promoter and expressed ProtienA/6-His tagged versions of CIDS-1 and CIDS-2. I 
heat shocked the tagged CIDS-1 strain and a wild-type strain and 2 hours later I isolated protein 
samples. Using an anti-polyHis antibody, I immunoprecipitated the tagged form of CIDS-1 and 
performed a western blot with antibodies to Serine 2 phosphorylated CTD and serine 5 
phosphorylated CTD. Lanes 1 and 2 show 1/100 of the input to the IP (Figure 41). Only Pol II is 
seen in the wild-type input lane (lane 1). In the input lane containing the CIDS-1 tagged strain 
(lane 2), both Pol II and tagged CIDS-1 can be seen, since the Protein A tag reacts with most 
antibodies. The lanes 3-6 show samples which were immunoprecipitated. I immunoprecipitated 
with anti-polyHis (lanes 2 and 3) and I mock immunoprecipitated (lanes 4 and 5) using no 
antibody. Only the lane containing the CIDS-1 tagged strain which was immunoprecipitated with 
anti-polyHis and blotted with anti-Ser2 or anti-Ser5 shows a band at the size of Pol II (lanes 4). 
Therefore, tagged CIDS-1 is able to interact with both Serine 2 phosphorylated CTD and Serine 
5 phosphorylated CTD (Figure 41). Under my guidance, an undergraduate in the lab, Peter 
Johnson, used the same procedure on the CIDS-2 tagged strain. However, in several 
experiments, the CIDS-2-tagged protein showed interactions only with Serine 2 phosphorylated 
CTD, but not Serine 5 phosphorylated CTD (data not shown). 
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Figure 41: CIDS-1 interacts with Serine 5 phosphorylated CTD and Serine 2 
phosphorylated CTD.  
The lanes 1 and 2 contain 1/100 of the input for the immunoprecipitation. The lanes 3-6 show 
immunoprecipitation with anti-polyHis or a mock immunoprecipitation with no antibody. The 
blot was probed with either anti-Ser2p or anti-Ser5p. Anti-light chain rabbit antibody was used 
as secondary. Of the immunoprecipitated lanes, only the lane containing the CIDS-1 strain, 
immunoprecipitated with anti-polyHis (lane 4) shows a band of the correct size to be Pol II, 
demonstrating that the tagged CIDS-1 is able to interact with Serine 2 phosphorylated CTD 
(Panel A) and Serine 5 phosphorylated CTD (Panel B). 
 
 
 
CIDS-1 and CIDS-2 enhance context-specific 3′-End Formation  
  
The yeast homologue of cids-1, RTT103, had previously been reported to crosslink at the 
3′ end of genes and to be associated with the protein required for degradation of the RNA 
downstream of the cleavage, XRN-2 (M. Kim et al. 2004). I therefore expected that CIDS-1 
might also be required for this step of transcription termination in C. elegans. To determine if 
CIDS-1 and CIDS-2 were involved in 3’ end formation or transcription termination, I performed 
qRT-PCR of two amplicons in lin-15B and one in lin-15A (Figure 42).  An increase in RT-PCR 
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A indicates a decrease in cleavage events, while an increase in RT-PCR B indicates either a lack 
of termination or a lack of degradation of the transcript downstream of the cleavage site. RT-
PCR C should increase if any of the above processes are terminated. 
 
Figure 42: The level of uncleaved lin-15B and the level of lin-15A transcript increases when 
cids-1 and cids-2 are deleted.  
For description of the figure see Figure 35 caption. In summary, RT-PCR A represents transcript 
uncleaved, RT-PCR represents transcript downstream of the insert and RT-PCR C represents lin-
15A transcript. Panel 1) The colored squares symbolize the cids-1(tm2715); lin-15B(n765) 
double mutant.  Panel 2) The colored squares symbolize the cids-2(tm2802); lin-15B(n765) 
double mutant. Each lane within each graph represents a set of biological replicates. 
  
Interestingly, in the strain with the cids-1 deletion, cleavage at the introduced 3′-end site 
is significantly reduced (Figure 42, Panel 1, RT-PCR A). Similarly, cleavage was reduced, but 
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to a lesser extent, in the cids-2 deletion strain (Figure 42, Panel 2, RT-PCR A).  Consistent with 
this result, both products downstream of the cleavage site also increase (Figure 42, RT-PCR B). 
The level of lin-15A also increased in both (Figure 42, RT-PCR C).  The reason for the variation 
in signal across biological replicates in unknown, but may be due to the low levels of the 
transcripts causing a lot of noise.  In any case, these findings suggest that both these Pol II-
interacting proteins facilitate 3′-end cleavage in this context.  
Comparing the levels of products A, B, and C across biological replicates using only the 
controls within that biological replicate gives another point of view.  In cids-1 RT-PCR A always 
increases more than RT-PCR B and RT-PCR C increases most of all.    In cids-2 RT-PCR A and 
RT-PCR B tend to increase to the same extent, but RT-PCR C increases most of all. This may 
mean that in cids-1(tm2715) cleavage is more affected, but termination sometimes still occurs. 
Conversely, in cids-2(tm2802) inhibition of cleavage more often inhibits transcription 
termination.  
Because my findings suggest that both cids-1 and cids-2 play roles in 3′-end cleavage in 
this context, I tested whether CIDS-1 and CIDS-2 functioned in the cleavage of other genes by 
RT-PCR across multiple 3’ end formation sites. I tested several genes: some operon genes and 
some non-operon genes. Of the five genes tested (C16C10.8, R10E4.2, R05D11.5, rnp-7 and 
Y37E3.8), none gave the expected result of an increase in the RT-PCR product across the 
cleavage site (which would indicate a decrease in cleavage) in the cids-1(tm2715) or cids-
2(tm2802) strains. Instead, three of the gene products (C16C10.8, R10E4.2, and R05D11.5) 
levels did not differ significantly from wild type (Figure 43; Figure 44). The RT-PCR from one 
of the genes (rnp-7) not only spanned the 3’ end of the gene but also spanned an intron (Figure 
44). This PCR shows an increase in unspliced, uncleaved product in the cids-1 deletion. 
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Furthermore, the product level is decreased in cids-2 deletion, which would indicate that CIDS-2 
inhibits cleavage in this gene instead of enhancing it, as seen in lin-15B(n765). Finally, the 
Y37E3.8 showed a decrease in the PCR product in both deletion strains. This is again opposite of 
what was seen in lin-15B(n765) (Figure 44). Consequently, I believe that the function of cids-1 
and cids-2 in the lin-15B(n765) background is to enhance 3’ end formation at the inserted site,  
but the enhancement is context specific or it plays only a stimulatory role and not all 3’ end 
formation events require the stimulation. Because the strains carrying deletion of each gene or 
even both genes are viable and show only a minor phenotype, it is not surprising that both CIDS-
1 and CIDS-2 do not function in all 3’end formation events.  
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Figure 43: The cids-1 and cids-2 deletions do not increase uncleaved transcript levels of 
several genes.  
Top shows diagrams of three genes tested for defects in cleavage by RT-PCR. Orange arrowhead 
indicates the position of the reverse transcription primer used and red box indicates the PCR 
product. Dotted orange line predicts how far the RT might have extended. Bottom shows results 
of PCR. As a loading control, I used the levels of rpl-26 (ribosomal protein large-26). Several 
cycle numbers were considered to ensure PCRs were in the linear range. Left most lane shows 
the wild-type levels of the PCR products. The cids-1(tm2175) and cids-2(tm2802) deletions did 
not show an increase in the uncleaved product for these genes.  
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Figure 44: The cids-1 and cids-2 deletions show decreases in uncleaved transcript levels of 
at least two genes.   
Top is a diagrams of two genes tested for defects in cleavage by RT-PCR. The orange arrowhead 
indicates the position of the reverse transcription primer used and the red box indicates the PCR 
product. Dotted orange line predicts how far the RT might have extended. Bottom shows results 
of PCR analysis of these genes. As a loading control, rpl-26 was used. Several cycle numbers 
were considered to ensure PCRs were in the linear range. Left most lane shows the wild-type 
levels of the PCR products. Black arrows by rnp-7 show sizes of spliced (bottom) and unspliced 
(top) product. In the PCR of rnp-7, the cids-2 deletion showed a decrease in the amount of 
uncleaved product.   In the PCR of Y37E3.8, cids-1 and cids-2 deletions showed a decrease in 
the uncleaved product.  
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The role of NRD-1 in transcription termination of lin-15B is unknown 
Using the same methods as above (RT-PCR A, B, and C) I performed RNAi to nrd-1 in 
attempt to discover how it is able to rescue the SynMuv phenotype of lin-15B(n765). The nrd-1 
RNAi resulted in a small increase in lin-15A RT-PCR product (Figure 45), and it did so without 
measurably increasing the levels of either lin-15B product (RT-PCR A, RT-PCR B). It is 
possible there were increases in the lin-15B products, but the increases were below my level of 
detection. Conversely, a CUT (cryptic unstable transcript) may be present somewhere 5′ to lin-
15A. When nrd-1 is knocked down by RNAi, termination of a low-level CUT is prevented, and 
could result in read-through of lin-15A. Presumably this transcript would be trans-spliced to 
make functional lin-15A mRNA.   
 
Figure 45: RNAi of nrd-1 increases the lin-15A level.  
For description of the igure see Figure 35 legend. In summary, RT-PCR A represents transcript 
uncleaved, RT-PCR represents transcript downstream of the insert and RT-PCR C represents lin-
15A transcript. The colored squares represent the signal in the RNAi of nrd-1 in lin-15B(n765). 
Each lane within the graph represents a set of biological replicates. 
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SRp20 deletions: effects on viability 
 In C. elegans, the rsp-6 gene encodes SRp20. We received two mutations in rsp-6: rsp-
6(ok1693) and rsp-6(tm367). The rsp-6(ok798) strain had the more severe phenotype. The rsp-
6(ok798) mutation (a 956-bp deletion and a 14-bp insertion) removes the first three exons of all 
three predicted isoforms of rsp-6 (Figure 46). Consistent with rsp-6(ok798) being a null allele, 
the mutant animals are sterile as homozygotes. The rsp-6(ok798) mutation demonstrates that 
SRp20 is an essential gene, but the sterility makes studying the strain difficult. Therefore, I did 
most of my SRp20 analysis on rsp-6(tm367).  
The rsp-6(tm367) allele contains a deletion of 395 bp from the middle of rsp-6, which 
frameshifts all isoforms.  Thus this mutant allele is expected to produce a truncated protein and 
might be a partial loss-of-function mutant. Consistent with this hypothesis, rsp-6(tm367) mutant 
animals are viable and fertile, though they display pleiotropic defects including slow growth, low 
brood size and abnormal body morphology. For instance, the worms produce far fewer progeny 
(10-50 per worm) compared with wild-type worms (~300 per worm). The production of progeny 
in rsp-6(tm367) is rescued by injections of a SRp20::GFP fusion, indicating this mutation may be 
a loss of function.   
 
Figure 46: Deletions in rsp-6.  
The top of the diagram depicts the five exons of the majorly expressed isoform of rsp-6. Exons 
are in blue, introns are lines, and the 3’ UTR is in grey. Below, red bars show the extent of both 
deletions.  
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The rsp-6(tm367) deletion alters the expressed isoforms of SRp20 
Wild-type worms have three predicted isoforms of rsp-6: Isoform A is the predominant 
isoform and the only isoform with a RS domain (necessary for many functions); Isoform B is 
transcribed and then degraded by NMD due to an early stop codon (Morrison et al. 1997); and 
Isoform C is not expressed at a detectable level and may not be real.  
In the rsp-6(tm367) strain, by tiling array and RT-PCR, I detected shortened versions of 
all three isoforms of rsp-6 missing the deleted region (Figure 47). The top of Figure 47 is tiling 
array data for the rsp-6 locus. The black line indicates expression in wild type and the red line 
the expression in the rsp-6(tm367) mutant. The middle of the figure is a diagram of the three 
isoforms predicted by WormBase. When the expression of the mutant is compared with wild 
type, the expected loss of expression in the deleted region is observed. Furthermore, expression 
upstream of the deletion increases in the mutant strain, possibly indicating alternative isoforms 
may be expressed.  
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Figure 47: Expressed forms of SRp20 are altered in the rsp-6(tm367) deletion. 
Top) Tiling array analysis comparing rsp-6 in wild type (black) and rsp-6(tm367) (red). Middle) 
Diagrams of the three isoforms of rsp-6, above a red box indicating the extent of the rsp-
6(tm367) deletion. The diagrams below the red box show the three isoforms seen by RT-PCR in 
the rsp-6(tm367) mutant.  Bottom) RT-PCR using the primers diagramed by arrows.  In wild-
type worms the major isoform is Isoform A. Isoform B is present, but regulated by NMD so total 
level is low (Morrison, Harris, and Roth 1997). Isoform C is not detected. In the rsp-6(tm367) 
deletion, versions of all three isoforms missing the deleted region are present (diagramed above) 
and each were confirmed by cloning and sequencing. Isoform B* is the dominant isoform in the 
mutant.   
 
I used RT-PCR to determine which isoforms of rsp-6 were expressed in the rsp-6(tm367) 
strain. There are two detectable products in the RT-PCR of rsp-6 in wild type and the products 
correspond to the product sizes expected if isoforms A and B were expressed. As expected, the 
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signal for isoform A is stronger than for isoform B, since in wild type, isoform B is degraded by 
NMD (Morrison et al. 1997). In the rsp-6(tm367) mutant (right lane) three products are present. I 
cloned, and then sequenced, the mutant products and their gene structures are diagramed above 
the RT-PCR.  A version of isoform B (isoform B*) lacking the deleted region is the highest 
expressed isoform. Interestingly, in rsp-6(tm367) the stop codon that causes NMD of isoform B 
is deleted (Figure 47). Because of frameshifting, none of the isoforms in the rsp-6(tm367) 
mutant are expected to encode a protein containing an RS domain, which is likely a cause of the 
rsp-6(tm367) deleterious phenotypes.  
   
SRp20 affects alternative splicing of C12D12.1 
 Since SRp20 is known to affect alternative splicing in other organisms, I used the tiling 
array of rsp-6(tm367) to look for changes in alternative splicing. One such example is shown in 
Figure 48. There are three isoforms of C12D12.1 annotated. The tiling array showed changes in 
expression over the alternatively spliced region of the gene. Therefore I did RT-PCR to 
determine if the alternative splice forms were more or less abundant in the rsp-6(tm367) deletion. 
The gel in Figure 48 shows that in wild-type, isoform B has the highest expression, but the other 
two isoforms are also expressed. In the rsp-6(tm367) strain, only isoform B is visible. Therefore 
either wild-type SRp20 enhances splicing of isoforms A and C or mutant SRp20 suppresses 
them. Under my guidance, an undergraduate in the Blumenthal lab, Elizabeth Doggett, continued 
to research alternative splicing in rsp-6(tm367) and found at least one other gene, let-653, with a 
change in alternative splicing in the SRp20 mutant background. Additional information about the 
SRp20 deletion tiling array can be found in Appendix A. 
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Figure 48: C12D12.1 alternative spicing is regulated by rsp-6.  
Top) Expression of C12D12.1 in the wild type and rsp-6(tm367) strains as measured by tiling 
array. The second to last exon changes expression levels in the rsp-6(tm367) mutant strain.  
Middle) Diagram of the three isoforms of C12D12.1. Pink boxes are exons. Black arrows 
represent primers used in the RT-PCR. Bottom) RT-PCR of C12D12.1. Predicted band location 
for each isoform is labeled to the right of the gel. In wild type most of the product corresponds to 
isoform B, but some is Isoform A, and a tiny amount is isoform C. In rsp-6(tm367) only isoform 
B is visibly present.   
 
 
SRp20 Increases RNA Downstream of the Cleavage Site Without Affecting Cleavage 
To determine the SRp20 function in the context of lin-15B(n765) I used the same three 
RT-PCR products mentioned above (RT-PCR A, RT-PCR B, and RT-PCR C). RT-PCR A did 
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not increase, indicating that the pre-mRNA is cleaved normally (Figure 49). Nonetheless, RT-
PCR B levels increased 4- to 25-fold and RT=PCR C increases 5-15 fold.  Therefore, SRp20 
seems to function in either transcription termination and/or degradation of the RNA downstream 
of the cleavage site but not in cleavage. In the SRp20 mutant, the product that would be expected 
to be degraded by XRN-2 exonuclease accumulates, and transcription fails to terminate within 
the insert. I confirmed the data from the qRT-PCR by comparing transcript levels from the two 
strains, lin-15B(n765) and lin-15B(n765);rsp-6(tm367), on tiling microarrays (Figure 50). I saw 
a difference at the lin-15 locus (Figure 50). In lin-15B(n765), RNA levels drop dramatically at 
the site of the insertion. In contrast, in the rsp-6 mutant strain, RNA levels recover some at the 
site of the insertion and remain higher throughout the operon. This result confirms and extends 
results seen in the qRT-PCR assay, because it also demonstrates that the RNA downstream of the 
cleavage event accumulates in the absence of SRp20.  
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Figure 49: SRp20 deletion increases the lin-15B levels downstream of the cleavage site 
without inhibition 3’ end formation.  
For description of the figure see Figure 35 caption except that for each graph the median grey 
circle was set to 10 while each of the white circles was set to 10. In summary, RT-PCR A 
represents transcript uncleaved, RT-PCR represents transcript downstream of the insert and RT-
PCR C represents lin-15A transcript.  The colored squares represent the level of the qRT-PCR 
product in the rsp-6(tm367);lin-15B(n765) strain as compared to the control strain.  
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Figure 50: Tiling array shows an increase in level of mRNA downstream of insert in SRp20 
deletion.  
Top shows a diagram of the lin-15 operon. The location of the insert located in lin-15(n765) is 
depicted by a yellow arrow. The signal in the lin-15(n765) strain is shown by a green line and the 
signal rsp-6(tm367);lin-15B(n765) strain is shown by blue line. Downstream of the insert, 
expression drops off in the lin-15(n765) strain. But when SRp20 is deleted, the RNA after the 
insert recovers for the rest of the operon.  
 
134 
 
 
Figure 51: lin-15A is trans-spliced to SL2 in lin-15B(n765);rsp-6(tm367). 
RNA was reverse transcribed with random primers. The trans-spliced lin-15A cDNA was 
amplified by PCR with SL1 and SL2 forward primers and a reverse primer specific to lin-15A. 
Labels indicate the strain the RNA was isolated from and the labels in red are minus RT controls. 
In wild-type C. elegans, lin-15A is trans-spliced to SL2. In lin-15B(n765) mutants lin-15A trans-
splicing cannot be confirmed, likely due to the low level of transcript. In a SRp20 deletion the 
level of lin-15A is rescued (Figure 50;Figure 49) and lin-15A is trans-spliced to SL2. 
 
SRp20 does not rescue the SynMuv phenotype through alterative splicing or alternative 
trans-splicing of lin-15B. 
I considered the possibility that the SRp20 mutation could suppress the phenotype by 
affecting the splicing of lin-15B. For example, the rsp-6 mutation could cause removal of the lin-
15B exon containing the insertion. However, RT-PCR from exon 1 to exon 5 in lin-15(n765); 
rsp-6(tm367) revealed no product missing this exon (Figure 52). Alternatively, a cap supplied by 
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a trans-spliced leader would stabilize the lin-15B mRNA downstream of the insert. However, I 
found no trans-splicing to downstream lin-15B exons in either the lin-15B(n765) or the lin-
15B(n765);rsp-6(tm367) mutant strain (Figure 53). Thus, the increase in the levels of lin-15B 
RNA downstream of the cleavage site probably implicates SRp20 in some aspect of transcription 
termination. Knockdown of SRp20 could prevent degradation of the RNA following cleavage. 
Alternatively, 3′-end cleavage in the insert could result in proximal transcription termination, in 
which case knockdown of SRp20 could act by preventing release of Pol II from the DNA.  
 
Figure 52: In rsp-6(tm367);lin-15B(n765), the SynMuv rescue is not due to exclusion of the 
intron with the insert by alternative splicing. 
For description of the Top diagram see  Figure 32.Below is an RT-PCR with the indicated 
primers in four strains. The wild type and rsp-6(tm367) strains do not have an insert and the 
products amplified by PCR are detectable. No product is detectable in the two strains containing 
the insert. If the exon containing the insert had been removed by splicing a product smaller than 
the wild-type product should have been detected. 
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Figure 53: In rsp-6(tm367);lin-15B(n765), the SynMuv rescue is not due to alternative 
trans-splicing. 
RT-PCRs of lin-15B using forward primers to SL1 and SL2 and a reverse primer downstream of 
the insert. The diagram above shows the location of the SL1 and SL2 oligos by a purple arrow 
and the reverse oligo by a blue arrow. Only the wild-type strain shows a band. If alterative trans-
splicing were key to rescue by rsp-6(tm367), a smaller band should be observed in one of the lin-
15B(n765);rsp-6(tm367) lanes. 
  
 
Discussion 
Strangely, a screen to find genes involved in regulation of the SynMuv pathway detected 
a group of allele-specific suppressors that included known 3’ end formation factors. 
Subsequently, we discovered the SynMuv mutant, lin-15B(n765), contained a unique insertion 
that causes premature 3’ end formation and transcription termination within the lin-15B operon. I 
demonstrated that knockdown of CstF and CPSF rescued the phenotype by preventing 3’ end 
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formation and transcription termination.  I theorized that the rest of the allele-specific group may 
also be involved in similar processes. Therefore, I analyzed four of the genes within the allele 
specific group in more detail (rsp-6, nrd-1, cids-1 and cids-2). I used knockouts and knockdowns 
to look at molecular and other phenotypes in an attempt to determine the function of the four 
proteins, both in their wild-type context and in the screen-specific context.  
 
CIDS-1 and CIDS-2 
The screen identified cids-1, a C. elegans orthologue of yeast RTT103, and cids-2, an 
protein of unknown function with a CID most similar to cids-1. Yeast RTT103 has been shown 
to co-immunoprecipitate with Pol II and Rat1 (Minkyu Kim et al. 2004). In agreement, I showed 
that in C. elegans, a tagged CIDS-1 was able to interact with Serine 2 and Serine 5 
phosphorylated Pol II CTD.  
In an attempt to determine functions of the two proteins, I examined the phenotypes 
associated with the deletions and the double deletion and determined that the strains are 
relatively healthy. However, they do produce 20-fold more males than wild type when grown at 
high temperature (25⁰). The fact that the double deletion creates the same percentage of males as 
both of the single deletions may imply that the males in both strains are created though the same 
mechanism.  
Two processes are known to cause males in C. elegans: nondisjunction of the X chromosome 
and sexual transformation. In nondisjunction of the X chromosome, the males are true XO males. 
These males are formed by joining of a normal gamete containing 1 X chromosome to a mutant 
gamete in which nondisjunction caused loss of the X chromosome. Conversely, in males formed 
by sexual transformation, the genotype of the males is XX even though they are phenotypically 
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male. These males are formed by mutations in the sex determination pathway. The XX males are 
sometimes able to mate, but naturally have only XX progeny. Unfortunately, I mated the males 
at 20⁰ where cids-1(tm2715) and cids-2(tm2802) have no phenotype. Therefore, if the males 
were caused by transformation, the XX progeny would have likely been phenotypically 
hermaphrodites. Because I judged whether the mating was successful by the presence of male 
progeny, in this circumstance I may not have known they had mated. However, genetic and 
molecular interaction studies in yeast have indicated that RTT103 interacts with many chromatin 
maintenance genes, and because non-disjunction may be related to chromatin maintenance, I 
theorize that the males are formed by nondisjunction.    
In the lin-15B(n765) context, molecular analysis of mutants of cids-1 and cids-2 genes 
suggests that CIDS-1 and CIDS-2 are both involved in the 3′-end cleavage. Their effect on 3′-end 
cleavage is consistent with the fact that both CIDS-1 and CIDS-2 contain a CID domain that 
interacts with the phosphorylated CTD of Pol II.  However, in the other genes tested, CIDS-1 
and CIDS-2 do not seem to enhance 3′-end cleavage.  Therefore, the effect on 3’ end formation 
or termination may be indirect, and the real function of the proteins may be to regulate Pol II 
elongation. On the other hand, CIDS-1 and CIDS-2  may play only a stimulatory role in 3’ end 
formation, and not all 3’ end events may benefit from such stimulation. Finally, CIDS-1 and 
CIDS-2 may function in 3’ end cleavage only in certain contexts, such as the context presented 
by lin-15B(n765). 
 What particular context might CIDS-1 and CIDS-2 function in? When Pol II transcribes 
most genes, there is a high amount of Serine 5 phosphorylated CTD at the 5’ end of the gene and 
a high amount of Serine 2 phosphorylated CTD at the 3’ end of the gene. How is the serine 
phosphorylation pattern of the CTD affected by the lin-15(n765) mutation? Does the CTD have 
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high Serine 2 phosphorylation over the inserted 3’ end or the lin-15B 3’ end or even both? It 
could be that CIDS-1 and CIDS-2 are able to recognize the inserted end because the 
phosphorylation pattern has changed. Recognition of this irregular pattern might therefore 
enhance 3’ end formation. 
 
NRD-1 
We also found that another CID-containing protein, NRD-1, was one of the best 
suppressors of the lin-15B(n765 Muv) phenotype (Figure 34). The yeast homologue of NRD-1, 
Nrd1p, is required for termination of non-polyadenylated transcripts from Pol II-transcribed 
small nuclear RNA and small nucleolar RNA genes (Eric J. Steinmetz et al. 2001). However, it is 
unclear whether NRD-1 also is involved in terminating polyadenylated transcripts, other than its 
own (John T. Arigo et al. 2006). Read-through transcription from pre-mRNA has been observed 
previously in Nrd1 mutants in yeast (Lidia Vasiljeva and Stephen Buratowski 2006a; E. J 
Steinmetz et al. 2006). Therefore, one could hypothesize that reduction of nrd-1 function may 
result in read-through transcription of the lin-15B gene in the lin-15B(n765) mutant. Because the 
lin-15A and lin-15B genes are in an operon with the lin-15A gene downstream, read-through of 
the short lin-15B transcript could increase the level of polycistronic lin-15B and lin-15A pre-
mRNA, resulting in a higher level of the lin-15A transcript. However, the nrd-1 mutant displayed 
no detectable increase in the levels of RT-PCR A or B in the qRT-PCR assay (Figure 45), and 
an increase in those products would be expected if the knockdown of nrd-1 was causing read-
through of the inserted 3′ end. An alternative hypothesis is that a CUT is present upstream of lin-
15A, and knockdown of nrd-1 allows read-through of the CUT. Perhaps the Muv suppression in 
this case is so strong, even though the lin-15A RNA increase much less than the other 
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suppressors, because in this case the knocked-down protein, nrd-1, is not required for 3’ end 
formation of lin-15A so more of the read-through product is full-length mature mRNA.  
 
CID domain proteins 
 Interestingly, three of the four CID containing proteins in C. elegans were found in the 
SynMuv suppression screen. RNAi of the fourth CID containing protein, pcf-11, is extremely 
lethal. Though pcf-11 has known roles in 3’ end formation, we are uncertain of the effect pcf-11 
might have on the lin-15B(n765) mutation. Recent evidence suggests a competition between 
Nrd1 and Pcf11 for CTD binding (Navjot Singh et al. 2009). Is it possible all of the CID domain 
proteins compete?  
When one of the CID containing proteins is deleted it may cause changes in the CTD binding of 
the other CID containing proteins. For example, cids-1, cids-2 and nrd-1 may all need to bind 
consecutively to the CTD before pcf-11 can bind and function in 3’ end formation and 
termination. Conversely, one missing protein could cause the other CID proteins to block 
binding of the termination factor pcf-11. Understanding the integration of the functions of these 
four proteins requires future research.  
 
SRp20  
 SRp20 is a known splicing factor in other organisms.  I have shown that SRp20 also 
affects splicing in C. elegans. Additionally, I have looked at the major phenotypes of two strains 
of SRp20 deletion worms and have shown it is an essential protein. Another potential molecular 
function is discussed in Appendix A. 
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My analysis indicates that in the lin-15B(n765) context, SRp20 is likely to function either 
in the degradation of the RNA downstream of the cleavage site or in release of Pol II from the 
DNA. I can envision two possibilities.  First, I propose that SRp20 may function through 
interactions with the exonuclease, XRN-2, to facilitate the RNA degradation. When SRp20 is 
missing, degradation is abrogated, so the lin-15B RNA downstream of the insert and lin-15A 
mRNA accumulate.  
The second possibility is that SRp20 plays a role in the termination of Pol II. In this case, the 
absence of SRp20 would prevent Pol II release from the DNA. Functions for SRp20 in 
termination have not been reported previously. However, there are two published examples of 
SRp20 adjacent to the 3′ ends of genes: SRp20 has been shown to co-immunoprecipitate with 
pre-messenger RNA cleavage factor 1 (CFIm), a factor involved in 3′-end formation in mammals 
(Dettwiler 2004) and to affect polyadenylation in Rous sarcoma virus (Maciolek and McNally 
2007). RNAi against the C. elegans homologue to CFIm did not suppress the Muv phenotype 
(Cui, personal communication), so interaction with CFlm is unlikely to be the mechanism by 
which SRp20 functions. However, RNAi against polyA polymerase did suppress the phenotype 
weakly, so the function of SRp20 may be through the polyadenylation process. Finally, the effect 
on termination may be indirect, either by an effect on elongation of polymerase, polyadenylation 
or splicing. For example, splicing of the last exon encourages 3′-end formation in mammals 
(Kyburz et al. 2006). Splicing of the last exon also affects release of Pol II from the DNA (Dye 
and N. J Proudfoot 1999).  
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Summary 
The precise roles of the three CID proteins and SRp20 in 3′ end formation and 
transcription termination, as well as how the CID interaction with Pol II contributes to those 
roles, await further experimentation. I have shown that in at least one context SRp20 also 
contributes in some way to events following mRNA 3′ cleavage that lead transcription to 
terminate. In addition I have shown in this specific context CIDS-1 and CIDS-2 function in 
formation of the inserted 3’ end.  This is likely not the only site at which 3’ end formation is 
enhanced by CIDS-1 and CIDS-2, and additional tests are needed to discover genes whose 
mRNA processing is affected by mutation of these two genes.   
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CHAPTER 5  
Bioinformatic analysis of the operon intercistronic region 
 
Portions taken from   
 
―Polycistronic pre-mRNA processing in vitro: snRNP and pre-mRNA role reversal in trans-
splicing.‖ Lasda EL, Allen MA, Blumenthal T. 
 
 
 
Introduction 
 Between two genes in an operon lies the intercistronic region (ICR). The ICR extends 
from the 3’ cleavage site of the upstream gene to the trans-splice site of the downstream gene 
and is necessary for expression of the downstream gene (T Huang et al. 2001). ICRs are 
generally small (median 129 nt-See Chapter 3) and the small size is thought to be necessary for 
expression of the downstream gene (T Huang et al. 2001). 
 Scanning mutagenesis of the ICR was used to determine if a specific region was both 
necessary for expression and/or for SL2 trans-splicing of the downstream gene (T Huang et al. 
2001). An operon containing gpd-2 and gpd-3 was placed under the control of a heat shock 
promoter. The wild-type construct was injected and a transgenic strain was created.  Many 
strains carrying mutant versions of the ICR were also created. The transgenics strains were heat-
shocked to induce expression of the operon, then expression and trans-splice choice of the 
downstream gene was examined. A few of the mutations led to the discovery of a so-called ―U-
rich (Ur) region‖, 50-70 nt downstream of the cleavage site, which was found to be necessary for 
expression of the downstream gene and trans-splicing to SL2 (T Huang et al. 2001). The Ur was 
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also sufficient to create a functional ICR when placed in an unrelated sequence of the same size 
(T Huang et al. 2001). 
 
  Since the constructs above were controlled by heat-shock promoters, several levels of 
heat shock were attempted to find the best expression. Because at high temperatures all splicing 
is inhibited (Yost and Lindquist 1986), when the transgenic worms caring the operon construct 
were heat shocked at high 
temperatures, trans-splicing was 
inhibited. When splicing was 
inhibited a novel RNA appeared. The 
RNA was called the ―Ur RNA‖ 
because the 5’ end of the Ur RNA 
corresponded to the 5’ end of the Ur 
element (Figure 54) (Liu et al. 2003). 
When the Ur was moved upstream or 
downstream within the ICR, the 5’ 
end of the Ur RNA was shifted as 
well. Because of the presence of the 
Ur RNA, the Ur is hypothesized to be where either a protein or RNA can to bind to the ICR and 
block degradation of the uncapped RNA created by cleavage. The temporary inhibition of 
degradation could increase the time allowed for the trans-splicing reaction to occur.  Both SL2 
and CstF have been suggested as potential binding partners of the Ur element (E. L. Lasda et al. 
2010; Yingmiao Liu et al. 2003). 
Figure 54: Diagram of the position of the Ur RNA 
relative to the construct. 
Construct contains a heat-shock promoter followed by the 
gpd-2(blue) and gpd-3(red) genes. The ICR between the 
genes is a black line and the Ur RNA is shown as a 
maroon line. The 3’ end of the line is dotted because it 
has not been confirmed. Below, the box around the ICR 
is magnified. The Ur is located in the middle of the ICR, 
and the 5’ end of the Ur RNA corresponds with the 5’ 
end of the Ur (Liu et al. 2003). 
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 A positional motif scan of the ICR was performed in an attempt to discover the motifs 
necessary to enhance trans-splicing (Graber et al. 2007). Using sequences available at the time 
from genes with well defined 3’ ends within operons (n=182) and 3’ ends which were not within 
operons (n=931), several potential motifs were found 50-60 nt downstream of the cleavage site, 
in the same region as the Ur. The Ur region was presumed to be U-rich signal with a core 
consensus of UAUUUU positioned 35–65 nt downstream from the processing site. Other 
statistically significant motifs included UACUU, UAUCU, UAUUU, UUUCU, UUUUA (Z 
scores of >4.5 and p-values of less than 2e-5).   
Interestingly, the constructs being used in the lab by Erika Lasda for in vitro analysis of 
trans-splicing contained a motif with an apparent consensus, UAYYUU. Deletion of the region 
containing this sequence inhibited trans-splicing. I used bioinformatics to analyze the global 
relevance of the molecular results by determining the prevalence of this motif within a group of 
well defined 3’ ends. 
 
Results 
Search for the UAYYUU motif within ICRs 
Using a set of well defined 3’ ends, I searched for a motif thought to be necessary for 
trans-splicing.  In order to analyze the prevalence of the UAYYUU motif in ICRs, I compared 
the incidence of the motif within 3’ sequences flanking genes in operons and control genes. The 
percentage of genes containing UAYYUU (Figure 55) or the 1-nt-shorter UAYYU element 
(Figure 55), was plotted in 10-nt windows for 140 nts upstream of, and downstream from, the 3′ 
end cleavage sites. Using the nt composition of the 100 nt after the cleavage site [A: 32%, C: 
16%, U: 41%, G: 14%] for all cleavage sites, the 6-nt motif should be present 3% of the time in 
each 10 nt block. Nevertheless, a sharp peak of this sequence occurs 50–70 nt downstream from 
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the cleavage site. The peak is present downstream of 3’ ends within operon ICRs but not 
downstream of 3’ ends not within operons (Figure 55). These data support the involvement of 
this sequence in trans-splicing, since only ICRs end in a trans-splice site. The 50- to 70-nt 
location is consistent with the UAYYUU position of the experimentally studied operons.  
 
Figure 55: Many 3’ ends within operons contain the UAYYUU and UAYYU motif. 
Analysis comparing the percentages of genes containing UAYYUU upstream and downstream of 
the cleavage site in 10 nt bins. Labels on X axis are nt from the 3′ end cleavage site.  Blue 
squares are cleavage sites within operons and blue diamonds are 3’ cleavage sites not with 
operons. The last nt of the motif was used to calculate the position of motif. 
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Multiple repeats of the UAYYUU and 1 nts variants are common in ICRs 
The rla-1 ICR, used extensively in the Blumenthal lab to study trans-splicing 
requirements, contains multiple, overlapping copies of UAYYUU, some with a single nucleotide 
mismatch (Erika Lasda et al. 2010). Experimentally, these extra copies act additively in SL2 
trans-splicing, and are partially redundant. To ask whether partial redundancy was widespread 
among ICRs, I searched for the UAYYUU motif or any single nucleotide mismatch within 20 nt 
blocks of sequence. I found the greatest difference between 3’ ends within operons compared 
with those not within operons, at the position 40–60 nt downstream from 3′ end cleavage sites 
(Figure 56). Within that limited 20 nt region, 75% of operon ICRs (column A) have at least one 
UAYYUU (or a one nt variant), while only 37% of non-operon genes do (column B). 
Furthermore, operons are far more likely to have multiple copies. The chart shows the 
percentages of genes with at least one, two, three, four, or even five copies. For example only 2% 
of non-operon genes have three or more copies within this region, 13% of ICRs within operons 
do. It is also notable that, within this very limited region, 33% of the operon genes have greater 
than two copies of the motif or a 1 nt variant. This shows that the multiple copies of UAYYUU, 
which were shown to be important to rla-1 trans-splicing, frequently occur in other operon ICRs. 
 
Probability of UAYYUU motif within ICRs 
To test if the UAYYUU motif and its 1nt variants were present at a higher frequency than 
would be predicted, I calculated the probability of finding one or more copies of the motif or any 
of its variants within a 20 nt window. In Figure 57 I have plotted the probability of finding the 
motif and the actual results as seen in Figure 56. Initially, I used equal nt frequencies [A: 25%, 
C: 25%, U: 25%, G: 25%] to calculate the probability. The percentage of 3’ ends predicted to 
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contain 1 or more copies (blue) is much lower than the actual percent for either the group within 
operons (green) or not within operons (red). In fact, when equal nt composition is used the 
predicted percentage of sequences with even one copy is quite low.  However, using an equal nt 
composition for the region is clearly not the appropriate control. Therefore, I calculated the local 
nt composition using the 100 nt after the cleavage site for all of the sequences in both data sets 
[A: 32%, C: 16%, U: 41%, G: 14%]. This composition is more similar to the overall nt 
composition of the C. elegans genome [A: 32%, C: 18%, U: 33%, G: 18%]. Figure 57 shows 
that the UAYYUU and variants seem to be present more often than expected in the group of 3’ 
ends within operons (red vs. purple).   
 
Figure 56: In operons, the window 40-60 nt downstream of the cleavage site contains 
multiple copies of the word UAYYUU and 1 nt variants. 
Analysis comparing the percentages of genes within (column A) or not within (column B) 
operons that contain multiple copies of the sequence motif UAYYUU (allowing a 1-nt 
mismatch), within a 20-nt window located 40–60 nt downstream from 3′ end cleavage sites. 
Motif copy # indicates the number of instances of the motif occurring within the window. Motif 
copies may overlap. 
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Figure 57: UAYYUU and variants are found in operons more frequently than expected. 
The probability of finding the UAYYUU motif or a 1 nt variant was calculated by adding the 
probabilities of finding the UAYYUU motif within a 20 nt window, to the probability of finding 
each possible variant. The blue bar indicates the predicted percent of sequences that would 
contain that number of motif copies if the region contain an equal nt composition [A: 25%, C: 
25%, U: 25%, G: 25%]. The red bar indicates the predicted percent of sequences that would 
contain that number of motif copies based on the regions true nt composition [A: 32%, C: 16%, 
U: 41%, G: 14%]. The green and purple bars indicate the actual percent of sequences that contain 
the indicated number of copies of the motif or a variant. 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
>=1 >=2 >=3
number of copies of word or variant
Occurrences of UAYYUU or 1 nt variant in Ur 
region
expectation with equal nt compostion 
expectation with known nt composition
found not within operons (n=931)
found within operons (n=182)
150 
 
 
Discussion 
 Between two genes in an operon, the ICR was shown to contain a ―U rich‖ region which 
was thought to be important for SL2 specificity (T Huang et al. 2001). Recently, an in vitro assay 
for trans-splicing was developed by Erika Lasda in the Blumenthal lab (Erika L Lasda et al. 
2010). Using the in vitro assay, she showed through mutational analysis that the UR element is 
composed of both a short stem loop and a UAYYUU motif. I have shown the prevalence of this 
UAYYUU motif, 50-70 nt downstream of the cleavage site within the ICR. The estimated 
frequency based on local nucleotide composition of the UAYYUU is far lower than the actual 
frequency, suggesting selection for this sequence.  
Lasda created numerous mutations within an ICR and test for SL specificity from each of 
the constructs.  The mutations she created lead to the discovery that there were multiple 
UAYYUU variants with 1 nt mismatches surrounding the UAYYUU. Experimentally, she 
showed that the multiple copies of the motif and 1 nt variants was necessary for efficient SL2 
trans-splicing. In addition, I have shown the global relevance of this result. Searching 
downstream of many 3’ cleavage sites I confirmed many operons contained the UAYYUU 
variant repeats. I also demonstrated by nucleotide frequency that the multiple copies are likely 
selected for in the region downstream of 3’ ends within operons.  
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CHAPTER 6 
 
Conclusion 
 
A Global Analysis of Trans-splicing and Bioinformatic Analysis of the Operon 
Intercistronic Region 
Major conclusions from this work 
This work provides the first global analysis of C. elegans trans-splicing, encompassing 
SL1 and SL2 trans-splicing, as well as information about non-trans-spliced genes, intercistronic 
regions of operons, and internal operon promoters. Through analysis of RNA-seq, I have 
determined that approximately 60% of C. elegans genes are subject to trans-splicing (Table 3). 
This work has also led to the creation of a list of trans-splice sites for each trans-spliced gene, a 
list of SL1 and SL2 trans-spliced genes, and a list of genes that are likely non-trans-spliced. 
These lists are invaluable for the C. elegans researcher. I also showed that genes with higher 
expression are more likely to be trans-spliced.  
The trans-spliced genes are trans-spliced to SL1, SL2, or an SL2 variant. I have shown 
SL1 and SL2 are primarily used in different contexts (Figure 19). The vast majority of trans-
spliced genes are trans-spliced nearly exclusively to SL1. While fewer genes are trans-spliced to 
SL2 (or an SL2 variant), these genes also splice with near exclusivity. A very small percentage 
of genes are trans-spliced to a mixture of both SL1 and SL2 (and variants). In contrast, 
unpublished analysis of ESTs had previously suggested that SL2 and SL2 variants were used in 
similar contexts. Using the RNA-seq data, I have demonstrated here that they may indeed be 
interchangeable, since they consistently trans-splice in approximately the same proportions to the 
majority of SL2-receiving genes (Figure 17).    
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I further analyzed these results to show that the SL1 trans-spliced genes are different 
from the SL2 trans-spliced genes in at least two ways. First, the distance to the nearest upstream 
gene is quite long for SL1 trans-spliced genes. Genes that receive SL2 have a short distance to 
the nearest upstream gene. Second, SL1 trans-spliced genes are 3-4 times more likely to be 
within a promoter peak than SL2 trans-spliced genes. This supports previous hypotheses that 
SL1 is used for trans-splicing non-operon genes and SL2 is used for trans-splicing downstream 
operon genes. 
Although there are few genes that receive mixtures of SL1 and SL2, these genes are 
unique in that they have features in common with both SL1 trans-spliced genes and SL2 trans-
spliced genes. SL mixture genes have adjacent promoters like SL1 trans-spliced genes. However, 
like SL2 trans-spliced genes  (and distinctly unlike SL1 trans-spliced genes), the SL mixture 
genes have a short distance to the next upstream gene.  
I theorized that the SL mixture genes were in hybrid operons and were being transcribed 
from two promoters. Within a hybrid operon, the use of SL2 is due to transcription originating at 
the 5’ end of the operon, whereas SL1 trans-splicing occurs on transcripts originating at the 
promoter internal to the operon. I tested select examples of these SL mixture genes 
experimentally, and results shown in Figure 25 support this possibility. 
This information is particularly useful for researchers interested in predicting promoter 
locations of trans-spliced genes. Promoter location (5’ of an operon vs. adjacent), as well as the 
existence of multiple promoters, can likely be inferred by considering the SL1/SL2 ratio. To 
avoid potential experimental pitfalls, C. elegans researchers should consider whether their gene 
of interest is trans-spliced, and if so, the gene’s position within an operon as well as the gene’s 
SL1/SL2 ratio. 
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Further analysis of the trans-splicing events in C. elegans has shown that intron 3’ splice 
sites are also trans-spliced, though infrequently (Choi and Newman 2006). When trans-splicing 
occurs at an intronic 3’ splice site, it tends to be to SL1 rather than SL2 (Figure 28). I have also 
shown that trans-splicing at intronic 3’ splice sites is more likely if the intron is quite long. These 
events may be due to low level promoters contained within long introns. Alternatively, the trans-
splicing to cis-splice sites may be mistakes by the trans-splicing machinery. Perhaps cis-splicing 
is less efficient when the 5’ and 3’ splice sites are far apart. Trans-splicing machinery may then 
view the intron as an outron and sometimes out-compete the cis-splicing machinery.  
Additionally, I have demonstrated that many ICRs contain the motif UAYYUU, which is 
important for SL2 trans-splicing (T Huang et al. 2001; Erika L Lasda et al. 2010; Graber et al. 
2007) within a small window located in the middle of the ICR. I show that ICRs often contain 
multiple copies of this motif or a 1 nt variant, supporting the molecular evidence that redundant 
copies are functional. Finally, I have shown that the sequence may be selected for within operons 
since the motif is overrepresented downstream of 3’ ends in operons  
 
How this work integrates with the work of others  
 In 1993 the presence of operons in C. elegans was demonstrated by detection of a few 
polycistronic RNAs (Spieth et al. 1993). However, since all polycistronic RNAs cannot be 
detected, operons have been annotated using the criteria of downstream SL2 trans-splicing and 
the short distance between genes (Blumenthal et al. 2002). Data presented in this work 
strengthens the argument that operons can and should be annotated according to SL2 trans-
splicing. This is apparent when considering that SL2 trans-splice sites are much less likely than 
SL1 trans-splice sites to be within an HTZ peak (Figure 22), indicating that they are less likely 
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to have adjacent promoters. Therefore, SL2 trans-spliced messages must originate from a 
promoter further upstream, supporting the idea of polycistronic transcription.  
 Prior to this work, C. elegans genes were generally categorized as either SL1 trans-
spliced, SL2 trans-spliced, or non trans-spliced. Only a very few cases of genes trans-splicing a  
mixture of  SL1 and SL2 were known. It was not definitively known how many genes were in 
this category, nor why certain genes trans-spliced to a mixture of SL1 and SL2. This work 
provides RNA-seq data concerning the number of genes trans-splicing to both SL1 and SL2, and 
also provides insight into the reason for SL choice. 
 At least three mechanisms explain why some genes trans-splice to a mixture of SL1 and 
SL2. First, if SL2 trans-splicing relied upon either 3’ end formation of the upstream gene, or 3’ 
end formation factors associating there, then long distances between genes in operons could 
cause mixtures of SL1 and SL2 trans-splicing because the 3’ end formation site of an upstream 
gene would be too far away from the trans-splice site of the downstream gene to efficiently 
contribute to SL2 trans-splicing (S Kuersten et al. 1997). Second, if both SL1 and SL2 trans-
splice sites had nearby cis-acting sequence motifs that signaled which SL should be used, then 
the genes that trans-splice a mixture of SL1 and SL2 could contain the signals for both SLs. 
Finally, if these genes were in hybrid operons and had both operon promoters at the 5’ end of the 
gene cluster and adjacent promoters immediately upstream, then the transcripts originating from 
the operon promoter could trans-splice to SL2 while the transcripts from the adjacent promoter 
could receive SL1 (Peiming Huang et al. 2007).      
 Data presented here provide strong support for two of these mechanisms. The hybrid 
operon mechanism is the most strongly supported by my work. First, a high proportion of the 
genes with mixtures of SL1 and SL2 are indeed classified as within hybrid operons, based on 
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having trans-splice sites within HTZ peaks and also having short distances to the next upstream 
gene (Figure 20; Figure 22). In addition, I have shown that deletion of a promoter internal to 
one of these operons reduces SL1 trans-splicing while a deletion upstream of one of these 
operons reduces SL2 trans-splicing (Figure 25). This supports the idea that hybrid operons can 
produce mixtures of SLs. However, in both situations the level of the SL is only reduced, not 
eliminated, when the predicted promoter is deleted. This implies another mechanism may be 
functioning in addition, perhaps nearby cis-acting sequence elements used to specify SL1 and 
SL2.  
My data demonstrates that distance from the next upstream gene may be a factor in SL1 
vs. SL2 trans-splicing (S Kuersten et al. 1997). Genes that receive 80-90% SL2 and 90-100% 
SL2 are both unlikely to have a promoter (Figure 22). However, genes with 80-90% SL are still 
further from their upstream gene then the genes receiving 90-100% SL2. This suggests that the 
high percent SL2 is caused by the close proximity to the upstream gene.    
 
 
Models and future directions 
 I demonstrate in this work that ~60% of genes in C. elegans are trans-spliced based on 
sequencing data. Unfortunately, RNA-seq cannot identify all of the genes that may be trans-
spliced. Some genes may be expressed at such a low level or in so few situations that RNA-seq 
would be an inefficient way to detect them. It would therefore be interesting to predict the 
percentage of trans-spliced genes based solely on the presence of a 3’ splice site upstream of the 
start codon.  In order to reliably predict trans-spliced genes, I would need to create a program 
that would search for a 3’ splice site consensus sequence within a defined distance upstream of 
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annotated start codons. Such a program would need to be trained on several existing data sets, 
such as those genes with similar expression levels. For instance, I could train the program to 
recognize the 3’ splice sites upstream of genes with an expression level between 2-5 dcpm 
(Figure 16) and then test the program on the genes with higher expression levels, where there is 
abundant RNA-seq data to verify trans-spliced genes vs. non-trans-spliced genes. If a program 
could be designed to accurately categorize both the trans-spliced genes and the non-trans-spliced 
genes with high expression levels, then the program could potentially be used to accurately 
predict trans-spliced genes with low expression levels. 
 One possible caveat of this program may be that it would identify too many trans-spliced 
genes. There may be unpaired 3’ splice site sequences within the 5’ UTRs of non-trans-spliced 
genes. However, these situations might also be interesting to study. How could an unpaired 3’ 
splice site consensus sequence exist within a 5’ UTR without being trans-spliced? Perhaps a 
protein could bind nearby, masking the splice site sequence or blocking trans-splicing, or maybe 
the splice site sequence requires a specific context (such as an AU rich region) in order to be 
used for splicing. Finally, the outron may be too short to trans-splice.  
This work has also led to speculation concerning the nature and origin of operons in C. 
elegans. Genes downstream in operons have four prominent attributes: no gene-specific 
promoters, mRNAs that are trans-spliced to SL2, ICRs with a Ur element, and short distances to 
the upstream gene. I have two theories about the order in which a gene, destined to be 
downstream in an operon, gains these four attributes. First, new operons could begin with a 
deletion between two non-operon genes. This deletion would need to be large enough to take out 
the downstream gene’s original promoter and at the same time bring the two genes into very 
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close proximity. The Ur element might be created by a random mutation following the deletion, 
but strongly selected for once present.  
A second theory is that operons may begin with the creation of a Ur element. The new 
downstream gene would then periodically be transcribed from the upstream gene’s promoter, 
thereby creating a hybrid operon. If the promoter for the upstream gene was strong enough, 
deletions between the two genes might no longer be deleterious, since transcription could still 
occur from the upstream gene’s promoter. This would allow the two genes to move closer to one 
another, effectively shortening the ICR. Either of these theories could explain the gaining of the 
four attributes associated with downstream genes in operons, or a combination of the two 
methods might occur in evolution. Using C. elegans transgenics, potential operon intermediates 
for each of these scenarios could be created and then tested for downstream gene expression and 
SL2 trans-splicing. This may shed light on what gene organization characteristics have the 
potential to give rise to operons. Additionally, we could use comparison with other closely 
related organisms in an attempt discover any recently evolved operons. 
  
 
 
CIDS-1, CIDS-2 and SRp20’s Context Specific Enhancement of 3’ End Formation and 
Transcription Termination 
Major conclusions from this work 
In Chapter 4, I demonstrated that lin-15(n765) is a unique deletion/insertion within an 
operon that causes premature 3’ end formation and a lack of expression of the downstream gene. 
An RNAi screen for phenotype suppression uncovered a group of allele specific suppressors. 
Included in this group are the known 3’ end formation factors CstF and CPSF.  I have shown that 
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RNAi of the 3’ end formation factors reduces 3’ end formation and allows transcription of the 
downstream gene, thereby rescuing the SynMuv phenotype. In addition, I have analyzed four 
other suppressors, to determine their effects on 3’ end formation and transcription termination.  
The cids-1(tm2715) and cids-2(tm2802) deletions each produce 4% males at 25⁰. They 
have no other strong phenotypes. Both deletions are able to rescue the lin-15B(n765) SynMuv 
phenotype. Using qRT-PCR, I demonstrated they rescue because they are both involved in 3’ end 
formation at the inserted locus. However, this effect is context specific because in the five other 
genes tested, deletion of cids-1 and cids-2 did not decrease 3’ end formation. It is possible that 
cids-1 and cids-2 may have effects on 3’ end formation for only a subset of genes. Indeed the 
poly A site of lin-15B(n765) seems indistinguishable from a typical gene. However, the effect on 
3’ end formation may be indirect and the main function of these two genes may be in Pol II 
elongation.  Finally, both CIDS-1 and CIDS-2 may stimulate 3’ ends of all genes, but not have a 
large effect in most situations. 
The SRp20 gene is a known splicing factor in other organisms. Indeed, I have 
demonstrated that it has effects on alternative splicing in C. elegans. Mutations of this gene 
demonstrate it is necessary for viability.  I have shown that in the lin-15B(n765) context, SRp20 
does not seem to affect splicing but functions in either degradation of the RNA downstream of 
the cleavage site and/or transcription termination. This effect may be direct through interactions 
with the transcription machinery or the RNA downstream of the cleavage site. On the other hand, 
the effect may be indirect though cross-talk with co-transcriptional processes. 
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How this work integrates with the work of others 
 RTT103, the yeast homolog of cids-1, was identified in a genetic screen for effects on Ty 
transposition. RTT103 was isolated in a purification of proteins bound to CTD peptides 
phosphorylated at Serine 2. In agreement, I have shown that Serine 2 phosphorylated CTD co-
immunoprecipitates with a tagged C. elegans CIDS-1. Serine 5 phosphorylated CTD also co-
immunoprecipitates with the tagged C. elegans CIDS-1.    This indicates that CIDS-1 may be 
functional at locations other than just the 3’ end of a gene. 
 RTT103 was proposed to function in transcription termination because when RTT103 
was deleted the level of RNA downstream of the cleavage site increased.  By ChIP, Pol II 
traveled further downstream of transcribed genes in the RTT103 deletion strain (M. Kim et al. 
2004). I have also shown that CIDS-1 deletion causes the level of RNA downstream of the 
cleavage site to increase in at least one C. elegans gene. However, I also see a decrease in the 
levels of cleavage in the mutant background, implying a function of CIDS-1 in 3’ end formation. 
Therefore, CIDS-1 may function in both 3’ end formation and transcription termination. 
Alternatively, CIDS-1’s function in 3’ end formation could indirectly enhance transcription 
termination.   
Tandem affinity purification (TAP) of RTT103 identified RAT-1 as an associating 
protein (Kim et al. 2004). Recently, it has been shown RAT-1 tracks with polymerase as it 
travels down the gene and is able to affect elongation of Pol II (Jimeno-González et al. 2010). 
CIDS-1 may function in these processes as well. An effect on elongation might indirectly 
enhance 3’ end formation at the inserted lin-15B(n765) 3’ end. 
SRp20 has known effects in alternative splicing in other organisms (de la Mata and 
Kornblihtt 2006; Cavaloc et al. 1999). I have confirmed SRp20 also affects alternative splicing in 
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C. elegans (Figure 48). Due to the more severe rsp-6(ok798) mutation, I suggest that SRp20 
function is essential in C. elegans, as it is in mouse (Hassan Jumaa et al. 1999). 
SRp20 has been shown to affect polyadenylation of the RSV virus (Maciolek and 
McNally 2007).  SRp20 has also been shown to associate with CFIm (Dettwiler 2004).These two 
functions may situate SRp20 near the 3’ ends of genes. I have shown SRp20 is either involved in 
transcription termination or in degradation of the RNA downstream of the cleavage site. I am 
unsure if any of these processes are linked, but I can envision that if SRp20 was involved in 
polyadenylation at the inserted 3’ end, the effect on polyadenylation might be able to enhance 
transcription termination.  
 
Models and future Directions 
 I have shown that lin-15B(n765) is a unique insertion, which can be useful in a screen for 
revealing 3’ end formation  and transcription termination factors. This strain could be useful in 
the future to test potential factors involved in these processes.  
 CIDS-1 and CIDS-2 were shown to function in 3’ end formation in at least one context. 
However, for several other genes tested, deletion of cids-1 and cids-2 did not affect 3’ end 
formation. It would be useful to know, in which contexts CIDS-1 and CIDS-2 function. I believe 
they may function in the lin-15B(n765) context because the insert is somehow recognized by the 
cell as abnormal. Perhaps, because of the insert, the phosphorylation pattern of the CTD as it 
travels across the gene has been altered and the alteration is recognized by CIDS-1 and CIDS-2. 
Alternatively, if the Serine 2 phosphorylation is not high enough at the inserted 3’ end, and yet 
the 3’ end signal is still recognized, it may trigger an alternative form of 3’ end formation 
involving CIDS-1 and CIDS-2. 
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 I would suggest that CIDS-1 and CIDS-2 should be examined using ChIP in attempt to 
discover their pattern across a transcribed gene. In addition, it would be useful to know what the 
pattern of Serine 5 and Serine 2 phosphorylation is in the lin-15B(n765) mutation and if the cids-
1 and cids-2 deletions affect this pattern. To attempt to identify other 3’ ends CIDS-1 and CIDS-
2 function at, ChIP-seq to the tag in the tagged CIDS-1 and CIDS-2 strains could be used. 
Finally the presences of males within this strain could be a clue to their function. If the males are 
a result of chromosome non-disjunction, then it would be interesting to study how loss of these 
proteins causes loss of chromosomes. 
 SRp20 was shown to function in either transcription termination or RNA degradation in 
these contexts. By performing a ChIP on Pol II in the SRp20 mutant background, it might be 
possible to determine if transcription termination has been altered. This might imply SRp20 had 
somehow affected Pol II stability. Alternatively, if the effect seen in SRp20 is on the downstream 
RNA, and if SRp20 binds directly to the RNA that is being degraded, RIP-seq may be able to 
identify the RNAs to which SRp20 is binding, thereby giving us a better picture of the function 
of this gene. 
 
Summary 
In summary, I have studied multiple processes involved in operon RNA processing in C. 
elegans. Some of the processes, such as 3’ end formation and transcription termination are 
widely applicable across species. My study of trans-splicing is very useful for the C. elegans 
researcher. And the research into the processes of trans-splicing can be used to give a better 
understanding of the process of cis-splicing. In all, through these studies we have come to a 
better understanding of how operon transcripts are processed in C. elegans. 
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APENDIX A-Tiling array analysis of an SRp20 deletion shows increases in intronless gene levels 
 
Introduction 
mRNAs have life cycles in which they are transcribed, processed, exported out of the 
nucleus, translated and then degraded. The processes in the mRNA life cycle are linked in many 
ways. For example, the level of mRNA splicing can affect its export into the nucleus, which in 
turn can affect the choice between translating an mRNA and degrading it. However, many of the 
factors that are involved in linking the mRNA life cycle are unknown. In working with a known 
splicing factor, SRp20, I believe I have discovered a context dependent important and 
unrecognized link between splicing and transcription termination (See Chapter 4).  In addition, 
tiling array analysis of this mutation has led us to link SRp20 to an increase in the RNA levels of 
several single-exon genes. SRp20 has several known functions other than splicing and has been 
studied across species. 
In eukaryotic cells SRp20 is involved in the export of mRNAs from the nucleus. The 
mouse histone H2a mRNA, an intronless gene, has a 22nt element that is required for export into 
the nucleus. SRp20 and another SR protein, 9G8, are able to bind this element (Huang et al. 
2003; Huang and Steitz 2001). Antibody inactivation of SRp20 inactivates export of the histone 
gene. SRp20 can bind to TAP, an export protein, and this binding is likely how SRp20 functions 
to export the histone mRNA (Huang et al. 2003; Huang and Steitz 2001).  SRp20 is also found in 
both the cytoplasm and nucleus crosslinked to mRNAs--another indication of its function in 
mRNA export(Huang et al. 2003; Huang and Steitz 2001).  
SRp20 not only has an effect on eukaryotic organisms, it also affects some viruses, 
including Rous Sarcoma Virus (RSV) and picorna viruses (Maciolek and McNally 2007; Bedard 
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et al. 2007). RSV is a retrovirus and therefore it has a positive strand RNA genome. A virus with 
an RNA genome must have a way to control splicing, because RNA copies of the genome 
destined for export must not be spliced but still need to be polyadenylated. RSV has a ~230 nt 
sequence called the Negative Regulator of Splicing (NRS) (Maciolek and McNally 2007). This 
sequence performs 2 functions: it prevents splicing, and it enhances polyadenylation of unspliced 
transcripts. The enhancement of polyadenylation is needed because the mammalian cells that 
RSV infects (and hijacks transcription machinery from) do not normally polyadenylate unspliced 
transcripts.  SRp20 enhances polyadenylation of the unspliced transcripts, as demonstrated by 
deleting the binding sites for SRp20 in the virus and by depleting SR proteins from extracts used 
in the experiments. This function of SRp20 should be explored in eukaryotic cells.  
 
Results 
 Because of its important role in development and because of its known role in alternative 
splicing I decided to analyze on a tiling array the genes affected by the rsp-6(tm367) strain. This 
could help define the role of SRp20- and the genes that it alternatively splices. A tiling array was 
used because a microarray will not necessarily contain information about alternative splice forms 
and because a tiling array can be used to examine genes not currently know to alternatively 
splice. A negative to the use of the tiling array is that the data is outputted on a per probe basis 
and not a per gene or per exon basis.  
Specifically, I prepared RNA from four strains, wild type (N2), rsp-6(tm367), lin-
15B(n765), lin-15B(n765); rsp-6(tm367). The RNA was reverse transcribed using random 
primers then the second strand of the cDNA was produced using DNA Pol I. The double 
stranded DNA was then fragmented and labeled and hybridized to the array.  Three biological 
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replicates were complete for lin-15B(n765) and lin-15B(n765); rsp-6(tm367). Because the arrays 
containing mutations in lin-15B were completed first and have replicates, the majority of data is 
based on those arrays.  
 
Potentially alternatively spliced exons 
Probes in the array are 25 nucleotides long and are tiled with 0-1 spaces between probes. 
Each probe is numbered by its start position along a chromosome. John Penners (Computer 
Science Department University of Colorado, Boulder, CO) and I created a program that would 
add the expression from multiple probes across a single exon. The program was used to find 
expression of each exon in both ―wild type‖ and ―SRp20 mutant‖. A t-test was done on each 
exon to determine if there was a statistically significant difference.  Exons with an expression 
greater than 525 and a p-value than less 0.05 on the t-test were identified as exons of interest for 
further investigation. 
A list of exons meeting the criteria is included as Supplementary File 1. As a positive 
control for the procedure three genes that have been shown to be alternately spliced in the 
―mutant‖ background by RT-PCR (C29E6.1, C12D12.1 and the gene for SRp20 itself, rsp-6, 
were investigated) (Figure 47; Figure 48). All of these genes are in the list of genes that scored 
significantly. Some of the genes in this list were checked visually by the tiling array program 
IGB and there are a number of genes that were discovered though this assay that may be 
alternatively spliced. Changes of splicing in these genes should be checked by RT-PCR.  
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The tiling array shows an increase in the levels of mRNA from single exon genes 
 I also visually inspected the tiling arrays for changes in alternative splicing and effects on 
3’ end formation. Upon visual inspection I saw no overall change in the levels of RNA 
downstream of cleavage site when SRp20 was deleted. I and an undergraduate under my 
direction, Elizabeth Doggett, both found changes in alternative splicing when SRp20 was 
mutated. I also noticed one other interesting molecular phenotype of the SRp20 deletion. The 
expression level of many intronless genes had increased (Figure 58). This was interesting 
because in mouse SRp20 is known to regulate nuclear export of at least one intronless gene 
(H2a) (Huang et al. 2003; Huang and Steitz 2001). 
 
Figure 58: Visual inspection of the tiling array reveals several intronless genes have higher 
expression in an SRp20 mutant.  
Top) a diagram of a region of the genome. Genes on the forward stand are above the black line 
depicting location and genes on the reverse strand are below the black line. Exons are depicted as 
black boxes while introns are depicted as black lines. I have outlined the multi-exon genes in 
blue and the intronless genes in orange. Bottom) Three biological repeats are depicted. The level 
of signal in ―Wild-type‖ is depicted by the red line, and the strain with a mutation in SRp20 is 
depicted by black lines. The array was not strand-specific. 
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RT-PCR confirms increases in expression of a single exon gene 
 To first determine if the changes in levels of mRNA from genes in the array was accurate 
or an artifact, I performed qRT-PCR to an intronless gene that showed changes in the array 
(nspa-8). I normalized the qRT-PCRs by the level of act-4, to account for loading differences.  
Analysis was completed on three biological replicates and all showed a significant increase in the 
level of nspa-8, but not in the control multi-exon gene (Figure 59).  
 
 
 
Figure 59: Over expression of an intronless gene confirmed by qRT-PCR.  
Transcript levels of the nspa-8 gene and a control multi-exon gene (F41H10.11) were measured 
by qRT-PCR in lin-15B(n765)(―wild type‖) and lin-15B(n765);rsp-6(tm367)(SRp20 mutant). 
The fold change in the level of each transcript in wild type vs. SRp20 mutant was plotted. Three 
biological replicates were competed (labeled run 1, run 2, and run 3). 
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~10 % of intronless genes increase expression dramatically in an SRp20 mutant strain 
 I wished to determine the percentage of intronless genes that show alterations in mRNA 
level on the tiling array so I designed a program to calculate the level of expression of each on 
the tiling array. The program adds all expression levels for each probe within the exons of a 
given gene, and then divides by the number of probes to get an ―expression value‖ for each gene. 
It then outputs an expression level for each gene in wild type and mutant strains and the 
difference between them. 
 I then categorized transcripts by the number of exons each transcript contains. I created a 
histogram grouping transcripts by the level of difference seen between the signal in the ―wild 
type‖ (lin-15B(n765)) tiling arrays and SRp20 deletion arrays. As seen in the column on the far 
right, at least 10% of intronless transcripts changed dramatically between the two arrays while a 
much smaller percentage of all transcripts or all two-exon transcripts change (Figure 60). 
  
Intronless genes do not increase in expression because they are small 
I first thought that the small size of the genes could be affecting the results. Larger genes 
encompass far more probes, so the arbitrary variations seen in hybridization might be stronger in 
genes with fewer probes. Therefore, I performed the analysis with only multi-exon transcripts 
that had a small length. The small multi-exon transcripts were required to have a length of less 
than 500 nts. I also made another category, smallest multi-exon transcripts for which the 
transcripts had to have a length of less than 200 nts. Neither control group showed a population 
with extreme differences in expression on the array, so length does not seem to cause the 
changes seen (Figure 61). 
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Figure 60: Ten percent of intronless genes show a dramatic upregulation of expression in a 
SRp20 mutant strain.  
The ―expression levels‖ of all genes in the lin-15B(n765) strain and the lin-15B(n765);rsp-
6(tm367) strain were calculated by adding all the signal of all the probes within a genes exons 
and dividing by the total probes in all the exons. The expression level of each gene on the lin-
15B(n765) array were subtracted from the level on the lin-15B(n765);rsp-6(tm367) array. Genes 
were binned by the difference in expression between the two arrays. The majority of genes do 
not change expression level (0_300 bin). Very few genes have large changes in expression level 
(―more than‖ and ―less than‖ bins). However, 10% of single exon genes show an expression 
difference of greater than 1800. 
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Figure 61: Small size of single exon genes does not seem to cause the population of 
intronless genes with large changes in expression. 
For description of graph see Figure 60. Two other categories of transcripts were gathered: Small 
genes that have a length of less than 500 nt and smallest multi-exon genes that have a length of 
less than 200. Only intronless genes show the large population of transcripts changing levels 
dramatically. 
 
Intronless genes whose mRNA level increases have longer polyA tails 
Because SRp20 is known to have effects on polyadenylation in Rous Sarcoma Virus, I 
wondered if the length of polyA tails of the single exon genes was changing in the mutant 
background. Therefore, I performed a northern blot to look at the length of the single exon genes 
in wild type and rsp-6(tm367). As a control to determine if the effect on the length of the 
intronless gene was due to an extension of the polyA tail, I also completed an RNase H with an 
oligo(dT) removing the polyA tail. Because the length of the F53A9.8 transcript is larger in the 
SRp20 mutant in the lanes not treated with oligo(dT) and RNase H and does not change in the 
SRp20 mutant sample treated with oligo(dT) and RNAse H, it is clear that the length of the 
polyA tail of the F53A9.8 transcript has increased in the SRp20 mutant background.  
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Figure 62: SRp20 affects the polyA tail length of the intronless gene F53A9.8. 
Total RNA was prepared from wild type and rsp-6(tm367) strains. Two samples were treated 
with RNase H and oligo(dT). Two samples were mock RNase H treated. Diagram on the right 
shows that after treatment with oligo(dT) and RNase H a transcript will no longer have a tail. 
Samples were run on an acrylamide gel and transferred to nitrocellulose, then blotted with a 
radioactive probe to F53A9.8. Samples without RNase H and oligo(dT) treatment show a smaller 
band at the same size in wild-type and SRp20 mutant. For samples not treated with RNase H and 
oligo(dT), F53A9.8 shows a more extended band in the SRp20 mutant suggesting a longer polyA 
tail. The rpl-43 gene which has two exons did not show the same size increase. 
 
 
 To confirm that the polyA tail extension of intronless genes was real, I used a second 
assay to look at polyA tail length. Briefly, an oligo that was partially RNA and partially DNA 
was ligated on to 3’ ends in total RNA. A primer complementary to the ligated oligo which 
extended into the polyA tail was then used to reverse transcribe total RNA. I then performed 
nested PCR on several intronless genes and a multi-exon gene using gene specific forward 
primers and primers that extended into the polyA tail and were specific to the ligated end. 
Therefore, if the length of the polyA tail had increased, the length of the PCR product would 
increase. Several single exon genes showed increase in the length of their polyA tails, while a 
control multi-exon gene did not show an increase in the length of the polyA tails (Figure 63). 
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Figure 63: Three intronless genes show increases in polyA in the SRp20 mutant 
background. 
Total RNA from two strains wild-type and SRp20 mutant was ligated to RNA:DNA hybrid 
oligos. The oligo contained a 3’ end alternative nt that would block ligation of the oligo 
anywhere other than the 3’ end of a gene. RNA was reverse transcribed using a primer specific to 
the ligated oligo and which extended into the polyA tail of the transcript so as to limit reverse 
transcription to those oligos which were ligated to transcripts. Nested PCR was used to amplify 
the 3’ ends of several intronless genes and a single control mutli-exon gene (F41H10.11). In the 
two left top gels both genes show longer transcripts than either wild-type sample implying the 
polyA tail is longer in the mutant strain. (Two wild type samples were used to make comparisons 
of size easier.) The right-most intronless gene only shows an increase in the case of one of the 
wild-type samples. Therefore its polyA tail may be longer in the SRp20 mutant. The band for the 
control multi-exon gene did not increase in size in the mutant, and in fact may have decreased in 
size, suggesting either the polyA tail in the SRp20 mutant is the same size, or the polyA tail is 
shorter. 
 
 Finally, after combing through the list of intronless genes that increased in the tiling 
array, I realized that the majority of the intronless genes that had changes in expression belonged 
to only three families of genes [nspa(Nematode Specific Peptide family, group A), msp (Major 
Sperm protein) and nspd (Nematode Specific Peptide family, group D)]. This meant that the 
observed changes in expression could be through regulation of families of genes instead of 
because these genes were intronless. In addition I was unsure if the effect on these genes was a 
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direct result of the mutation of SRp20 or an indirect result. Because this project had strong 
caveats I did not continue to pursue the reason behind the increase in expression of the single 
exon genes or the change in the polyadenylation of the intronless transcripts.  
 
Discussion 
SRp20 appears to function in multiple ways. One known function is in alterative splicing. 
This research has produced a list of genes that can be checked for alternative splicing. 
Alternative splicing by SRp20 may be key to the phenotypes seen in higher organisms. A new 
function of SRp20 may be in the regulation of single exon genes. This could be due to the small 
size of single exon genes, although when compared to small multi exon genes I showed only the 
intronless genes had a change in expression.   
In Eukaryotes, export from the nucleus is enhanced by splicing. Indeed, if a transgene 
without an intron is used very little of the transcript is able to escape from the nucleus
 
(Valencia 
et al. 2008). This raises the question of how do single exon genes escape from the nucleus. 
SRp20 may enhance or block export of single exon genes which might explain the increase in the 
levels of many single exon genes. One single exon gene, histone H2a gene requires SRp20 for 
export of its transcript from the nucleus in mammalian cells (Y. Huang and J. A Steitz 2001). 
The data included in this paper may indicate SRp20 functions in the export of many other single 
exon genes. One reason for this hypothesis is the fact that long polyA tails can be a consequence 
of mRNAs being stuck in the nucleus (M. Macmorris 2003). 
 It is interesting that the length of the polyA tail is increased in the single exon genes, 
which are upregulated in the SRp20 mutant background. This may imply some sort of common 
regulation. This may also imply that SRp20 interacts directly with these genes though that has 
yet to be tested. Unfortunately, most of the single exon genes that change in levels belong to only 
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three families of genes, and therefore they may be co-regulated because of function and not 
because they are single exon genes. However, this could be tested in the future by creating single 
exon transgenes.  
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APENDIX B-Glossary of Abbreviations  
bp = base pair 
CFIm = Cleavage Factor I  
ChIP = Chromatin Immunoprecipitation 
ChIP-chip = Chromatin Immunoprecipitation followed by a microarray 
CID = CTD interaction domain 
Co-IP = Co-Immunoprecipitation  
CPSF = cleavage polyadenylation specificity factor 
CstF = cleavage stimulation factor 
CTD = C-terminal Domain  of the largest subunit of Pol II (RPB1)  
CUTS = cryptic unstable transcripts 
ICR = Intercistronic region 
nt = nucleotide 
Pol II = RNA polymerase II 
PolyA = polyadenylation 
qRT-PCR = quantitative RT-PCR 
RNA-seq = transcriptome sequencing 
RT-PCR = Reverse transcription followed by polymerase chain reaction 
SL = spliced leader 
snoRNAs = small nucleolar RNA 
snRNA = small nuclear RNA 
SynMuv = synthetic multivulva  
snRNP = small nuclear ribonucleoproteins particles 
TMG = trimethylguanosine cap 
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APPENDIX C - Oligo table 
Figure Gene OLIGO name Sequence 
13 lin-15B MA439 CGTTCCGTCAACAGCTACAG 
13 lin-15B MA440 GCATTCTGAAATTTGTGGGTTT 
25 SL2 1963,2246,2247,
2248 
GGTTTTAACCCAGTTACTCAAGA,GGTTTTA
ACCCAGTTACTCAAGC,GGTTTTAACCCAGT
TACTCAAGT,GGTTTTAACCCAGTTACTCAA
GG 
25 SL1 2146,2243,2244,
2245 
GGTTTAATTACCCAAGTTTGAGA,GGTTTAA
TTACCCAAGTTTGAGC,GGTTTAATTACCCA
AGTTTGAGT,GGTTTAATTACCCAAGTTTGA
GG 
25 rpl-26 MA486 CGTGCTATTCCAATCAGAACCG 
25 rpl-26 MA487 GCTTGGTGATAGCGACCTTCGA 
25 C23H3.4 MA741 TGGTTCCTGAAACACCACAA 
25 C23H3.4 MA742 ACGATCCTACGCCGTACTTG 
25 tbb-1 MA759 CGAAGTACGAGGAGTTCTTG 
25 tbb-1 MA760 CCCTCTAGAGCCGATAGTTC 
25 K01G5.8 MA765 TTCGGTTCGAGGCTAGAAGA 
25 K01G5.8 MA766 CGTCCAGGAAACTTTTGGAA 
25 W09D10.1 MA767 CAAGGCTTCCTGTTGGACAT 
25 W09D10.1 MA768 CTGAGCGCACTTTTGAGATG 
32 lin-15B MA358 GTCAATTACACAAAGACTGTTGG 
32 lin-15B MA391 TTACTTTGAGGATTTGTACGAGCG 
32 lin-15B MA512 TAATTTGCCGAAGCCATTTC 
32 lin-15B MA514 ACCCAGCAACGAATAAGTGG 
32 oligo(dT) oligo(dT) TTTTTTTTTTTTTTTTTTTT 
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33 lin-15B MA379 CATCGACGACTTTGTAAACTCT 
33 lin-15B MA380 GCTGTTCTTGATTCAGGATCGAAATA 
33 lin-15B MA381 GTGATTCCACCTACAAATGTAACGA 
33 lin-15B MA382 TGTGTAATTGACTTGCGGTTTAGA 
33 lin-15A MA403 CCACACGAGAGGGATCTCA 
33 lin-15A MA404 CCTTCTCGCAGAGTATGCAC 
33 rpl-26 MA486 CGTGCTATTCCAATCAGAACCG 
33 rpl-26 MA487 GCTTGGTGATAGCGACCTTCGA 
35 lin-15B MA379 CATCGACGACTTTGTAAACTCT 
35 lin-15B MA380 GCTGTTCTTGATTCAGGATCGAAATA 
35 lin-15B MA381 GTGATTCCACCTACAAATGTAACGA 
35 lin-15B MA382 TGTGTAATTGACTTGCGGTTTAGA 
35 lin-15A MA403 CCACACGAGAGGGATCTCA 
35 lin-15A MA404 CCTTCTCGCAGAGTATGCAC 
36 lin-15A MA403 CCACACGAGAGGGATCTCA 
36 lin-15A MA404 CCTTCTCGCAGAGTATGCAC 
38 lin-15A MA403 CCACACGAGAGGGATCTCA 
38 lin-15A MA404 CCTTCTCGCAGAGTATGCAC 
42 lin-15B MA379 CATCGACGACTTTGTAAACTCT 
42 lin-15B MA380 GCTGTTCTTGATTCAGGATCGAAATA 
42 lin-15B MA381 GTGATTCCACCTACAAATGTAACGA 
42 lin-15B MA382 TGTGTAATTGACTTGCGGTTTAGA 
42 lin-15A MA403 CCACACGAGAGGGATCTCA 
42 lin-15A MA404 CCTTCTCGCAGAGTATGCAC 
43 C16C10.8 AGL337 AGGGGATAAAATCAACGAAAAAACAAA 
43 C16C10.8 AGL338 GAAATGTGCGGCGGTTAC 
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43 R10E4.2 AGL549 ATGTCACCTCCACCATTCG 
43 R10E4.2 AGL550 TAACTCGTTGGCTTCACAGAT 
43 R05D11.5 AGL557 GCTGCTGCTGCTGTAGAC 
43 R05D11.5 AGL558 CTCCCTCACTCATTCTCCTT 
43 rpl-26 MA486 CGTGCTATTCCAATCAGAACCG 
43 rpl-26 MA487 GCTTGGTGATAGCGACCTTCGA 
44 rpl-26 MA486 CGTGCTATTCCAATCAGAACCG 
44 rpl-26 MA487 GCTTGGTGATAGCGACCTTCGA 
44 Y37E3.8 MA551 GGAAAAGGACTCCTCCCAGA 
44 Y37E3.8 MA552 CCACCAAAACACAAGCTCCT 
44 rnp-7 MA557 CCGTAATGGTGGAGGAAATG 
44 rnp-7 MA558 CACCACCACTTCGATCATTG 
45 lin-15B MA379 CATCGACGACTTTGTAAACTCT 
45 lin-15B MA380 GCTGTTCTTGATTCAGGATCGAAATA 
45 lin-15B MA381 GTGATTCCACCTACAAATGTAACGA 
45 lin-15B MA382 TGTGTAATTGACTTGCGGTTTAGA 
45 lin-15A MA403 CCACACGAGAGGGATCTCA 
45 lin-15A MA404 CCTTCTCGCAGAGTATGCAC 
47 rsp-6 MA499 CCGTGCTCGTGTTGAACTT 
47 rsp-6 MA504 TCTCTGCTTCGGTCACGACT 
48 C12D12.1 MA543 ACAAACACACCACCTGCAAA 
48 C12D12.1 MA544 GGTGTAGTGACCACCGGAGT 
49 lin-15B MA379 CATCGACGACTTTGTAAACTCT 
49 lin-15B MA380 GCTGTTCTTGATTCAGGATCGAAATA 
49 lin-15B MA381 GTGATTCCACCTACAAATGTAACGA 
49 lin-15B MA382 TGTGTAATTGACTTGCGGTTTAGA 
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49 lin-15A MA403 CCACACGAGAGGGATCTCA 
49 lin-15A MA404 CCTTCTCGCAGAGTATGCAC 
51 SL2 1963,2246,2247,
2248 
GGTTTTAACCCAGTTACTCAAGA,GGTTTTA
ACCCAGTTACTCAAGC,GGTTTTAACCCAGT
TACTCAAGT,GGTTTTAACCCAGTTACTCAA
GG 
51 SL1 2146,2243,2244,
2245 
GGTTTAATTACCCAAGTTTGAGA,GGTTTAA
TTACCCAAGTTTGAGC,GGTTTAATTACCCA
AGTTTGAGT,GGTTTAATTACCCAAGTTTGA
GG 
51 lin-15A MA517 GCAGAGTATGCACGGAGTCA 
52 lin-15B MA355 CTGAAGTAATCTCTTTGAATGAAGTAG 
52 lin-15B MA506 CTTACATCAAACCCGGCATC 
53 SL2 1963,2246,2247,
2248 
GGTTTTAACCCAGTTACTCAAGA,GGTTTTA
ACCCAGTTACTCAAGC,GGTTTTAACCCAGT
TACTCAAGT,GGTTTTAACCCAGTTACTCAA
GG 
53 SL1 2146,2243,2244,
2245 
GGTTTAATTACCCAAGTTTGAGA,GGTTTAA
TTACCCAAGTTTGAGC,GGTTTAATTACCCA
AGTTTGAGT,GGTTTAATTACCCAAGTTTGA
GG 
53 lin-15B MA355 CTGAAGTAATCTCTTTGAATGAAGTAG 
59 F41H10.1 MA484 GTGCAATAAAGAGCAAGATATTCCTG 
59 F41H10.1 MA485 AATTTGTTGTCGAACTTCCTTGAG 
59 nspa-8 MA523 CATCTACACTGCCGTCCTTGTTGCT 
59 nspa-8 MA524 ATCCTCGTTGGCGGCTTCAATGC 
62 F53A9.8 
(asymmetric 
radioactive 
PCR for probe) 
MA577 GATGTCCTTCATGGGAGTCG 
62 rpl-43 
(asymmetric 
radioactive 
MA607 CATCTTACGGAGGGAAGCAC 
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PCR for probe) 
63 compliment to 
adapter 
MA611 AGC GGG CTG GCA AGG CAA ATT  
63 Adapter MA616 /5Phos/rUrUrU GCC TTG CCA GCC CGC TCA 
G/3AmM/ 
63 nspa-8 MA624 ATGGCTTGGATTGGACTCAG 
63 F53A9.2 MA626 GGAGAGCACTGCGCTAAAAC 
63 rpl-39 MA628 CGCATGAAGACTGGAAACAC 
63 F53A9.2 MA653 TGGTATATTTAAATTTTCAGCGGTA 
 
 
 
 
 
 
 
 
 
